Vyhláška Ministerstva zdravotnictví, kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek
§ 1
Léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek náležejících do anatomicko terapeuticko chemických (dále jen „ATC“) skupin uvedených v příloze č. 2 zákona jsou uvedeny v příloze, která je součástí této vyhlášky.
§ 2
Tato vyhláška nabývá účinnosti dnem 1. dubna 1997.
Ministr:
PhDr. Stráský v. r.
Příloha k vyhlášce č. 57/1997 Sb.
Léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek
ODDÍL A
Léčivé přípravky plně hrazené ze zdravotního pojištění jsou v seznamu léčivých přípravků plně hrazených ze zdravotního pojištění a v přehledu jednotlivých léčivých látek s výší jejich úhrad (dále jen „seznam“) označeny jejich kódem a názvem s uvedením lékové formy a velikosti balení.
Výše úhrady jednotlivých léčivých látek v korunách za uvedené jednotkové množství těchto léčivých látek je stanovena v sedmém sloupci příslušných řádků seznamu.
V seznamu mají použité zkratky tento význam
- a) způsob podání (aplikace)
| inhal. | inhalační aplikační formy (spraye, prášky a roztoky k inhalaci) |
|---|---|
| intraderm. | aplikační cesta některých alergenů (nitrokožně) |
| lok. | lokální (zevní) aplikační formy |
| parent. | injekční aplikační formy (injekce, suché injekce, infúze) |
| p.o. | perorální aplikační formy (tablety, tobolky, dražé, potahované tablety) |
| p.rect. | rektální aplikační formy |
| PRICK test | k diagnostice |
| subkut. | aplikační cesta některých alergenů |
| sublng | perorální aplikační formy pod jazyk (apikace do dutiny ústní) |
| transd. | transdermální (kožní) aplikační formy (náplasti) |
| vag. | vaginální (poševní) aplikační formy |
- b) lékové formy
| LF | lékové formy |
|---|---|
| aer | aerosol |
| aer dos | aerosol s dávkovačem |
| cap | kapsle, tobolka |
| cap inh | kapsle inhalační (inhaleta) |
| cap ret | kapsle retardovaná |
| crm | krém |
| crm fett | krém mastný |
| crm vag | krém vaginální |
| drg | dražé |
| drg ret | dražé retardované |
| emp | náplast |
| enm | enema, klyzma |
| foa | pěna |
| gel | gel |
| gel oph | gel oční |
| gel vag | gel vaginální |
| glo | globule |
| glo vag | globule vaginální |
| gra | granulát |
| gtt | kapky k vnitřnímu použití |
| gtt oph | kapky oční |
| gít oph+nas | kapky oční a nosní |
| gtt oto | kapky ušní |
| inf | infúze |
| inf sic | lyophilisát pro infúze |
| inh | inhalát |
| inh sol | roztok k inhalaci |
| inj | injekce |
| inj sic | lyophilisát pro injekce |
| kit | kit, souprava |
| lac | lak |
| liq | roztok k zevnímu použití |
| lot | emulze |
| ole | olej |
| pla | náplast |
| plv | prášek (nikoliv zásyp) |
| plv ads | zásyp (pulvis adspersorius) |
| plv por | prášek k perorální aplikaci |
| PRICK sol | roztok diagnostického alergenu |
| pst | pasta |
| sir | sirup |
| sol | roztok k vnitřnímu použití |
| sol nas | roztok nasální |
| sph | šampon |
| spn | houba |
| spr | spray |
| spr nas | spray nasální |
| sup | čípek |
| sus | suspenze |
| sus oph | suspenze oční |
| tab | tableta |
| tab eff | tableta effervescentní |
| tab ent | tableta acidorezistentní obdukovaná |
| tab fc | tableta potahovaná |
| tab obd | tableta obdukovaná (potahovaná) |
| tab ret | tableta retardovaná |
| tab vag | tableta vaginální |
| tct | tinktura |
| ung | mast |
| ung oph | mast oční |
- c) jednotky množství dávek léčivých látek (popř. mezinárodní jednotky)
| amp | ampule |
|---|---|
| BA | jedno originální balení |
| C2 | centimetr čtvereční |
| DF | jedna dávka lékové formy |
| Fl | mezinárodní jednotka |
| GM | gram |
| g | gram |
| U | mezinárodní jednotka |
| KU | tisíc U |
| kU | tisíc U |
| MU | milion U |
| MG | miligram |
| mg | miligram |
| ML | mililitr |
| ml | mililitr |
| ks | kus |
| RG | mikrogram |
Léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek
ODDÍL B
| 1 | A01AA | léčiva k profylaxi zubního kazu (fluorid sodný) | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.1 | MG | 0,90 | |
| 00211 | NATRIUM FLUORATUM SLOVAKOFARMA | tbl 250x0.55mg | SLO | SK | |||
| 2 | A01AB | protiinfekční léčiva pro lokální aplikaci | lok. | H | |||
| 2.1 | A01AB08 | neomycin | lok. | 5 | GM | 623,90 | H |
| 2.2 | A01AB10 | natamycin | lok. | 20 | MG | 8,80 | |
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | L/DER,STO, ORL | |||
| 3.1 | A01AC01 | triamcinolon | lok. | 1 | GM | 12,20 | L/DER,STO, ORL |
| 03613 | KENALOG IN ORABASE | pst 5gm 0.1% | BMS | GB | |||
| 3.2 | A01AC02 | dexametason | lok. | 1 | GM | 11,95 | L/DER,STO, ORL |
| 4 | A02A | adsorbční antacida | p.o. | ||||
| 4.1 | A02AD | kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10 | DF | 5,20 | |
| 00156 | GASTROGEL SLOVAKOFARMA | tbl 50x500mg | SLO | SK | |||
| 4.2 | A02AD | kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50 | ML | 12,15 | |
| 94028 | ANACID COMPOSITUM | sus 10x(2x10ml) | GNO | CZ | |||
| 5 | A02BA | antiulceróza ze skupiny H2-antagonistů | p.o. | ||||
| 5.1 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 4,30 | |
| 5.2 | A02BA02 | ranitidin | p.o. | 0.30 | GM | 4,30 | |
| 68857 | APO-RANITIDINE | tbl obd 60x150mg | APT | CND | |||
| 96056 | RANISAN | tbl obd 30x150mg | PMP | CZ | |||
| 80541 | RANITIN 150 | tbl obd 100x150mg | TRT | IND | |||
| 80542 | RANITIN 300 | tbl obd 100x300mg | TRT | IND | |||
| 96283 | ULCOSAN | tbl obd 30 | GNO | CZ | |||
| 5.3 | A02BA03 | famotidin | p.o. | 40 | MG | 4,30 | |
| 5.4 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 4,30 | |
| 5.5 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 4,30 | |
| 5.6 | A02BA07 | ranitidin bismut citrat | p.o. | 0.8 | GM | 30,70 | |
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | parent. | H | |||
| 6.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 37,00 | H |
| 6.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 70,00 | H |
| 6.3 | A02BA03 | famotidin | parent. | 40 | MG | 70,00 | H |
| 7 | A02BB | antiulceróza ze skupiny prostaglandinů | p.o. | Z | |||
| 7.1 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 46,05 | Z |
| 97404 | CYTOTEC | tbl 50x200rg | SEA | GB | |||
| 8 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | p.o. | L/GIT,INT | |||
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 44,65 | L/GIT,INT |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 39,65 | L/GIT,INT |
| 53345 | GASEC-20 | cps 7x20mg | MHA | CH | |||
| 12507 | GASEC-20 | cps 14x20mg | MHA | CH | |||
| 53346 | GASEC-20 | cps 28x20mg | MHA | CH | |||
| 56500 | HELICID | cps 14x20mg | LEX | CZ | |||
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | MG | 39,65 | L/GIT,INT |
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | MG | 39,65 | L/GIT,INT |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | parent. | H | |||
| 9.1 | A02BC01 | omeprazol | parent. | 20 | MG | 195,95 | H |
| 10 | A02BX | ostatní léčiva peptického vředu | p.o. | ||||
| 10.1 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3 | DF | 22,80 | |
| 10.2 | A02BX02 | sukralfát | p.o. | 4 | GM | 11,40 | |
| 10.3 | A02BX03 | pirenzepin | p.o. | 0.1 | GM | 8,75 | |
| 93547 | GASTROZEM | tbl 20x25mg | ALK | MAC | |||
| 91602 | GASTROZEPIN | tbl 50(5x10)x25mg | SLO | SK | |||
| 10.4 | A02BX12 | bizmut subcitrát | p.o. | 0.48 | GM | 23,60 | |
| 11 | A02BX | ostatní léčiva peptického vředu | parent. | H | |||
| 11.1 | A02BX03 | pirenzepin | parent. | 20 | MG | 114,35 | H |
| 12 | A02DA | antiflatulencia a spasmolytika ATC skupiny A03A | p.o. | ||||
| 12.1 | A02DA01 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 11,15 | |
| 91846 | CEOLAT | tbl 20x80mg | KCH | D | |||
| 12.2 | A02DA01 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 21,00 | |
| 55950 | SAB SIMPLEX | sus 50x15ml(sacky) | PDA | D | |||
| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D | |||
| 93501 | SAB SIMPLEX | sus 4x30ml | PDA | D | |||
| 12.3 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 5,10 | |
| 12.4 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 5,10 | |
| 12.5 | A03AX58 | alverin | p.o. | 0.18 | GM | 5,10 | |
| 13 | A03AB | anticholinergika s kvarterní oniovou skupinou | p.o. | ||||
| 13.1 | A03AB03 | oxyfenon | p.o. | 25 | MG | 2,35 | |
| 00241 | OXYPHENON LECIVA | tbl 30x5mg(lahv.) | LEX | CZ | |||
| 13.2 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 5,10 | |
| 13.3 | A03AB11 | poldin | p.o. | 12 | MG | 2,35 | |
| 13.4 | A03AB20 | trospium chlorid | p.o. | 40 | MG | 5,10 | |
| 14 | A03AD | muskulotropní spasmolytika | p.o. | ||||
| 14.1 | A03AD01 | papaverin | p.o. | 0.1 | GM | 0,70 | |
| 14.2 | A03AD02 | drotaverin | p.o. | 0.1 | GM | 5,05 | |
| 02551 | NO-SPA | tbl 20x40mg | CHN | H | |||
| 15 | A03AD | muskulotropní spasmolytika | parent. | ||||
| 15.1 | A03AD01 | papaverin | parent. | 0.1 | GM | 16,90 | |
| 15.2 | A03AD02 | drotaverin | parent. | 0.1 | GM | 25,90 | |
| 02552 | NO-SPA | inj 5x2ml/40mg | CHN | H | |||
| 16 | A03BA | alkaloidy beladony s terciální aminovou skupinou | p.o. | ||||
| 16.1 | A03BA01 | atropin | p.o. | 1.5 | MG | 0,50 | |
| 000444 | ATROPIN SPOFA | tbl 20x0.5mg | LEX | CZ | |||
| 17 | A03BA | alkaloidy beladony s terciální aminovou skupinou | parent. | ||||
| 17.1 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 7,55 | |
| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK | |||
| 17.2 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.5 | MG | 14,65 | |
| 00392 | ATROPIN BIOTIKA 0.5MG | inj 10x1ml/0.5mg | HBS | SK | |||
| 18 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.o. | ||||
| 18.1 | A03BB01 | butylskopolamin | p.o. | 60 | MG | 14,95 | |
| 10154 | BUSCOLYSIN | drg 20x10mg | PMM | BG | |||
| 01317 | BUSCOPAN | drg 20x10mg | BOE | D | |||
| 19 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.rect. | ||||
| 19.1 | A03BB01 | butylskopolamin | p.rect. | 60 | MG | 15,00 | |
| 06045 | BUSCOPAN | sup 6x10mg | ZDR | YU | |||
| 20 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | parent. | ||||
| 20.1 | A03BB01 | butylskopolamin | parent. | 60 | MG | 39,60 | |
| 03712 | BUSCOLYSIN | inj | 10x1ml 20mg | PMM | BG | ||
| 98169 | BUSCOPAN | inj | 5x1ml/20mg | BOE | D | ||
| 21 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.o. | ||||
| 21.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2 | DF | 3,75 | |
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 3,75 | |
| 88708 | ALGIFEN | tbl 20 | LEX | CZ | |||
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 4,10 | |
| 91981 | ALGIFEN | gtt 1x10ml 500mg/ml | GNO | CZ | |||
| 22 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.rect. | ||||
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 10,15 | |
| 91517 | ALGIFEN | sup 5 | LEX | CZ | |||
| 23 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | parent. | ||||
| 23.1 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2 | DF | 46,40 | |
| 88709 | ALGIFEN | inj 5x5ml | HBS | SK | |||
| 24 | A03EA | Spasmolytika, psycholeptika, analgetika v kombinaci | p.rect. | ||||
| 24.1 | A03EA | antispasmodik, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 9,60 | |
| 91261 | SPASMOPAN | sup 5 | LEX | CZ | |||
| 25 | A03FA | prokinetika (cisaprid) | p.o. | L/GIT,INT,PDD,PSY | |||
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, do 5 mg v 1 tabletě včetně) | p.o. | 30 | MG | 43,00 | L/GIT,INT,PDD,PSY |
| 94898 | PREPULSID | tbl 30x5mg | JAN | B | |||
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg v 1 tabletě) | p.o. | 30 | MG | 39,95 | L/GIT,INT,PDD,PSY |
| 25.3 | A03FA02 | cisaprid (tekuté lékové formy) | p.o. | 30 | MG | 60,00 | L/GIT,INT,PDD,PSY |
| 93392 | PREPULSID | sus 1x200ml | JAN | B | |||
| 93393 | PREPULSID | sus 1x100ml | JAN | B | |||
| 26 | A03FA | prokinetika (ostatní) | p.o. | ||||
| 26.1 | A03FA01 | metoclopramid | p.o. | 30 | MG | 3,80 | |
| 03376 | CERUCAL | tbl 50x10mg | VAD | D | |||
| 26.2 | A03FA03 | domperidon | p.o. | 30 | MG | 3,80 | |
| 26.3 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 3,80 | |
| 27 | A03FA | prokinetika | p.rect. | ||||
| 27.1 | A03FA01 | metoclopramid | p.rect. | 30 | MG | 41,25 | |
| 09519 | PASPERTIN PRO INFANTIBUS | sup 5x10mg | KCH | D | |||
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 54,65 | |
| 27.3 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 41,25 | |
| 28 | A03FA | prokinetika | parent. | O | |||
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 17,85 | O |
| 91688 | PASPERTIN 10 | inj 5x10ml/50mg | KCH | D | |||
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,85 | O |
| 29 | A04AA | antiemetika ze skupiny serotoninových antagonistů | p.o. | X | |||
| 29.1 | A04AA01 | ondansetron (do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 1138,00 | X |
| 98171 | ZOFRAN | tbl 10x4mg | GLA | D | |||
| 29.2 | A04AA01 | ondansetron (nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 820,00 | X |
| 29.3 | A04AA02 | granisetron | p.o. | 2 | MG | 820,00 | X |
| 29.4 | A04AA03 | tropisetron | p.o. | 5 | MG | 740,00 | X |
| 30 | A04AA | antiemetika ze skupiny serotoninových antagonistů | parent. | X | |||
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 1584,00 | X |
| 98214 | ZOFRAN | inj 5x2ml/2mg/ml | GLA | D | |||
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 1440,00 | X |
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 961,75 | X |
| 30.4 | A04AA03 | tropisetron | parent. | 5 | MG | 850,00 | X |
| 31 | A04AD | různá antiemetika | p.o. | ||||
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 | MG | 2,85 | |
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,40 | |
| 00320 | THEADRYL | tbl 10x100mg | LEX | CZ | |||
| 32 | A04AD | různá antiemetika | p.rect. | ||||
| 32.1 | A04AD | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 | GM | 9,60 | |
| 00951 | THEADRYL | sup 10x50mg | LEX | CZ | |||
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | p.o. | L/GIT,INF | |||
| 33.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1 | GM | 21,95 | L/GIT,INF |
| 85721 | CHENOFALK | cps 100x250mg | FAK | D | |||
| 94865 | CHENOSAN | cps 50x250mg | PMP | CZ | |||
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 31,30 | L/GIT,INF |
| 34 | A05AX | ostatní hepatika | p.o. | ||||
| 34.1 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3 | DF | 1,60 | |
| 34.2 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,65 | |
| 93157 | ISOCHOL (DRAZOVKA) | drg 30x400mg | LEX | CZ | |||
| 97881 | ISOCHOL (BLISTR 3X10) | drg 30x400mg | LEX | CZ | |||
| 35 | A05BA | léčiva onemocnění jater | p.o. | ||||
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4 | DF | 13,95 | |
| 35.2 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 6,60 | |
| 35.3 | A05BA03 | silymarin | p.o. | 0.21 | GM | 6,60 | |
| 04368 | FLAVOBION | tbl obd 50x70mg | LEX | CZ | |||
| 36 | A05BA | léčiva onemocnění jater | parent. | H | |||
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 46,50 | H |
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2093,60 | H |
| 37 | A06A | osmoticky působící nevstřebatelné cukry | p.o., p.rect. | L/GIT,INT,GER | |||
| 37.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4 | DF | 308,80 | L/GIT,INT,GER, CHI |
| 37.2 | A06AD11 | laktulóza | p.o. | 6.7 | GM | 5,40 | L/GIT,INT,GER, PDD |
| 62563 | DUPHALAC | sir 1x200ml | SDU | NL | |||
| 62564 | DUPHALAC | sir 1x300ml | SDU | NL | |||
| 62565 | DUPHALAC | sir 1x500ml | SDU | NL | |||
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 5,75 | L/GIT,INT,GER |
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 | DF | 180,00 | L/GIT,INT,GER, CHI |
| 38 | A07AA | střevní antimykotická léčiva | p.o. | ||||
| 38.1 | A07AA02 | nystatin | p.o. | 1.5 | MU | 6,10 | |
| 01067 | FUNGICIDIN LECIVA | drg 20x500ku | LEX | CZ | |||
| 38.2 | A07AA03 | natamycin | p.o. | 0.3 | GM | 6,10 | |
| 39 | A07EA | kortikosteroidy pro rektální aplikaci | p.rect. | ||||
| 39.1 | A07EA03 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 18,00 | |
| 84000 | RECTODELT | sup 6x5mg | TRM | D | |||
| 84001 | RECTODELT | sup 6x10mg | TRM | D | |||
| 39.1 | A07EA03 | prednison (nad 30mg) | p.rect. | 10 | MG | 4,90 | |
| 84003 | RECTODELT | sup 6x100mg | TRM | D | |||
| 39.3 | A07EA03 | prednison (od 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,65 | |
| 84002 | RECTODELT | sup 6x30mg | TRM | D | |||
| 39.4 | A07EA06 | budesonid | p.rect. | 2 | MG | 278,20 | L/GIT,INT |
| 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | L/GIT,INT | |||
| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 18,40 | L/GIT,INT,REV |
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 29,60 | L/GIT,INT |
| 76479 | ASACOL | tbl obd 100x400mg | TLT | CH | |||
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 50,00 | L/GIT,INT |
| 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | L/GIT,INT | |||
| 41.1 | A07EC02 | mesalazin | p.rect. | 1.5 | GM | 131,00 | L/GIT,INT |
| 76700 | ASACOL 4GM | enm 1x100ml/4gm | TLT | CH | |||
| 83135 | PENTASA | sup 28x1gm | FEI | DK | |||
| 93238 | SALOFALK 250 | sup 10x250mg | FAK | D | |||
| 93770 | SALOFALK KLYSMEN | enm 7x60gm | FAK | D | |||
| 42 | A07FA | protiprůjmové mikroorganismy | p.o. | L/PDD,GIT,GER | |||
| 42.1 | A07FA | protiprůjmové mikroorganismy | p.o. | 2 | ML | 3,95 | L/PDD,GIT,GER |
| 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D | |||
| 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D | |||
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou | p.o. | 4 | DF | 3,95 | L/PDD,GIT,GER |
| 43 | A09AA | enzymové přípravky | p.o. |
Léčbu Wobenzymem indikuje onkolog, chirurg nebo lymfolog u lymfedému po radikálních operacích pro malignitu.
| 43.1 | A09AA | enzymové přípravky (s pankreatinem, dle lipázy) | p.o. | 5000 | FI | 1,05 | |
|---|---|---|---|---|---|---|---|
| 98046 | PANKREON COMPOSITUM | drg 20 | KCH | D | |||
| 43.2 | A09AA | multienzymy (Wobenzym) | p.o. | 6 | DF | 19,00 | P |
| 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 FI v 1 tabletě včetně) | p.o. | 5000 | FI | 2,30 | |
| 04316 | KREON | cps 20 | KCH | D | |||
| 02420 | PANCREOLAN FORTE | tbl ent 30x220mg | LEX | CZ | |||
| 43.4 | A09AA02 | multienzymy (dle lipázy, nad 10.000 FI v 1 tabletě) | p.o. | 5000 | FI | 2,10 | |
| 68989 | KREON 25000 | cps 50 | KCH | D | |||
| 67418 | PANCREASE HL | cps 100 | CIL | CH | |||
| 21362 | PANGROL 400 | tbl obd 48 | BCE | D | |||
| 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | ||||
| 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,85 | |
| 00007 | ACIPEPSOL | tbl 20x400mg | LEX | CZ | |||
| 45 | A10A | insuliny (rozpustné humánní) | parent. | L/DIA | |||
| 45.1 | A10AA | insuliny (rozpustné humánní, 100 U/ml, cartridge) | parent. | 40 | U | 28,60 | L/DIA |
| 45.2 | A10AA | insuliny (rozpustné humánní, 40 U/ml) | parent. | 40 | U | 25,40 | L/DIA |
| 97520 | HUMULIN R | inj 1x10ml/400ut | LIL | F | |||
| 99192 | HUMULIN R | inj 1x10ml/400ut | LIL | D | |||
| 45.3 | A10AA | insuliny (rozpustné lisylinsuliny) | parent. | 40 | U | 33,80 | L/DIA |
| 89133 | HUMALOG 40 IU | inj 1x10ml/400ut | LIL | F | |||
| 89134 | HUMALOG 100 IU | inj 1x10ml/1ku | LIL | F | |||
| 45.4 | A10AA | insuliny (rozpustné lisylinsuliny, 100 U/ml, cartridge) | parent. | 40 | U | 36,40 | L/DIA |
| 46 | A10A | insuliny (rozpustné monokomponentní) | parent. | ||||
| 46.1 | A10AA | insuliny (rozpustné monokomponentní) | parent. | 40 | U | 13,50 | |
| 83725 | INSULIN-MONO N | inj 1x10ml/400ut | LEX | CZ | |||
| 03992 | PUR-INSULIN-NEUTRAL LECIVA | inj 1x10ml/400ut | LEX | CZ | |||
| 47 | A10A | insuliny (suspenzní humánní) | parent. | L/DIA | |||
| 47.1 | A10AA | insuliny (suspenzní humánní, 100 U/ml, cartridge) | parent. | 40 | U | 28,60 | L/DIA |
| 47.2 | A10AA | insuliny (suspenzní humánní, 40 U/ml) | parent. | 40 | U | 25,40 | L/DIA |
| 42468 | HUMULIN L | inj 1x10ml 40ut/ml | LIL | F | |||
| 99313 | HUMULIN L | inj 1x10ml 40ut/ml | LIL | D | |||
| 78282 | HUMULIN M1(10/90) | inj 1x10ml | LIL | F | |||
| 99196 | HUMULIN M1(10/90) | inj 1x10ml | LIL | D | |||
| 78283 | HUMULIN M2(20/80) | inj 1x10ml | LIL | F | |||
| 99195 | HUMULIN M2(20/80) | inj 1x10ml | LIL | D | |||
| 78284 | HUMULIN M3(30/70) | inj 1x10ml | LIL | F | |||
| 99187 | HUMULIN M3(30/70) | inj 1x10ml | LIL | D | |||
| 78285 | HUMULIN M4(40/60) | inj 1x10ml | LIL | F | |||
| 99206 | HUMULIN M4(40/60) | inj 1x10ml | LIL | D | |||
| 97521 | HUMULIN N | inj 1x10ml/400ut | LIL | F | |||
| 99628 | HUMULIN N | inj 1x10ml/400ut | LIL | D | |||
| 78281 | HUMULIN U | inj 1x10ml 40ut/ml | LIL | F | |||
| 99189 | HUMULIN U | inj 1x10ml 40ut/ml | LIL | D | |||
| 48 | A10A | insuliny (suspenzní monokomponentní) | parent. | ||||
| 48.1 | A10AA | insuliny (suspenzní monokomponentní) | parent. | 40 | U | 10,70 | |
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ | |||
| 83727 | INSULIN-MONO ID | inj 1x10ml/400ut | LEX | CZ | |||
| 83728 | INSULIN-MONO SD | inj 1x10ml/400ut | LEX | CZ | |||
| 03990 | PUR-INSULIN-DEP LECIVA | inj 1x10ml/400ut | LEX | CZ | |||
| 03991 | PUR-INSULIN-INTERDEP LECIVA | inj 1x10ml/400ut | LEX | CZ | |||
| 04128 | PUR-INSULIN-SUPERDEP LECIVA | inj 1x10ml/400ut | LEX | CZ | |||
| 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | ||||
| 49.1 | A10BA02 | metformin | p.o. | 2 | GM | 10,50 | |
| 56503 | SIOFOR 500 | tbl obd 60x500mg | BCE | D | |||
| 56504 | SIOFOR 850 | tbl obd 60x850mg | BCE | D | |||
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,80 | |
| 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,50 | |
| 50 | A10BB | léčiva snižující hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | ||||
| 50.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,25 | |
| 91881 | MANINIL 1 | tbl 120x1mg | BCE | D | |||
| 50.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10 | MG | 0,95 | |
| 91783 | BETANASE | tbl 10x10x5mg | CAD | IND | |||
| 30132 | GILEMAL | tbl 28x5mg | CHN | H | |||
| 94556 | GILEMAL | tbl 120x5mg | CHN | H | |||
| 91880 | MANINIL 5 | tbl 120x5mg | BCE | D | |||
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 1,55 | |
| 94523 | GLUCOBENE | tbl 120x1.75mg | MCK | D | |||
| 56966 | MANINIL 1.75 | tbl 120x1.75mg-blis | BCE | D | |||
| 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,90 | |
| 96870 | GLI-BASAN | tbl 120x3.5mg | SGW | D | |||
| 94525 | GLUCOBENE | tbl 120x3.5mg | MCK | D | |||
| 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,80 | |
| 50.6 | A10BB03 | tolbutamid | p.o. | 1.5 | GM | 2,55 | |
| 50.7 | A10BB04 | glibornurid | p.o. | 38 | MG | 4,90 | |
| 50.8 | A10BB05 | tolazamid | p.o. | 1 | GM | 2,55 | |
| 50.9 | A10BB07 | glipizid | p.o. | 10 | MG | 4,90 | |
| 50.10 | A10BB08 | gliquidon | p.o. | 60 | MG | 5,95 | |
| 50.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 8,50 | |
| 50.12 | A10BB12 | glymepirid | p.o. | 2 | MG | 6,40 | |
| 51 | A11CA | vitamin A a jeho deriváty | p.o. | ||||
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | kU | 1,05 | |
| 00347 | VITAMIN A SLOVAKOFARMA | cps 50x30ku | SLO | SK | |||
| 52 | A11CA | vitamin A a jeho deriváty | parent. | ||||
| 52.1 | A11CA01 | retinol (vitamin A) | parent. | 50 | KU | 11,25 | |
| 00396 | AXEROPHTHOL BIOTIKA | inj 5x1ml/50ku | BTA | SK | |||
| 53 | A11CC | vitamin D a jeho deriváty (kalcitriol) | p.o. | P |
Léčbu ordinuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce:
- a) léčba renální osteodystrofie u nemocných s chronickou renální insuficiencií (především u dialyzovaných nemocných),
- b) léčba křivice rezistentní na vitamin D,
- c) léčba osteomalacie rezistentní na vitamin D,
- d) léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem.
| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 61,35 | P |
|---|---|---|---|---|---|---|---|
| 91548 | ROCALTROL | cps 30x0.25rg | HLR | CH | |||
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | ||||
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | kU | 10,75 | |
| 00679 | INFADIN RYBI TUK | sol 100ml 0.1mg/1ml | SLO | SK | |||
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | kU | 0,70 | |
| 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK | |||
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | kU | 0,35 | |
| 00353 | VITAMIN D SLOVAKOFARMA | cps 1x300ku | SLO | SK | |||
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 19,40 | |
| 54.5 | A11CC03 | alfacalciferol | p.o. | 1 | MG | 0,70 | |
| 54.6 | A11CC05 | cholecalciferol | p.o. | 0.5 | MG | 0,70 | |
| 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | P |
Léčbu ordinuje internista, endokrinolog, urolog, pediatr nebo lékař pracující na dialyzační jednotce: léčba těžkých forem renální osteopatie nereagující na perorální léčbu kalcitriolem.
| 55.1 | A11CC04 | kalcitriol | parent. | 1 | RG | 170,45 | P |
|---|---|---|---|---|---|---|---|
| 76423 | CALCIJEX | inj 25x1ml/2rg | ABB | USA | |||
| 94426 | CALCIJEX | inj 25x1ml/1rg | ABB | USA | |||
| 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | ||||
| 56.1 | A11CC01 | ergokalciferol | parent. | 6 | kU | 0,80 | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK | |||
| 57 | A11DA | vitamin B1 a jeho deriváty | parent. | H | |||
| 57.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75 | MG | 6,10 | H |
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 6,10 | H |
| 58 | A11GA | vitamin C | parent. | H | |||
| 58.1 | A11GA01 | kyselina askorbová (vitamín C) | parent. | 0.2 | GM | 3,80 | H |
| 59 | A11HA | vitamin B2, B6 a E | parent. | H | |||
| 59.1 | A11HA02 | pyridoxin (vitamín B6) | parent. | 0.16 | GM | 16,20 | H |
| 59.2 | A11HA03 | tokoferol (vitamín E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 72,95 | H |
| 59.3 | A11HA03 | tokoferol (vitamín E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,75 | H |
| 59.4 | A11HA04 | riboflavin (vitamín B2) | parent. | 20 | MG | 6,25 | H |
| 60 | A11JA | kombinace vitamínů | parent. | H | |||
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 126,90 | H |
| 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | ||||
| 61.1 | A12AA | vápník (na obsah vápníku) | p.o. | 0.5 | GM | 3,15 | |
| 61.2 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 3,15 | |
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 3,15 | |
| 62322 | MAXI-KALZ 500 | tbl eff 20x500mg | ASD | A | |||
| 62323 | MAXI-KALZ 1000 | tbl eff 10x1000mg | ASD | A | |||
| 88663 | TBL.CALCII CARBONICI 0.5 GLO | tbl 100 | GAO | CZ | |||
| 61.4 | A12AA07 | chlorid vápenatý (tekuté lékové formy, na obsah vápníku) | p.o. | 0.2 | GM | 0,55 | |
| 61.5 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.5 | GM | 3,15 | |
| 61.6 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 7,25 | L/INT,GYN,ORT, REV |
| 61.7 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,85 | L/INT,GYN,ORT, REV |
| 62 | A12AA | soli vápníku | parent. | ||||
| 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 62,05 | |
| 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK | |||
| 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 2,75 | |
| 63 | A12BA | soli draslíku | p.o. | ||||
| 63.1 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1 | GM | 20,90 | |
| 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,50 | |
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,50 | |
| 91600 | KALNORMIN | tbl 30x1gm | IDA | H | |||
| 64 | A12BA | soli draslíku | parent. | O | |||
| 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,50 | O |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 51,70 | O |
| 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ | |||
| 65 | A12CC | soli hořčíku | p.o. | L/INT,NEU,PSY | |||
| 65.1 | A12CC | hořčík (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 99891 | MAGNESIUM 250MG PHARMAVIT | tbl eff 20 | PVI | H | |||
| 65.2 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 65.3 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 65.4 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 65.5 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 65.6 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 65.7 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY |
| 66 | A12CC | soli hořčíku | parent. | O | |||
| 66.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1 | GM | 20,70 | O |
| 00498 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 10% | HBS | SK | |||
| 66.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1 | GM | 9,30 | O |
| 00499 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 20% | HBS | SK | |||
| 67 | A12CD | soli fluoru | p.o. | ||||
| 67.1 | A12CD01 | fluorid sodný | p.o. | 88 | MG | 3,95 | |
| 09495 | OSSIN RETARDDRAGEES | tbl obd 100x40mg | GRU | D | |||
| 68 | A14A | anabolické steroidy | parent. | ||||
| 68.1 | A14AB01 | nandrolon | parent. | 2 | MG | 1,80 | |
| 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ | |||
| 69 | A16A | ostatní léčiva alimentárního traktu | parent. | O | |||
| 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 365,00 | O |
| 69.2 | A16AX01 | tioktová kyselina | parent. | 0.2 | GM | 103,65 | O |
| 86092 | THIOCTACID 600 T | inj 5x24ml/600mg | ASD | D | |||
| 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | ||||
| 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 3,55 | |
| 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 5,25 | |
| 00256 | PELENTANETTAE | tbl obd 100x75mg | LEX | CZ | |||
| 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 6,20 | |
| 00254 | PELENTAN | tbl 10x300mg | LEX | CZ | |||
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | U | |||
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 28560,00 | U |
| 94228 | ANTITHROMBIN III GRIFOLS | inj sic 500ut+10ml | GFO | E | |||
| 94229 | ANTITHROMBIN III GRIFOLS | inj sic 1000ut+20ml | GFO | E | |||
| 66533 | KYBERNIN P | inj 1x500ut+10ml aq | BEH | A | |||
| 85771 | KYBERNIN P | inj 1x500ut+10ml aq | BEH | D | |||
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | BEH | A | |||
| 85772 | KYBERNIN P | inj 1x1ku+20ml aqua | BEH | D | |||
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 28560,00 | U |
| 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | O | |||
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,70 | O |
| 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A | |||
| 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ | |||
| 00477 | HEPARIN RETARD LECIVA | inj 5x1ml/25ku | LEX | CZ | |||
| 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | O | |||
| 73.1 | B01AB04 | dalteparin | parent. | 3 | KU | 81,10 | O |
| 73.2 | B01AB05 | enoxaparin | parent. | 3 | KU | 81,10 | O |
| 73.3 | B01AB06 | nadroparin | parent. | 3 | KU | 81,10 | O |
| 96988 | FRAXIPARINE | inj 10x1ml/25ku | CHO | F | |||
| 73.4 | B01AB07 | parnaparin | parent. | 3 | KU | 81,10 | O |
| 73.5 | B01AB11 | sulodexid | parent. | 600 | U | 81,10 | O |
| 73.6 | B01AB11 | sulodexid | p.o. | 250 | U | 13,80 | L/OPH,INT,NEU, DIA |
| 73.7 | B01AB08 | reviparin | parent. | 3 | KU | 81,10 | O |
| 74 | B01AC | antiagregancia trombocytů | p.o. |
Léčbu tiklopidinem ordinuje internista, kardiolog nebo neurolog:
- a) alergie a prokazatelná intolerance kyseliny acetylsalicylové,
- b) necitlivost na kyselinu acetylsalicylovou zjištěná agregačním vyšetřením v hemokoagulační laboratoři,
- c) podání pacientům po interavaskulárních intervencích (stenty, PTCA, rotablace, atherektomie, laserové atheroplastiky a pod.), podání obvykle v kombinaci s kyselinou acetylsalicylovou po dobu časově omezenou (obvykle jeden měsíc po výkonu).
Léčbu indobufenem ordinuje internista, kardiolog nebo neurolog:
- a) alergie a prokazatelná intolerance kyseliny acetylsalicylové,
- b) nutno pouze krátkodobého antiagregačního účinku (např. před chirurgickým výkonem).
| 74.1 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 55,00 | P |
|---|---|---|---|---|---|---|---|
| 74.2 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,50 | |
| 72813 | ANOPYRIN | 30MG | tbl 20x30mg | SLO | SK | ||
| 72812 | ANOPYRIN | 30MG | tbl 50x30mg | SLO | SK | ||
| 74.3 | B01AC06 | kyselina acetylsalicylová (od 0,1 do 0,5 g v jedné tabletě včetně) | p.o. | 1 | DF | 1,00 | |
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,60 | |
| 99295 | ANOPYRIN | 100MG | tbl 20x100mg | SLO | SK | ||
| 71960 | ANOPYRIN | 100MG | tbl 50x100mg | SLO | SK | ||
| 74.5 | B01AC10 | indobufen | p.o. | 0.3 | GM | 15,00 | P |
| 75 | B01AC | antiagregancia trombocytů | parent. | H | |||
| 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 229,60 | H |
| 75.2 | B01AC10 | indobufen | parent. | 0.3 | GM | 91,40 | H |
| 75.3 | B01AC13 | abciximab | parent. | 1 | DF | 14779,25 | H |
| 76 | B01AD | trombolytika | parent. | U |
Alteplasa a urokináza na všech pracovištích:
- a) léčba akutního infarktu myokardu, kteří byli v posledních 12 měsících léčeni streptokinázou, nebo mají v anamnéze alergickou reakci na streptokinázu.
Na pracovištích, která mají specializovaný léčebný postup ve smlouvě se zdravotní pojišťovnou:
- a) intrakoronární trombolýza,
- b) trombolýza akutních a subakutních uzávěrů periferních cév.
| 76.1 | B01AD01 | streptokináza | parent. | 1.5 | MU | 3691,20 | U |
|---|---|---|---|---|---|---|---|
| 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S | |||
| 76.2 | B01AD02 | alteplaza | parent. | 0.1 | GM | 48234,50 | U |
| 76.3 | B01AD04 | urokináza (do 100 kU v jedné dávce včetně) | parent. | 3 | MU | 76267,30 | U |
| 76.4 | B01AD04 | urokináza (nad 500 kU v jedné dávce) | parent. | 3 | MU | 43542,15 | U |
| 76.5 | B01AD04 | urokináza (od 100 do 500 kU v jedné dávce) | parent. | 3 | MU | 46386,55 | U |
| 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. | ||||
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 39,75 | |
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 41,65 | |
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 39,40 | |
| 97410 | EXACYL | tbl fc 20x500mg | SFH | F | |||
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 20,75 | |
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | ||||
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 66,50 | |
| 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 65,20 | |
| 97411 | EXACYL I.V. | inj 5x5ml/500mg | SFH | F | |||
| 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 202,00 | |
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H | |||
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 683,50 | H |
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | ||||
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 9,65 | |
| 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK | |||
| 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 30,00 | L/OPH,HEM |
| 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. | ||||
| 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,60 | |
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,10 | |
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK | |||
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 89,70 | O/OPH,HEM |
| 82 | B02BB | lidský fibrinogen | parent. | U | |||
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5922,00 | U |
| 52772 | FIBRINOGEN IMMUNO I.V. 1000MG | inj sic 1000mg+50ml | IMM | A | |||
| 83 | B02BC | lokální hemostatika | lok. | ||||
| 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 5,65 | |
| 88753 | SPOFAX (CIPKY HEMOSTAT.KON.) | sup 5x2.2gm | LEX | CZ | |||
| 83.2 | B02BC | lokální hemostatika (pěna) | lok. | 1 | C2 | 3,15 | |
| 94888 | HYPRO-SORB (60X100X3.5MM) | ext 1 ks | HVV | CZ | |||
| 97230 | HYPRO-SORB O (TVAR TROJUHELN.) | ext 20ks | HVV | CZ | |||
| 83.3 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 3,15 | |
| 02198 | GELASPON | spn 1ks(8.5x4x1cm) | ANW | D | |||
| 83113 | SPONGOSTAN STANDARD | spn 20ks 70x50x10mm | FER | DK | |||
| 83114 | SPONGOSTAN SPECIAL | spn 20ks 70x50x1mm | FER | DK | |||
| 83115 | SPONGOSTAN FILM (200X70X0.5MM) | spn 20ks | FER | DK | |||
| 83.4 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 58,10 | |
| 83.5 | B02BC | lokální hemostatin (zásip) | lok. | 1 | GM | 3,15 | |
| 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B |
Léčbu koagulačním faktorem VIII ordinuje hematolog:
- a) prevence a léčba krvácivých stavů u nemocných s vrozeným či získaným nedostatkem faktoru VIII,
- b) u nemocných s výskytem inhibitoru proti fakotru VIII v nízkém titru (do 5 Bethesda jednotek),
- c) vepřový faktor VIII je indikován u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem protilátek proti vepřovému faktoru VIII.
Léčbu koagulačním faktorem IX ordinuje hematolog:
prevence a léčba krvácivých stavů u nemocných s prokázaným deficitem faktoru IX. eventuálně u nemocných s přítomností inhibitoru faktoru VIII.
| 84.1 | B02BD02 | koagulační faktor VIII (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 5200,00 | B |
|---|---|---|---|---|---|---|---|
| 84.2 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500 | U | 5200,00 | B |
| 88800 | PORCINE FACTOR VIII:C(HYATE:C) | inj 20ml/400-700ut | SPY | GB | |||
| 84.3 | B02BD04 | koagulační faktor IX (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 3360,00 | B |
| 84.4 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350 | U | 3360,00 | B |
| 83781 | FAKTOR IX P BEHRING 300UT | inj sic 300ut+10ml | BEH | A | |||
| 83782 | FAKTOR IX P BEHRING 600UT | inj sic 600ut+20ml | BEH | A | |||
| 83783 | FAKTOR IX P BEHRING 1200UT | inj sic 1.2ku+30ml | BEH | A | |||
| 84.5 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350 | U | 3360,00 | B |
| 94227 | HEMOFACTOR HT | inj sic 1x500ut+sol | GFO | E | |||
| 84.6 | B02BD02 | koagulační faktor VIII (vysoce čištěný z tuzemské plazmy zakázkovou frakcionací) | parent. | 5000 | U | 6250,00 | B |
| 89027 | IMMUNATE STIM PLUS 250 | inj sic 1x250ut+sol | IMM | A | |||
| 89028 | IMMUNATE STIM PLUS 500 | inj sic 1x500ut+sol | IMM | A | |||
| 89029 | IMMUNATE STIM PLUS 1000 | inj sic 1x1ku+solv. | IMM | A | |||
| 84.7 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500 | U | 6250,00 | B |
| 84.8 | B02BD04 | koagulační faktor IX (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 4270,00 | B |
| 84.9 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350 | U | 4270,00 | B |
| 85 | B02BD | koagulační faktory (ostatní koagulační faktory) | parent. | X | |||
| 85.1 | B02BD | srážecí faktory | parent. | 350 | U | 3110,40 | X |
| 85667 | FIBROGAMMIN P | inj 1x250ut+1x4ml | BEH | D | |||
| 85668 | FIBROGAMMIN P | inj 1x1.25ku+1x20ml | BEH | D | |||
| 85.2 | B02BD02 | koagulační faktor VIII středně čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 9534,35 | X |
| 85.3 | B02BD03 | aktivita obcházející inhibitor faktoru VIII | parent. | 10 | KU | 339500,00 | X |
| 85.4 | B02BD05 | koagulační faktor VII | parent. | 6 | KU | 90000,00 | X |
| 85.5 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | kU | 1543,25 | X |
| 89825 | NOVOSEVEN 1.2MG(=60KU) | inj sic 1x1.2mg+sol | NOO | DK | |||
| 89826 | NOVOSEVEN 2.4MG(=120KU) | inj sic 1x2.4mg+sol | NOO | DK | |||
| 92641 | NOVOSEVEN 4.8MG(=240KU) | inj sic 1x4.8mg+sol | NOO | DK | |||
| 85.6 | B02BD08 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 8750.00 | X |
| 86 | B03AA | soli dvojmocného železa | p.o. | ||||
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 2,80 | |
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 2,80 | |
| 00677 | FERRONAT | sus 1x100ml/3gm | GNO | CZ | |||
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,45 | |
| 86.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,45 | |
| 86.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,45 | |
| 86.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,85 | |
| 86.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,55 | |
| 86.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,45 | |
| 87 | B03AC | soli trojmocného železa | parent. | O | |||
| 87.1 | B03AC | železo trojmocné, parenterální přípravky | parent. | 0.1 | GM | 26,40 | O |
| 04084 | FERRUM | LEK I.M. | inj 50x2ml/100mg | LEK | SLO | ||
| 02788 | FERRUM | LEK I.V. | inj 50x5ml/100mg | LEK | SLO | ||
| 87.2 | B03AC02 | hydroxid železitý se sacharózou | parent. | 0.1 | GM | 27,75 | O |
| 87.3 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.1 | GM | 26,15 | O |
| 88 | B03AD | soli dvojmocného železa v kombinaci s kyselinou listovou | p.o. | L/GYN,HEM | |||
| 88.1 | B03AD | chlorid železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM |
| 88.2 | B03AD | glukonat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM |
| 97861 | LOSFERRON FOL BRAUSENTABLETTEN | tbl eff 30 | ASD | A | |||
| 88.3 | B03AD02 | fumarat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM |
| 88.4 | B03AD03 | síran železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM |
| 89 | B03AE | soli dvojmocného železa v ostatních kombinacích | p.o. | ||||
| 89.1 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.1 | GM | 5,45 | |
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 5,45 | |
| 89.3 | B03AE10 | chlorid železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,45 | |
| 89.4 | B03AE10 | fumarat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,45 | |
| 89.5 | B03AE10 | glukonat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,45 | |
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 2,80 | |
| 89.7 | B03AE10 | síran železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,35 | |
| 96043 | AKTIFERRIN COMPOSITUM | cps 100 | MCK | A | |||
| 89.8 | B03AE10 | síran železnatý/serin (pevné lékové formy) | p.o. | 0.1 | GM | 5,45 | |
| 94584 | AKTIFERRIN | cps 50 | MCK | D | |||
| 89.9 | B03AE10 | síran železnatý/serin (tekuté lékové formy) | p.o. | 0.1 | GM | 6,75 | |
| 99138 | AKTIFERRIN | gtt 1x30ml | MCK | D | |||
| 90 | B03BA | vitamin B12 a jeho deriváty | parent. | ||||
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,50 | |
| 00641 | VITAMIN B12 LECIVA 300RG | inj 5x1ml/300rg | LEX | CZ | |||
| 90.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | |
| 66997 | B12 ANKERMANN 1000RG | inj 1x5ml 1000rg/ml | WGP | D | |||
| 66998 | B12 ANKERMANN 1000RG | inj 5x5ml 1000rg/ml | WGP | D | |||
| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D | |||
| 09979 | VITAMIN B12 | inj 10x1ml/1mg | VJP | D | |||
| 23608 | VITAMIN B12 | inj 100x1ml/1mg | VJP | D | |||
| 66949 | VITAMIN B12 | inj 5x2ml/1000rg | POL | PL | |||
| 00643 | VITAMIN B12 LECIVA 1000RG | inj 5x1ml/1000rg | LEX | CZ | |||
| 97506 | VITAMIN B12-RATIOPHARM | inj 6x1ml/1000rg | MCK | D | |||
| 91 | B03BB | kyselina listová a její deriváty | p.o. | ||||
| 91.1 | B03BB01 | kyselina listová | p.o. | 10 | MG | 1,15 | |
| 76064 | ACIDUM FOLICUM LECIVA | drg 30x10mg | LEX | CZ | |||
| 92 | B03XA | ostatní protianemická léčiva | parent. | K/P |
Léčbu erythropoetinem ordinuje onkolog, hematolog, internista nebo pediatr:
- a) léčba klinicky významné anémie (s hladinou hemoglobinu nižší než 90 g/l, s vyššími hodnotami při manifestních příznacích anémie) u nemocných zařazených do dialyzačního programu, nemocných s chronickým renálním selháním, nemocných s nádorovým onemocněním po radikální cytostatické léčbě nebo ozáření,
- b) léčba anémie u nemocných s aplastickou anémií, erythroblastoftýzou, myelodysplastickým syndromem a anémií po transplantaci kostní dřeně,
- c) léčba těžké anémie nezralých dětí.
| 92.1 | B03XA01 | erythropoetin | parent. | 2 | KU | 1060,90 | K/P |
|---|---|---|---|---|---|---|---|
| 85528 | EPREX | inj 6x1ku/0.5ml+str | CIL | CH | |||
| 85529 | EPREX | inj 6x2ku/0.5ml+str | CIL | CH | |||
| 85530 | EPREX | inj 6x3ku/0.3ml+str | CIL | CH | |||
| 85531 | EPREX | inj 6x4ku/0.4ml+str | CIL | CH | |||
| 85532 | EPREX | inj 6x10ku/ml+str | CIL | CH | |||
| 93579 | EPREX | inj 6x2ku/ml | CIL | CH | |||
| 94345 | EPREX | inj 6x4ku/ml | CIL | CH | |||
| 94346 | EPREX | inj 6x10ku/ml | CIL | CH | |||
| 96354 | RECORMON | inj 10x1ku | BOM | A | |||
| 96355 | RECORMON | inj 10x2ku | BOM | A | |||
| 96356 | RECORMON | inj 5x5ku | BOM | A | |||
| 56526 | RECORMON S 1000IU | inj sic 10x1ku+solv | BOM | A | |||
| 56527 | RECORMON S 2000IU | inj sic 10x2ku+solv | BOM | A | |||
| 56528 | RECORMON S 5000IU | inj sic 10x5ku+solv | BOM | A | |||
| 56529 | RECORMON S 10000IU | inj sic 10x10ku+sol | BOM | A | |||
| 93 | B05AA | substituenty plazmy a plazmatické proteiny (albumin) | parent. | B | |||
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2880,30 | B |
| 75089 | ALBUMIN LIDSKY SP 5% SEVAC | inf 1x250ml | USO | CZ | |||
| 93787 | ALBUMIN LIDSKY SP 20% SEVAC | inf 1x100ml(nts) | USO | CZ | |||
| 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ | |||
| 20821 | HUMAN-ALBUMIN 20% BEHRING | inj 1x10ml 20% | BEH | D | |||
| 20816 | HUMAN-ALBUMIN 20% BEHRING | inf 1x50ml 20% | BEH | D | |||
| 20822 | HUMAN-ALBUMIN 20% BEHRING | inf 1x100ml 20% | BEH | D | |||
| 83789 | HUMAN-ALBUMIN 20% BEHRING | inj 1x10ml 20% | BEH | A | |||
| 83788 | HUMAN-ALBUMIN 20% BEHRING | inf 1x50ml 20% | BEH | A | |||
| 83790 | HUMAN-ALBUMIN 20% BEHRING | inf 1x100ml 20% | BEH | A | |||
| 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E | |||
| 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E | |||
| 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E | |||
| 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E | |||
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2880,30 | B |
| 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D | |||
| 20817 | HUMAN ALBUMIN 50 DESSAU | inf 1x20ml 5% | PDE | D | |||
| 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml 5% | PDE | D | |||
| 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml 5% | PDE | D | |||
| 20831 | HUMAN ALBUMIN 200 DESSAU | inf 1x10ml 20% | PDE | D | |||
| 20832 | HUMAN ALBUMIN 200 DESSAU | inf 1x50ml 20% | PDE | D | |||
| 20833 | HUMAN ALBUMIN 200 DESSAU | inf 1x100ml 20% | PDE | D | |||
| 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 974,00 | B |
| 94 | B05AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | O | |||
| 94.1 | B05AA05 | dextran (koncentrace 10%) | parent. | 500 | ML | 172,80 | O |
| 00589 | RHEODEXTRAN INFUSIA (SOL.PHYS.) | inf 1x500ml 10% | IHO | CZ | |||
| 00590 | RHEODEXTRAN INFUSIA 10% V GLUC. | inf 1x500ml | IHO | CZ | |||
| 94.2 | B05AA05 | dextran (koncentrace 6%) | parent. | 500 | ML | 101,20 | O |
| 00431 | DEXTRAN INFUSIA 6% V F1/1 | inf 1x500ml(sklo) | IHO | CZ | |||
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 115,20 | O |
| 96380 | TENSITON I.V.(KREVNI EXPANDER) | inf 1x500ml(lahev) | IHO | CZ | |||
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 266,70 | O |
| 94.5 | B05AA07 | hydroxyethylškrob | parent. | 500 | ML | 411,00 | O |
| 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | O | |||
| 95.1 | B05BA03 | glukóza 10% (od 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 13,00 | O |
| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml (sklo) | IMA | SK | |||
| 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x250ml (sklo) | IHO | CZ | |||
| 95.2 | B05BA03 | glukóza 10% (od 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,60 | O |
| 78248 | 10% GLUCOSE I.V. INFUSION BAXTER | inf 20x500ml (vak) | BXT | GB | |||
| 96877 | GLUCOSE 10 BRAUN (PLASCO LAHV.) | inf 1x500ml 10% | BME | D | |||
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 35,00 | O |
| 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml (sklo) | SFR | ||||
| 69747 | ARDEANUTRISOL G 10 | inf 1x80ml | ARD | CZ | |||
| 86524 | ARDEANUTRISOL G 10 | inf 40x80ml | ARD | CZ | |||
| 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml (sklo) | IMA | SK | |||
| 86346 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x100ml (sklo) | IHO | CZ | |||
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 5,15 | O |
| 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml(vak) | SFR | I | |||
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 30,40 | O |
| 97012 | DEXTROSE 20% IN WATER-INST.HUM. | inf 1x100ml | HUA | H | |||
| 55623 | INFUSIO GLUCOSI 20 IMUNA | inf 1x100ml (sklo) | IMA | SK | |||
| 95.6 | B05BA03 | glukóza 20% (více než 100 ml v jednom balení) | parent. | 100 | ML | 6,85 | O |
| 75194 | GLUCOSE-LOSUNG 20 SALVIA (PLAST) | inf 1x1000ml 20% | CLS | D | |||
| 95.7 | B05BA03 | glukóza 5% (od 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,45 | O |
| 96872 | GLUCOSE 5 BRAUN (PLASCO LAHV.) | inf 1x250ml 5% | BME | D | |||
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml (sklo) | IMA | SK | |||
| 95.8 | B05BA03 | glukóza 5% (od 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,95 | O |
| 75615 | 5% GLUCOSE I.V.BP | inf 1x500ml (vak) | BXT | GB | |||
| 69045 | DEXTROSE 5% IN WATER-HUMAN | inf 1x500ml (plast) | HUA | H | |||
| 97010 | DEXTROSE 5% IN WATER-HUMAN | inf 1x500ml (sklo) | HUA | H | |||
| 96873 | GLUCOSE 5 BRAUN (PLASCO LAHV.) | inf 1x500ml 5% | BME | D | |||
| 83695 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x500ml | CPL | IND | |||
| 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,10 | O |
| 75613 | 5% GLUCOSE I.V.BP | inf 1x100ml (vak) | BXT | GB | |||
| 96871 | GLUCOSE 5 BRAUN (SKLO LAHV.) | inf 1x100ml 5% | BME | D | |||
| 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 4,10 | O |
| 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml (vak) | SFR | I | |||
| 83696 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x1000ml | CPL | IND | |||
| 55620 | INFUSIO GLUCOSI 5 IMUNA | inf 1x3000ml (vak) | IMA | SK | |||
| 95.11 | B05BA03 | glukóza do 10% vč. (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 93,40 | O |
| 00465 | GLUCOSUM LECIVA 10% | inj 10x10ml 10% | LEX | CZ | |||
| 95.12 | B05BA03 | glukóza nad 10% (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 101,00 | O |
| 95.13 | B05BA03 | glukóza nad 20% (od 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,60 | O |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ | |||
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml (sklo) | IMA | SK | |||
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 32,40 | O |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml (sklo) | IMA | SK | |||
| 95.15 | B05BA03 | glukóza nad 20% (více než 250 ml v jednom balení) | parent. | 100 | ML | 8,45 | O |
| 75199 | GLUCOSE-LOSUNG 40 SALVIA (SKLO) | inf 1x1000ml 40% | CLS | D | |||
| 75206 | GLUCOSE-LOSUNG 40 SALVIA (PLAST) | inf 1x1000ml 40% | CLS | D | |||
| 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | H | |||
| 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 39,65 | H |
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 76,20 | H |
| 96.3 | B05BA01 | aminokyseliny (koncentrace od 10 do 14% včetně) | parent. | 100 | ML | 82,00 | H |
| 96.4 | B05BA01 | aminokyseliny (koncentrace od 6 do 10 % včetně) | parent. | 100 | ML | 49,50 | H |
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml) | parent. | 100 | ML | 220,80 | H |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml) | parent. | 100 | ML | 200,90 | H |
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml) | parent. | 100 | ML | 55,55 | H |
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml) | parent. | 100 | ML | 75,90 | H |
| 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,80 | H |
| 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 18,15 | H |
| 96.11 | B05BA03 | fruktóza (koncentrace od 5 do 10% včetně) | parent. | 100 | ML | 15,90 | H |
| 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 6,35 | H |
| 96.13 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100 | ML | 11,25 | H |
| 96.14 | B05BA03 | sorbitol (koncentrace od 5 do 10% včetně) | parent. | 100 | ML | 8,90 | H |
| 96.15 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100 | ML | 17,00 | H |
| 96.16 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100 | ML | 23,35 | H |
| 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,50 | H |
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 60,00 | H |
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | O | |||
| 97.1 | B05BB01 | chlorid sodný 0.9% (od 100 do 250 ml včetně) | parent. | 100 | ML | 11,80 | O |
| 97682 | 0.9% W/V SODIUM CHLORIDE I.V. | inf 1x250ml (pe) | BME | D | |||
| 62328 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x250ml (sklo) | IMA | SK | |||
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 23,50 | O |
| 96882 | 0.9% W/V SODIUM CHLORIDE I.V. | inf 1x100ml (sklo) | BME | D | |||
| 97.3 | B05BB01 | chlorid sodný 0.9% (více než 250 ml v balení) | parent. | 100 | ML | 3,90 | O |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml (vak) | IMA | SK | |||
| 83698 | SODIUM CHLORIDE I.V.B.P.CORE | inf 1x1000ml 0.9% | CPL | IND | |||
| 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | H | |||
| 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML | 10,85 | H |
| 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML | 8,25 | H |
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,45 | H |
| 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,55 | H |
| 99 | B05BC | roztoky k osmotické diuréze | parent. | H | |||
| 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml) | parent. | 100 | ML | 12,45 | H |
| 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml včetně) | parent. | 100 | ML | 19,90 | H |
| 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml) | parent. | 100 | ML | 14,95 | H |
| 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml včetně) | parent. | 100 | ML | 22,65 | H |
| 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 983,50 | H |
| 100 | B05C | roztoky k irigaci | lok. | H | |||
| 100.1 | B05CB01 | chlorid sodný | lok. | 1000 | ML | 38,15 | H |
| 100.2 | B05CX02 | sorbitol | lok. | 1000 | ML | 38,15 | H |
| 100.3 | B05CX03 | glycin | lok. | 1000 | ML | 54,75 | H |
| 100.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1000 | ML | 20,00 | H |
| 101 | B05D | roztoky k peritoneální dialýze | parent. | H | |||
| 101.1 | B05D | přípravky pro peritoneální dialýzu | parent. | 1000 | ML | 236,50 | H |
| 101.2 | B05DA | isotonické roztoky | parent. | 1000 | ML | 236,50 | H |
| 101.3 | B05DB | hypertonické roztoky | parent. | 1000 | ML | 236,50 | H |
| 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | O | |||
| 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 127,90 | O |
| 00524 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 6x20ml 4.2% | LEX | CZ | |||
| 03569 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 5x20ml 4.2% | LEX | CZ | |||
| 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 10,40 | O |
| 31352 | ALKALIGEN-INSTITUTE HUMAN | inf 1x400ml | HUA | H | |||
| 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | H | |||
| 103.1 | B05X | přídavky do i.v. roztoků | parent. | 100 | ML | 284,25 | H |
| 103.2 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 19,60 | H |
| 103.3 | B05XA03 | chlorid sodný (koncentrace 5,85% včetně) | parent. | 100 | ML | 24,75 | H |
| 103.4 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 25,75 | H |
| 103.5 | B05XA04 | chlorid amonný | parent. | 100 | ML | 11,95 | H |
| 103.6 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100 | ML | 53,55 | H |
| 103.7 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,85 | H |
| 103.8 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 130,80 | H |
| 103.9 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 28,30 | H |
| 103.10 | B05XC | vitaminy | parent. | 1 | DF | 47,60 | H |
| 103.11 | B05XX | ostatní i.v. roztoky | parent. | 100 | ML | 7,80 | H |
| 104 | B05Z | roztoky k hemodialýze a hemofiltraci | lok. | H | |||
| 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 170,00 | H |
| 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 128,60 | H |
| 105 | C01AA | kardioglykosidy z náprstníku | p.o. | ||||
| 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,05 | |
| 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,05 | |
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,05 | |
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | GNO | CZ | |||
| 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ | |||
| 83318 | DIGOXIN 0.125 LECIVA | tbl 30x0.125mg | LEX | CZ | |||
| 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,05 | |
| 106 | C01AA | kardioglykosidy z náprstníku | parent. | ||||
| 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 5,35 | |
| 00435 | DIGOXIN SPOFA | inj 10x2ml/0.5mg | SPX | CZ | |||
| 106.2 | C01AA08 | metildigoxin | parent. | 0.2 | MG | 4,95 | |
| 106.3 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 24,00 | |
| 107 | C01BA | antiarytmika, třída Ia | p.o. | ||||
| 107.1 | C01B | ipratropium | p.o. | 30 | MG | 55,00 | |
| 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 15,60 | |
| 107.3 | C01BA01 | chinidin | p.o. | 1.2 | GM | 20,20 | |
| 107.4 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,90 | |
| 02606 | KINIDIN DURULES | tbl ret 100x200mg | AST | S | |||
| 107.5 | C01BA02 | prokainamid | p.o. | 3 | GM | 39,50 | |
| 107.6 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,65 | |
| 107.7 | C01BA08 | prajmalin | p.o. | 30 | MG | 14,35 | |
| 108 | C01BA | antiarytmika, třída Ia | parent. | O | |||
| 108.1 | C01B | ipratropium | parent. | 3 | MG | 800,90 | O |
| 108.2 | C01BA02 | prokainamid | parent. | 3 | GM | 248,20 | O |
| 108.3 | C01BA03 | disopyramid | parent. | 0.4 | GM | 248,20 | O |
| 108.4 | C01BA05 | ajmalin | parent. | 0.3 | GM | 248,20 | O |
| 99356 | GILURYTMAL 10 I.V. | inj 5x10ml/50mg | GIU | D | |||
| 109 | C01BB | antiarytmika, třída Ib | p.o. | ||||
| 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 10,45 | |
| 91178 | KATEN | cps 100x100mg | SLO | SK | |||
| 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK | |||
| 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,45 | |
| 110 | C01BB | antiarytmika, třída Ib | parent. | O/INT,KAR | |||
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,25 | O/INT,KAR |
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 359,70 | O/INT,KAR |
| 04100 | MEXITIL | inj 5x10ml 250mg | BOE | D | |||
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 359,70 | O/INT,KAR |
| 111 | C01BC | antiarytmika, třída Ic | p.o. | ||||
| 111.1 | C01BC03 | propafenon (100 mg a více v jedné tabletě) | p.o. | 0.3 | GM | 12,95 | |
| 111.2 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,60 | |
| 76761 | RYTMONORM 10MG | tbl obd 500x10mg | KNO | D | |||
| 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT,KAR | |||
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 150,95 | O/INT,KAR |
| 91275 | PROLEKOFEN | inj 10x10ml/35mg | LEK | SLO | |||
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 142,20 | O/INT,KAR |
| 113 | C01BD | antiarytmika, třída III | p.o. | ||||
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 5,10 | |
| 96599 | SEDACORON 200MG | tbl 50x200mg | EBW | A | |||
| 114 | C01BD | antiarytmika, třída III a adenosin | parent. | O/INT,KAR | |||
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 22,00 | O/INT,KAR |
| 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A | |||
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 142,20 | O/INT,KAR |
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 698,60 | O/INT,KAR |
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | O | |||
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 68,30 | O |
| 00536 | NORADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | |||
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 111,90 | O |
| 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | H | |||
| 116.1 | C01CA02 | isoprenalin | parent. | 90 | MG | 15978,40 | H |
| 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 24,30 | H |
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 692,60 | H |
| 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 195,65 | H |
| 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 41,85 | H |
| 116.6 | C01CA11 | mepentermin | parent. | 30 | MG | 104,00 | H |
| 116.7 | C01CA17 | midodrin | parent. | 7.5 | MG | 85,35 | H |
| 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X | |||
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4228,65 | X |
| 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F | |||
| 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | ||||
| 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,20 | |
| 86677 | NIT-RET | tbl 50x2.5mg | SLO | SK | |||
| 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 4,15 | |
| 94692 | NITRO MACK RETARD 2.5MG | cps 30x2.5mg | SLO | SK | |||
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,55 | |
| 99304 | NITRO MACK RETARD 5MG | cps 30x5mg | SLO | SK | |||
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 4,85 | |
| 118.5 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 5,00 | |
| 118.6 | C01DA08 | isosorbid dinitrát (od 20 do 80 mg v jedné tabletě včetně) | p.o. | 60 | MG | 3,15 | |
| 118.7 | C01DA14 | isosorbid mononitrát | p.o. | 40 | MG | 3,70 | |
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H | |||
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 15,45 | H |
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 116,70 | H |
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | ||||
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,65 | |
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | |||
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 12,65 | |
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | ||||
| 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 4,05 | |
| 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | |||
| 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,10 | |
| 122 | C01DX | ostatní vazodilatancia | p.o. | ||||
| 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,90 | |
| 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 7,20 | |
| 86440 | MOLSIHEXAL 1MG | tbl 60x1mg | HEX | D | |||
| 83473 | MOLSIHEXAL 2MG | tbl 30x2mg | HEX | D | |||
| 83662 | MOLSIHEXAL 2MG | tbl 50x2mg | HEX | D | |||
| 86441 | MOLSIHEXAL 2MG | tbl 60x2mg | HEX | D | |||
| 83663 | MOLSIHEXAL 2MG | tbl 100x2mg | HEX | D | |||
| 122.3 | C01DX12 | molsidomin (od 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,05 | |
| 83474 | MOLSIHEXAL 4MG | tbl 30x4mg | HEX | D | |||
| 83664 | MOLSIHEXAL 4MG | tbl 50x4mg | HEX | D | |||
| 86442 | MOLSIHEXAL 4MG | tbl 60x4mg | HEX | D | |||
| 83665 | MOLSIHEXAL 4MG | tbl 100x4mg | HEX | D | |||
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 9,75 | |
| 60446 | CORVATON RETARD | tbl ret 30x8mg | HOE | D | |||
| 83666 | MOLSIHEXAL RETARD | tbl ret 50x8mg | HEX | D | |||
| 86432 | MOLSIHEXAL RETARD | tbl ret 30x8mg | HEX | D | |||
| 86443 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D | |||
| 83475 | MOLSIHEXAL RETARD | tbl ret 100x8mg | HEX | D | |||
| 122.5 | C01DX17 | trimetazidin | p.o. | 40 | MG | 8,20 | |
| 123 | C01DX | ostatní vazodilatancia | parent. | H | |||
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 14,10 | H |
| 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 107,80 | H |
| 124 | C01EA | prostaglandiny | parent. | X | |||
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3442,50 | X |
| 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ | |||
| 70426 | KARON | inj 0.2ml/100rg+sol | LEX | CZ | |||
| 61219 | PROSTIN VR | inj 1x1ml/0.5mg | UPJ | B | |||
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 765,90 | X |
| 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D | |||
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | ||||
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 6,65 | |
| 68571 | DOPAGEN | tbl obd 50x250mg | ANN | IRL | |||
| 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 15,20 | |
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 15,20 | |
| 125.4 | C02AC05 | moxonidin | p.o. | 0.3 | MG | 15,20 | |
| 125.5 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,60 | |
| 125.6 | C02LB01 | methyldopa/ hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 5,05 | |
| 125.7 | C02LB01 | methyldopa/ hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,50 | |
| 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H | |||
| 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 71,70 | H |
| 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | ||||
| 127.1 | C02CA | metazosin | p.o. | 20 | MG | 6,10 | |
| 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 7,05 | |
| 23338 | ADVERSUTEN-1 | tbl 50x1mg | VAD | D | |||
| 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ | |||
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 2,55 | |
| 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ | |||
| 127.4 | C02CA06 | urapidil | p.o. | 50 | MG | 10,30 | |
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | |||
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 219,20 | O |
| 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D | |||
| 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D | |||
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | ||||
| 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 1,15 | |
| 00110 | DIHYDRALAZIN SLOVAKOFARMA | tbl 50x25mg | SLO | SK | |||
| 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,65 | |
| 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,60 | L/INT,KAR |
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H | |||
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 290,50 | H |
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 35,50 | H |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 286,70 | H |
| 131 | C03AA | thiazidová diuretika | p.o. | ||||
| 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,80 | |
| 00168 | HYDROCHLOROTHIAD LECIVA | tbl 20x25mg | LEX | CZ | |||
| 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | ||||
| 132.1 | C03BA | metipamid | p.o. | 2.5 | MG | 1,05 | |
| 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ | |||
| 132.2 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,50 | |
| 132.3 | C03BA10 | xipamid | p.o. | 20 | MG | 1,05 | |
| 132.4 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,05 | |
| 132.5 | C03B | cikletanin | p.o. | 50 | MG | 1,05 | |
| 133 | C03CA | kličková diuretika | p.o. | ||||
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,90 | |
| 86717 | FURANTHRIL | tbl 50x40mg | PMM | BG | |||
| 96375 | FUROMEX | tbl 100x40mg | ORN | SF | |||
| 98219 | FURON | tbl 50x40mg | MCK | D | |||
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK | |||
| 97935 | FURSEMID | tbl 100x40mg | BLU | CHO | |||
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,20 | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | |||
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,90 | |
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,20 | |
| 134 | C03CA | kličková diuretika | parent. | O | |||
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 15,60 | O |
| 08984 | FURANTRAL | inj 25x2ml/20mg | PWO | PL | |||
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | BTA | SK | |||
| 75072 | FUROSEMID-RATIOPHARM | inj 5x2ml/20mg | MCK | D | |||
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 6,95 | O |
| 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK | |||
| 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 15,60 | O |
| 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 6,75 | O |
| 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 556,10 | O |
| 135 | C03D | kalium šetřící diuretika | p.o. | ||||
| 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,75 | |
| 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,25 | |
| 87662 | AMICLARAN | tbl 50x5mg | SLO | SK | |||
| 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,25 | |
| 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | ||||
| 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,30 | |
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,70 | |
| 83716 | AMILORID HCT AL | tbl 20 | APA | D | |||
| 55924 | AMILORID HCT AL | tbl 30 | APA | D | |||
| 83717 | AMILORID HCT AL | tbl 50 | APA | D | |||
| 83718 | AMILORID HCT AL | tbl 100 | APA | D | |||
| 70515 | APO-AMILZIDE 5/50MG | tbl 100x5mg/50mg | APT | CND | |||
| 92621 | AQUARETIC | tbl 20 | AZU | D | |||
| 60194 | AQUARETIC | tbl 30 | AZU | D | |||
| 60195 | AQUARETIC | tbl 50 | AZU | D | |||
| 60196 | AQUARETIC | tbl 100 | AZU | D | |||
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ | |||
| 136.3 | C03EA14 | spironolakton/ butizid | p.o. | 1 | DF | 10,00 | |
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O | |||
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 21,40 | O |
| 01511 | REGITIN | inj 5x1ml 10mg | CGC | CH | |||
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 98,40 | O |
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | ||||
| 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,45 | |
| 138.2 | C04AD | etophyllin | p.o. | 0.3 | GM | 1,75 | |
| 138.3 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 5,20 | |
| 138.4 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 9,70 | |
| 04184 | AGAPURIN | drg 60x100mg | SLO | SK | |||
| 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 8,65 | |
| 96180 | AGAPURIN 600 RETARD | tbl obd 20x600mg | SLO | SK | |||
| 138.6 | C04AD03 | pentoxifyllin (od 100 do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 9,20 | |
| 74961 | AZUPENTAT 400 RETARD | tbl obd 20x400mg | AZU | D | |||
| 74962 | AZUPENTAT 400 RETARD | tbl obd 50x400mg | AZU | D | |||
| 89990 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 20x400mg | APA | D | |||
| 89991 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 50x400mg | APA | D | |||
| 89992 | PENTOXIFYLLIN AL 400 RETARD | tbl obd 100x400mg | APA | D | |||
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | ||||
| 139.1 | C04AC | olamini nicotinas | parent. | 0.9 | GM | 20,50 | |
| 139.2 | C04AD | etophyllin/ theophyllin | parent. | 0.3 | GM | 12,65 | |
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,35 | |
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 29,95 | |
| 31409 | TRENTAL | inj 10x15ml/300mg | HOE | D | |||
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | ||||
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 1,85 | |
| 91032 | SECATOXIN FORTE | gtt 1x25ml/62.5mg | GNO | CZ | |||
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,70 | |
| 140.3 | C04AE51 | hydrogenované ergotové alkaloidy, kombinace | p.o. | 2 | ML | 1,85 | |
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | ||||
| 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 59,00 | |
| 00432 | DH-ERGOTOXIN LECIVA | inj 5x1ml/0.3mg | LEX | CZ | |||
| 142 | C04AX | jiná periferní vasodilatancia | p.o. | ||||
| 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,40 | |
| 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,90 | |
| 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,40 | |
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,40 | |
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,40 | |
| 97026 | ENELBIN RETARD | tbl obd 50x100mg | LEX | CZ | |||
| 143 | C04AX | jiná periferní vasodilatancia | parent. | ||||
| 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 15,20 | |
| 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 52,70 | |
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 52,70 | |
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | |||
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | ||||
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 1,00 | |
| 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,70 | |
| 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 1,00 | |
| 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,70 | |
| 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 1,00 | |
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,70 | |
| 00832 | AVIRIL H | ung 1x30gm | LEX | CZ | |||
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | ||||
| 145.1 | C05AX | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,80 | |
| 01966 | KETAZON H | ung 1x20gm 5% | LEX | CZ | |||
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | ||||
| 146.1 | C05BA | přípravky s heparinem k zevnímu použití | lok. | 1 | GM | 0,85 | |
| 146.2 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,85 | |
| 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D | |||
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | |||
| 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ | |||
| 72931 | THROMBAREDUCT 60000 | ung 1x200gm | AZU | D | |||
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | ||||
| 147.1 | C05CA | bioflavonoidy (hydroxyethylrutosid) | p.o. | 0.9 | GM | 7,25 | |
| 147.2 | C05CA | bioflavonoidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,30 | |
| 147.3 | C05CA | bioflavonoidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 2,70 | |
| 147.4 | C05CA | bioflavonoidy (tribenosid) | p.o. | 0.6 | GM | 7,25 | |
| 147.5 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 7,25 | |
| 04336 | CILKANOL | cps 30x300mg | LEX | CZ | |||
| 147.6 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 7,25 | |
| 148 | C05 | jiné kapiláry stabilizující látky | p.o. | ||||
| 148.1 | C05BX01 | jiné kapiláry stabilizující látky (dobesilat vápenatý) | p.o. | 0.75 | GM | 6,90 | |
| 148.2 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 5,90 | |
| 94708 | AESCIN | tbl obd 30x20mg | POL | PL | |||
| 94327 | YELLON | cps 30x20mg | SLO | SK | |||
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | H | |||
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 55,50 | H |
| 149.2 | C05BB02 | polidokanol (do 0.5% včetně) | parent. | 1 | ML | 13,75 | H |
| 149.3 | C05BB02 | polidokanol (od 0.5 do 1% včetně) | parent. | 1 | ML | 15,85 | O |
| 149.4 | C05BB02 | polidokanol (od 1 do 3% včetně) | parent. | 1 | ML | 17,50 | O |
| 149.5 | C05BB02 | polidokanol (více než 3%) | parent. | 1 | ML | 19,25 | O |
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT | |||
| 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 6,50 | L/KAR,INT |
| 83480 | SOTAHEXAL MITE | tbl 20x80mg | HEX | D | |||
| 83668 | SOTAHEXAL MITE | tbl 50x80mg | HEX | D | |||
| 83669 | SOTAHEXAL MITE | tbl 100x80mg | HEX | D | |||
| 83481 | SOTAHEXAL | tbl 20x160mg | HEX | D | |||
| 83670 | SOTAHEXAL | tbl 50x160mg | HEX | D | |||
| 83671 | SOTAHEXAL | tbl 100x160mg | HEX | D | |||
| 67342 | SOTALEX | tbl 30x160mg | BRI | D | |||
| 67343 | SOTALEX MITE | tbl 30x80mg | BRI | D | |||
| 86641 | SOTALEX MITE | tbl 50x80mg | BRI | D | |||
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | ||||
| 151.1 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,30 | |
| 02484 | TRIMEPRANOL | tbl 50x40mg | SLO | SK | |||
| 151.2 | C07AA | metipranolol (do 10 mg v 1 tabletě včetně) | p.o. | 10 | MG | 0,60 | |
| 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK | |||
| 151.3 | C07AA02 | oxprenolol | p.o. | 0.1 | GM | 2,60 | |
| 151.4 | C07AA03 | pindolol | p.o. | 15 | MG | 2,60 | |
| 151.5 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,60 | |
| 151.6 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,60 | |
| 151.7 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,60 | |
| 151.8 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,40 | |
| 151.9 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,60 | |
| 151.10 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,60 | |
| 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O | |||
| 152.1 | C07AA | metipranolol | parent. | 10 | MG | 64,10 | O |
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | |||
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 101,40 | O |
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 101,40 | O |
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 101,40 | O |
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 895,20 | O |
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | ||||
| 153.1 | C07AB02 | metoprolol | p.o. | 0.15 | GM | 2,60 | |
| 153.2 | C07AB03 | atenolol | p.o. | 75 | MG | 3,60 | |
| 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D | |||
| 83644 | ATEHEXAL 50 | tbl obd 100x50mg | HEX | D | |||
| 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D | |||
| 83647 | ATEHEXAL 100 | tbl obd 50x100mg | HEX | D | |||
| 83648 | ATEHEXAL 100 | tbl obd 100x100mg | HEX | D | |||
| 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D | |||
| 62860 | ATENOBENE 100MG | tbl obd 50x100mg | MCK | D | |||
| 89255 | ATENOLOL AL 50 | tbl obd 30x50mg | APA | D | |||
| 89256 | ATENOLOL AL 50 | tbl obd 50x50mg | APA | D | |||
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | |||
| 89258 | ATENOLOL AL 100 | tbl obd 30x100mg | APA | D | |||
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | |||
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D | |||
| 89769 | BETASYN 100 | tbl obd 30x100mg | TRM | D | |||
| 80438 | BETASYN 100 | tbl obd 100x100mg | TRM | D | |||
| 61487 | BLOCOTENOL 25 | tbl obd 50x25mg | AZU | D | |||
| 72987 | CATENOL 50 | tbl 100x50mg | CAD | IND | |||
| 72988 | CATENOL 100 | tbl 100x100mg | CAD | IND | |||
| 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH | |||
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB | |||
| 153.3 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 6,00 | |
| 153.4 | C07AB05 | betaxolol | p.o. | 20 | MG | 6,00 | |
| 153.5 | C07AB07 | bisoprolol | p.o. | 10 | MG | 6,00 | |
| 153.6 | C07AB08 | celiprolol | p.o. | 0.2 | GM | 6,00 | |
| 153.7 | C07AB12 | nebivolol | p.o. | 5 | MG | 6,00 | |
| 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent. | O | |||
| 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1430,25 | O |
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 2046,35 | O |
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB | |||
| 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1430,25 | O |
| 155 | C07AG | alfa, beta-blokátory | p.o. | L/KAR,INT | |||
| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 18,05 | L/KAR,INT |
| 87669 | TRANDATE | tbl 250x200mg | GLA | GB | |||
| 155.2 | C07AG02 | karvedilol (do 6,25mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 73,00 | L/KAR,INT |
| 155.3 | C07AG02 | karvedilol (nad 6,25mg v 1 tabletě) | p.o. | 37.5 | MG | 30,00 | L/KAR,INT |
| 156 | C07AG | alfa, beta-blokátory | parent. | H | |||
| 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 959,40 | H |
| 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | ||||
| 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,50 | |
| 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,50 | |
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertens. | p.o. | 0.5 | DF | 0,60 | |
| 04367 | TRIMECRYTON | tbl 30(lekovka) | LEX | CZ | |||
| 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ | |||
| 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | ||||
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 13,50 | L/INT,KAR |
| 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 10,30 | |
| 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 10,30 | |
| 158.4 | C08CA05 | nifedipin | p.o. | 30 | MG | 2,00 | |
| 91634 | CORDAFEN | tbl obd 50x10mg | POL | PL | |||
| 91199 | CORINFAR | drg 100x10mg | VAD | D | |||
| 97771 | NIFESAN | tbl obd 50x10mg | PMP | CZ | |||
| 87164 | SPONIF 10 | tbl obd 50x10mg | SLO | SK | |||
| 158.5 | C08CA05 | nifedipin (retadrované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,15 | |
| 98043 | CORINFAR RETARD | drg 30x20mg | VAD | D | |||
| 98044 | CORINFAR RETARD | drg 50x20mg | VAD | D | |||
| 98045 | CORINFAR RETARD | drg 100x20mg | VAD | D | |||
| 94129 | DEPIN-E RETARD | tbl ret 100x20mg | CAD | IND | |||
| 91692 | NIFECARD RETARD | tbl ret 30x20mg | LEK | SLO | |||
| 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D | |||
| 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D | |||
| 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,65 | |
| 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D | |||
| 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D | |||
| 83667 | NIFEHEXAL 40 RETARD | tbl ret 20x40mg | HEX | D | |||
| 158.7 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 172,80 | X |
| 158.8 | C08CA07 | nisoldipin | p.o. | 20 | MG | 10,30 | |
| 158.9 | C08CA08 | nitrendipin | p.o. | 20 | MG | 10,30 | |
| 158.10 | C08CA09 | lacidipin | p.o. | 4 | MG | 12,50 | L/INT,KAR |
| 158.11 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,50 | L/INT,KAR |
| 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | H | |||
| 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3204,50 | H |
| 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3204,50 | H |
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3779,00 | X |
| 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | ||||
| 160.1 | C08DA01 | verapamil | p.o. | 0.24 | GM | 5,25 | |
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | |||
| 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D | |||
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | |||
| 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D | |||
| 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D | |||
| 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D | |||
| 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 mg) | p.o. | 0.24 | GM | 6,30 | |
| 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO | |||
| 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,25 | |
| 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H | |||
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 318,00 | H |
| 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | ||||
| 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,40 | |
| 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ | |||
| 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ | |||
| 93711 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ | |||
| 94314 | DIACORDIN 90 RETARD | tbl obd 30x90mg | LEX | CZ | |||
| 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,45 | |
| 76736 | DIACORDIN 120 RETARD | tbl ret 30x120mg | LEX | CZ | |||
| 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H | |||
| 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 330,15 | H |
| 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | ||||
| 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 5,50 | |
| 164.2 | C09AA01 | kaptopril (od 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 5,00 | |
| 164.3 | C09AA02 | enalapril (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 6,05 | |
| 83505 | EDNYT 2.5MG | tbl 28x2.5mg | GED | H | |||
| 83507 | EDNYT 5MG | tbl 28x5mg | GED | H | |||
| 83509 | EDNYT 10MG | tbl 28x10mg | GED | H | |||
| 164.4 | C09AA02 | enalapril (od 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,15 | |
| 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5mg | LCM | CZ | |||
| 55638 | ENALAPRIL LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 164.5 | C09AA02 | enalapril (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 4,05 | |
| 83511 | EDNYT 20MG | tbl 28x20mg | GED | H | |||
| 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ | |||
| 164.6 | C09AA03 | lisinopril | p.o. | 10 | MG | 9,00 | |
| 164.7 | C09AA04 | perindopril | p.o. | 4 | MG | 10,30 | |
| 164.8 | C09AA05 | ramipril | p.o. | 2.5 | MG | 10,30 | |
| 164.9 | C09AA06 | quinapril | p.o. | 15 | MG | 10,30 | |
| 164.10 | C09AA07 | benazepril | p.o. | 7.5 | MG | 10,30 | |
| 164.11 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 10,30 | |
| 164.12 | C09AA10 | trandolapril | p.o. | 2 | MG | 10,30 | |
| 164.13 | C09AA11 | spirapril | p.o. | 6 | MG | 10,30 | |
| 164.14 | C09AA12 | delapril | p.o. | 30 | MG | 10,30 | |
| 164.15 | C09AA13 | moexipril | p.o. | 15 | MG | 10,30 | |
| 164.16 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,70 | |
| 165 | C09AA | inhibitory angiotenzin konvertujícího enzymu | parent. | H | |||
| 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 27,35 | H |
| 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | ||||
| 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 6,10 | |
| 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 6,10 | |
| 60148 | ENAP H | tbl 20 | KRK | SLO | |||
| 166.3 | C09BA06 | quinapril a diuretika | p.o. | 1 | DF | 6,95 | |
| 166.4 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 6,95 | |
| 166.5 | C09B | trandolapril/ verapamil | p.o. | 1 | DF | 16,60 | |
| 167 | C09CA | antagonisté angiotensinu II | p.o. | Z | |||
| 167.1 | C09CA01 | losartan | p.o. | 50 | MG | 39,75 | Z |
| 84019 | COZAAR 50MG | tbl obd 28x50mg | MSD | NL | |||
| 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | P |
Léčbu ordinuje kardiolog, internista nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:
- a) léčba pacientů s familiární hypercholesterolemií,
- b) léčba pacientů s manifestní atherosklerózou s izolovanou hypercholesterolemií nebo s kombinovanou hyperlipoproteinemií s pouze mírným zvýšením triacylglycerolu,
- c) léčba pacientů s kumulací rizikových faktorů s izolovanou hypercholesterolemií nebo s kombinovanou hyperlipoproteinemií s pouze mírným zvýšením triacylglycerolu,
- d) u ostatních pacientů pouze po předchozím schválení revizním lékařem.
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 39,60 | P |
|---|---|---|---|---|---|---|---|
| 168.2 | C10AA01 | simvastatin (od 10 do 20 mg v jedné tabletě včetně) | p.o. | 15 | MG | 31,50 | P |
| 168.3 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 30 | MG | 39,60 | P |
| 168.4 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě) | p.o. | 30 | MG | 31,50 | P |
| 168.5 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 20 | MG | 44,00 | P |
| 86039 | LIPOSTAT 10MG | tbl 30x10mg | BMS | I | |||
| 168.6 | C10AA03 | pravastatin (nad 10 mg v jedné tabletě) | p.o. | 20 | MG | 35,00 | P |
| 86040 | LIPOSTAT 20MG | tbl 30x20mg | BMS | I | |||
| 168.7 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 40 | MG | 37,40 | P |
| 168.8 | C10AA04 | fluvastatin (nad 20 mg v jedné tabletě) | p.o. | 40 | MG | 29,75 | P |
| 168.9 | C10AA01 | simvastatin (nad 20 mg v jedné tabletě) | p.o. | 15 | MG | 23,65 | P |
| 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | ||||
| 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 5,65 | |
| 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 13,50 | |
| 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 13,50 | |
| 96574 | GEVILON | tbl obd 30x450mg | LEX | CZ | |||
| 67026 | IPOLIPID | cps 50 | MOE | CY | |||
| 76221 | IPOLIPID | cps 100 | MOE | CY | |||
| 76222 | IPOLIPID | cps 250 | MOE | CY | |||
| 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 13,50 | |
| 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 0.3 | GM | 22,30 | |
| 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 10,00 | |
| 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 13,50 | |
| 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P |
Léčbu ordinuje kardiolog, internista nebo lékař pracující v poradnách pro léčbu poruch metabolismu lipidů:
- a) léčba pacientů s hyperlipoproteinemií s vysokou hladinou cholesterolu,
- b) léčba pacientů s pruritem při biliární cirhóze.
| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 35,45 | P |
|---|---|---|---|---|---|---|---|
| 03599 | QUESTRAN LIGHT | plv 50x4gm | BMS | D | |||
| 94031 | VASOSAN P | plv 1x400gm | FOP | D | |||
| 94033 | VASOSAN S | plv 1x400gm | FOP | D | |||
| 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 67,50 | P |
| 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | ||||
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 1,40 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ | |||
| 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 2,00 | |
| 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | ||||
| 172.1 | D01AC01 | klotrimazol | lok. | 1 | GM | 2,00 | |
| 86262 | CANESTEN | crm 1x20gm | LEX | CZ | |||
| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D | |||
| 86397 | CLOTRIMAZOL AL 1% | crm 1x50gm 1% | APA | D | |||
| 93483 | CLOTRIMAZOLUM POLFA | crm 20gm 1% | POL | PL | |||
| 172.2 | D01AC02 | mikonazol | lok. | 1 | GM | 2,00 | |
| 172.3 | D01AC03 | ekonazol | lok. | 1 | GM | 4,00 | |
| 172.4 | D01AC03 | ekonazol (lékové formy lipogelu a pasty) | lok. | 1 | GM | 5,00 | |
| 172.5 | D01AC05 | isokonazol | lok. | 1 | ML | 2,00 | |
| 172.6 | D01AC08 | ketokonazol | lok. | 1 | GM | 2,00 | |
| 172.7 | D01AC10 | bifonazol | lok. | 1 | GM | 6,00 | |
| 172.8 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,00 | |
| 172.9 | D01AC12 | fenticonazol | lok. | 1 | GM | 2,00 | |
| 172.10 | D01AC20 | kombinace | lok. | 1 | GM | 2,00 | |
| 172.11 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 2,00 | |
| 172.12 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 20,00 | |
| 173 | D01AE | antimykotika pro lokální podání ostatních skupin | lok. | ||||
| 173.1 | D01AE | jiná antimykotika k zevnímu použití (nitroethanoldodecylsulfonat) | lok. | 1 | ML | 1,00 | |
| 173.2 | D01AE04 | kyselina undecylenová | lok. | 1 | GM | 0,85 | |
| 00871 | MYKOSEPTIN | ung 1x30gm | LEX | CZ | |||
| 173.3 | D01AE14 | ciclopirox | lok. | 1 | GM | 4,00 | |
| 173.4 | D01AE15 | terbinafin | lok. | 1 | GM | 4,00 | |
| 173.5 | D01AE16 | amorolfin | lok. | 1 | GM | 4,00 | |
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 2,00 | |
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 2,00 | |
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 2,00 | |
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1 | GM | 2,00 | |
| 174 | D01BA | antimykotika pro celkové podání | p.o. | P |
Léčbu terbinafinem ordinuje dermatolog:
- a) léčba onychomykóz způsobených dermatofyty (doložených laboratorním nebo mikroskopickým vyšetřením),
- b) léčba těžkých forem dermatomykóz způsobených dermatofyty (doložených laboratorním nebo mikroskopickým vyšetřením).
| 174.1 | D01BA01 | griseofulvin | p.o. | 0.5 | GM | 6,20 | |
|---|---|---|---|---|---|---|---|
| 01606 | GRICIN | tbl 100x125mg | VAD | D | |||
| 174.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 71,50 | P |
| 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | ||||
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,70 | |
| 88597 | TEKUTY PUDR AA 100GM GLO | sus 1x100gm | GAO | CZ | |||
| 88598 | TEKUTY PUDR S MENTOLEM | sus 1x116gm | GAO | CZ | |||
| 00909 | UNGUENTUM ZINCI OXYDATI SLOVAK. | ung 1x20gm | SLO | SK | |||
| 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | L/DER,PDD | |||
| 176.1 | D02AC | měkký parafin a tukové produkty (do 500 ml v 1 balení včetně) | lok. | 1 | ML | 0,80 | L/DER,PDD |
| 07399 | BALMANDOL OLEJ | ole 1x225ml | SEG | CH | |||
| 60404 | BALNEUM HERMAL | liq 1x200ml | HEM | D | |||
| 60408 | BALNEUM HERMAL F | liq 1x200ml | HEM | D | |||
| 60078 | LINOLA-FETT OLBAD | ole 1x250ml | WOL | D | |||
| 89996 | LINOLA-FETT OLBAD | ole 1x200ml | WOL | D | |||
| 89997 | LINOLA-FETT OLBAD | ole 1x400ml | WOL | D | |||
| 60079 | LINOLA-FETT OLBAD | ole 1x500ml | WOL | D | |||
| 176.2 | D02AC | měkký parafin a tukové produkty (nad 500 ml v 1 balení) | lok. | 1 | ML | 0,60 | L/DER,PDD |
| 176.3 | D02AC01 | měkký parafin a tukové produkty (do 500 gm v 1 balení včetně) | lok. | 1 | GM | 0,80 | L/DER,PDD |
| 176.4 | D02AC01 | měkký parafin a tukové produkty (nad 500 gm v 1 balení) | lok. | 1 | GM | 0,60 | L/DER,PDD |
| 176.5 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny | lok. | 1 | ML | 0,60 | L/DER,PDD |
| 177 | D02AX | jiná emolliencia a protektiva | lok. | ||||
| 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1 | GM | 1,75 | |
| 00891 | POLYSAN | pst 1x50gm | SLO | SK | |||
| 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1 | GM | 0,65 | |
| 04192 | POLYSAN | pst 1x650gm | SLO | SK | |||
| 88603 | POLYSAN CUM OLEUM HELIANTI GLO | ung 1x900gm | GAO | CZ | |||
| 177.3 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1 | ML | 0,50 | |
| 177.4 | D03AX02 | dextranomer | lok. | 1 | GM | 4,00 | |
| 178 | D03BA | proteolytické enzymy | lok. | P |
Léčbu ordinuje chirurg, ortoped nebo dermatolog:
- a) léčba bércových vředů,
- b) léčba nekrotických poúrazových nebo pooperačních ran,
- c) ošetřování nekrotických ran a dekubitů.
| 178.1 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1 | GM | 81,10 | P |
|---|---|---|---|---|---|---|---|
| 178.2 | D03BA | proteolytické enzymy (kolagenáza) | lok. | 1 | GM | 19,00 | P |
| 178.3 | D03BA | proteolytické enzymy (plasmin/ deoxiribonukleáza) | lok. | 1 | GM | 15,00 | P |
| 42262 | FIBROLAN | ung 1x25gm | PDA | D | |||
| 62518 | FIBROLAN | ung 1x50gm | PDA | D | |||
| 42261 | FIBROLAN | ung 1x100gm | PDA | D | |||
| 178.4 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1 | GM | 29,50 | P |
| 179 | D05AA | antipsoriatika ze skupiny dehtů a derivátů vitaminu D | lok. |
Léčbu deriváty vitaminu D v lokálních lékových formách ordinuje dermatolog:
- a) léčba torpidních lokalizovaných forem psoriázy v místech nekrytých oděvem nereagující na standardní léčbu v množství maximálně 100 g týdně.
- b) v ostatních případech pouze po schválení revizním lékařem zdravotní pojišťovny.
| 179.1 | D05AA | dehty (odbarvený dehet) | lok. | 1 | GM | 1,25 | |
|---|---|---|---|---|---|---|---|
| 179.2 | D05AA | dehty | lok. | 1 | GM | 0,75 | |
| 92428 | BALSAMUM VISNEVSKI CSC | sus 1x600gm | CSP | CZ | |||
| 92430 | BALSAMUM VISNEVSKI CSC | sus 1x3kg | CSP | CZ | |||
| 00859 | ICHTOXYL | ung 1x30gm | LEX | CZ | |||
| 00860 | ICHTOXYL | ung 1x1000gm | LEX | CZ | |||
| 00889 | PITYOL | ung 1x30gm | LEX | CZ | |||
| 00894 | SALOXYL | ung 1x30gm | LEX | CZ | |||
| 00895 | SALOXYL | ung 1x1000gm | LEX | CZ | |||
| 85950 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ | |||
| 86399 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | PSR | CZ | |||
| 92553 | SUSPENSIO VISNEV.+PICE LIQ.TAU. | sus 1x400gm | TAU | CZ | |||
| 92554 | SUSPENSIO VISNEV.+PICE LIQ.TAU. | sus 1x800gm | TAU | CZ | |||
| 05595 | UNGUENTUM ICHTHAMOLI LECIVA 10% | ung 1x1000gm 10% | LEX | CZ | |||
| 05868 | UNGUENTUM ICHTHAMOLI LECIVA 10% | ung 1x900gm 10% | LEX | CZ | |||
| 83870 | UNGUENTUM ICHTAMOLI 10% MVM | ung 1x1kg | MVM | CZ | |||
| 83871 | UNGUENTUM ICHTAMOLI 20% MVM | ung 1x1kg | MVM | CZ | |||
| 85331 | UNGUENTUM ICHTHAMOLI LECIVA 10% | ung 1x20gm 10% | LEX | CZ | |||
| 92547 | UNGUENTUM ICHTAMOLI 10% TAURUS | ung 1x400gm | TAU | CZ | |||
| 92548 | UNGUENTUM ICHTAMOLI 10% TAURUS | ung 1x800gm | TAU | CZ | |||
| 179.3 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1 | ML | 4,20 | |
| 179.4 | D05AC01 | dithranol | lok. | 1 | GM | 4,00 | |
| 179.5 | D05AX02 | kalcipotriol | lok. | 1 | GM | 12,00 | P |
| 179.6 | D05AX04 | tacalcitol | lok. | 1 | GM | 12,00 | P |
| 180 | D05BB | retinoidy pro celkové podání | p.o. | P |
Léčbu ordinuje dermatolog:
- a) léčba těžkých generalizovaných forem psoriázy nereagujících na jinou léčbu,
- b) ostatní těžké formy poruchy keratinizace nereagující na jinou léčbu pouze po předchozím schválení revizním lékařem
| 180.1 | D05BB01 | etretinát | p.o. | 35 | MG | 86,20 | P |
|---|---|---|---|---|---|---|---|
| 180.2 | D05BB02 | acitretin | p.o. | 35 | MG | 86,20 | P |
| 76660 | NEOTIGASON ROCHE 10MG | cps 30x10mg | HLR | CH | |||
| 76661 | NEOTIGASON ROCHE 25MG | cps 30x25mg | HLR | CH | |||
| 180.3 | D05BA02 | methoxalen | p.o. | 10 | MG | 3,95 | L/DER |
| 181 | D06AX | antibiotika k zevnímu použití | lok. | ||||
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 3,00 | |
| 181.2 | D06AX | neomycin/ bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,55 | |
| 181.3 | D06AX | neomycin/ bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 14,00 | |
| 181.4 | D06AX | neomycin/ bacitracin (zásyp nad 2 g) | lok. | 1 | GM | 2,50 | |
| 181.5 | D06AX | neomycin/ bacitracin (mast) | lok. | 1 | GM | 2,50 | |
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,50 | |
| 181.7 | D06AX02 | chloramfenikol | lok. | 1 | GM | 2,95 | |
| 03015 | CHLORAMPHENICOL LECIVA | ung 1x10gm 1% | LEX | CZ | |||
| 181.8 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1 | GM | 8,50 | |
| 181.9 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1 | GM | 5,30 | |
| 182 | D06BA | sulfonamidy s obsahem stříbrných solí k lokálnímu podání | lok. | L/DER,CHI | |||
| 182.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,10 | L/DER,CHI |
| 182.2 | D06BA | sulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,00 | L/DER,CHI |
| 182.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,20 | L/DER,CHI |
| 62229 | DERMAZIN | crm 1x50gm 1% | LEK | SLO | |||
| 182.4 | D06BA01 | sulfadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,15 | L/DER,CHI |
| 80128 | DERMAZIN | crm 1x250gm 1% | LEK | SLO | |||
| 182.5 | D06BA01 | sulfadiazin stříbrný | lok. | 100 | CM2 | 21,45 | L/DER,CHI |
| 55952 | IALUGEN PLUS | ext 5 (10x10cm) | IBS | CH | |||
| 76906 | IALUGEN PLUS | ext 10 (10x10cm) | IBS | CH | |||
| 182.6 | D06BA02 | sulfathiazol | lok. | 1 | GM | 0,90 | |
| 182.7 | D06BA03 | mafenid | lok. | 1 | GM | 1,00 | L/DER,CHI |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | ||||
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 2,55 | |
| 00858 | HYDROCORTISON LECIVA | ung 1x10gm 1% | LEX | CZ | |||
| 01958 | HYDROCORTISON LECIVA | ung 1x50gm 1% | LEX | CZ | |||
| 183.2 | D07AA03 | prednisolon | lok. | 1 | GM | 3,50 | |
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | ||||
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,50 | |
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,50 | |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,50 | |
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,50 | |
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,25 | |
| 02828 | TRIAMCINOLON LECIVA | crm 1x10gm 0.1% | LEX | CZ | |||
| 02829 | TRIAMCINOLON LECIVA | ung 1x10gm 0.1% | LEX | CZ | |||
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1 | ML | 2,65 | |
| 02826 | TRIAMCINOLON | lot 1x15gm | GNO | CZ | |||
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,75 | |
| 02488 | TRIAMCINOLON | spr 1x55.8gm | GNO | CZ | |||
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 1,00 | |
| 184.9 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 1,50 | |
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | ||||
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,55 | |
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,35 | |
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,50 | |
| 185.4 | D07AC04 | fluocinolon | lok. | 1 | GM | 3,00 | |
| 04156 | GELARGIN | gel 1x25gm | LEX | CZ | |||
| 42182 | FLUCINAR | gel 15gm 0.025% | POL | PL | |||
| 03388 | FLUCINAR | ung 1x15gm 0.025% | PWJ | PL | |||
| 185.5 | D07AC06 | diflukortolon | lok. | 1 | GM | 3,50 | |
| 185.6 | D07AC08 | fluocinonid | lok. | 1 | GM | 3,00 | |
| 185.7 | D07AC09 | budesonid | lok. | 1 | GM | 3,25 | |
| 185.8 | D07AC12 | halometason | lok. | 1 | GM | 3,35 | |
| 185.9 | D07AC17 | flutikason | lok. | 1 | GM | 3,50 | |
| 186 | D07AC | kortikosteroidy třídy III, účinné (nefluorované) | lok. | L/DER,ALG,PDD | |||
| 186.1 | D07AC13 | mometazon | lok. | 1 | GM | 6,85 | L/DER,ALG,PDD |
| 94004 | ELOCOM | ung 1x15gm 0.1% | ESX | CH | |||
| 94006 | ELOCOM | crm 1x15gm 0.1% | ESX | CH | |||
| 186.2 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,85 | L/DER,ALG,PDD |
| 186.3 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 6,00 | L/DER,ALG,PDD |
| 187 | D07AD | kortikosteroidy třídy IV, vysoce účinné | lok. | L/DER | |||
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,50 | L/DER |
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,90 | L/DER |
| 97019 | BETACORTON | liq 1x25ml | SEG | CH | |||
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | ||||
| 188.1 | D07B | prednisolon/ cloroxin | lok. | 1 | GM | 3,80 | |
| 188.2 | D07BB | flumethason pivalat/kyselina salicylová | lok. | 1 | GM | 3,00 | |
| 188.3 | D07BB01 | flumetason a antiseptika | lok. | 1 | GM | 4,50 | |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 0,90 | |
| 02975 | TRIAMCINOLON | spm 40gm | GNO | CZ | |||
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,60 | |
| 02825 | TRIAMCINOLON COMPOSITUM | spr 51.4gm | GNO | CZ | |||
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,30 | |
| 02827 | TRIAMCINOLON | tct 1x10ml | GNO | CZ | |||
| 188.7 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,85 | |
| 04178 | TRIAMCINOLON E LECIVA | ung 1x20gm | LEX | CZ | |||
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | ||||
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 2,00 | |
| 189.2 | D07XA02 | prednisolon/ kyselina salicylová | lok. | 1 | ML | 1,55 | |
| 189.3 | D07XB01 | flumetason | lok. | 1 | GM | 4,50 | |
| 189.4 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,85 | |
| 189.5 | D07XC | diflucortolon/ isoconasol | lok. | 1 | GM | 2,80 | |
| 189.6 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,80 | |
| 85864 | BELOSALIC | ung 1x30gm | BLU | CHO | |||
| 189.7 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,80 | |
| 189.8 | D07XD | halcinonid/ kyselina salicylová | lok. | 1 | ML | 4,30 | |
| 189.9 | D07XD | halcinonid/ močovina | lok. | 1 | GM | 4,30 | |
| 189.10 | D07XA01 | hydrocortison/ natamycin/ neomycin | lok. | 1 | GM | 2,00 | |
| 189.11 | D07XA01 | hydrocortison/ natamycin/ neomycin | lok. | 1 | ML | 2,00 | |
| 190 | D08A | antiseptika a desinficiencia | lok. | ||||
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 182,80 | |
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,65 | |
| 05579 | UNGUENTUM ACIDI BORICI LECIVA | ung 1x1000gm 3% | LEX | CZ | |||
| 00905 | UNGUENTUM ACIDI BORICI SLOVAK | ung 1x20gm 3% | SLO | SK | |||
| 84467 | UNGUENTUM ACIDI BORICI 10% CSC | ung 1x1000gm | CSP | CZ | |||
| 92479 | UNGUENTUM ACIDI BORICI 10% TAU. | ung 1x400gm | TAU | CZ | |||
| 92480 | UNGUENTUM ACIDI BORICI 10% TAU. | ung 1x800gm | TAU | CZ | |||
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,35 | |
| 84469 | SOLUTIO JARISCH CSC | liq 1x1000gm | CSP | CZ | |||
| 92555 | SOLUTIO JARISCH TAURUS | sol 1x500gm | TAU | CZ | |||
| 92556 | SOLUTIO JARISCH TAURUS | sol 1x1000gm | TAU | CZ | |||
| 92780 | SOLUTIO JARISCH CSL4 PROFARMA | sol 1x500gm | PSR | CZ | |||
| 92781 | SOLUTIO JARISCH CSL4 PROFARMA | sol 1x1000gm | PSR | CZ | |||
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml roztoku v jednom balení včetně) | lok. | 1 | ML | 1,00 | |
| 190.5 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 2,00 | |
| 190.6 | D08AH | kloroxin | lok. | 1 | GM | 0,75 | |
| 190.7 | D08AJ | bromid benzododecinia (vodný roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,35 | |
| 190.8 | D08AJ | bromid benzododecinia (tinktura do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,30 | |
| 190.9 | D08AJ | chlorid karbetopendecinia (tinktura do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,30 | |
| 191 | D08AX | jiná antiseptika a desinficiencia | lok. | H | |||
| 191.1 | D08AX | hexamidin/ chlorhexidin | lok. | 1 | ML | 124,15 | H |
| 191.2 | D08AX | noxytiolin | lok. | 2.5 | GM | 503,40 | H |
| 191.3 | D08AX | noxytiolin/ tetrakain | lok. | 2.5 | GM | 503,40 | H |
| 191.4 | D08AX | taurolidin | lok. | 1 | GM | 96,65 | H |
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | ||||
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 4,20 | |
| 98205 | LOCACID | crm 1x30gm 0.05% | PFB | F | |||
| 03740 | RETIN A | crm 1x30gm 0.05% | CIL | CH | |||
| 97573 | RETIN A | crm 1x30gm 0.025% | CIL | CH | |||
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1 | GM | 4,50 | |
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,20 | |
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,50 | |
| 192.5 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,50 | |
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,40 | |
| 192.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,60 | |
| 192.8 | D10AF01 | klindamycin | lok. | 1 | ML | 2,00 | |
| 192.9 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,00 | |
| 192.10 | D10AF02 | erythromycin (lékové formy roztoků) | lok. | 1 | ML | 2,00 | |
| 192.11 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,00 | |
| 192.12 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 2,00 | |
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | X | |||
| 193.1 | D10BA01 | isotretinoin | p.o. | 30 | MG | 94,95 | X |
| 91843 | ROACCUTANE ROCHE | cps 30x20mg | HLR | CH | |||
| 194 | D11AX | jiná dermatologika | lok. | L/DER | |||
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 10,00 | L/DER |
| 194.2 | D11AX | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 10,00 | L/DER |
| 194.3 | D11AX | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,70 | L/DER,ONK |
| 03739 | EFUDIX | ung 1x20gm 5% | HLR | CH | |||
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. |
Léčbu vaginálním clindamycinem ordinuje gynekolog:
- a) léčba bakteriální vaginózy v těhotenství,
- b) vaginitis s průkazem citlivosti bakteriálních kmenů na clindamycin.
| 195.1 | G01AA01 | nystatin | vag. | 100 | KU | 1,00 | |
|---|---|---|---|---|---|---|---|
| 195.2 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25 | MG | 4,60 | |
| 02047 | PIMAFUCIN | tbl vag 20x25mg+apl | YEU | NL | |||
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 7,65 | |
| 78213 | PIMAFUCIN | glo vag 3x100mg | YEU | NL | |||
| 195.4 | G01AA10 | klindamycin | vag. | 1 | GM | 13,10 | P |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | ||||
| 196.1 | G01AF | deriváty imidazolu | vag. | 0.1 | GM | 6,50 | |
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,80 | |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet, do 100 mg včetně) | vag. | 0.1 | GM | 8,75 | |
| 62862 | CANDIBENE(FUNGIZID-RATIOPHARM) | tbl vag 6x100mg | MCK | D | |||
| 93484 | CLOTRIMAZOLUM POLFA | tbl vag 6x100mg | POL | PL | |||
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních tablet, nad 100 mg) | vag. | 0.1 | GM | 13,75 | |
| 62863 | CANDIBENE(FUNGIZID-RATIOPHARM) | tbl vag 3x200mg | MCK | D | |||
| 196.5 | G01AF02 | Iklotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,10 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D | |||
| 196.6 | G01AF04 | mikonazol | vag. | 0.1 | GM | 8,75 | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,10 | |
| 196.8 | G01AF05 | ekonazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 35,05 | |
| 196.9 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,75 | |
| 196.10 | G01AF12 | fenticonazol | vag. | 0.1 | GM | 13,75 | |
| 196.11 | G01AF17 | oxikonazol | vag. | 0.6 | GM | 82,90 | |
| 196.12 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 13,10 | |
| 196.13 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80 | MG | 35,05 | |
| 197 | G01AX | vaginálně podávaná jiná antiinfektiva a antiseptika | vag. | ||||
| 197.1 | G01AX | laktobacillus | vag. | 1 | DF | 10,50 | |
| 197.2 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1 | DF | 22,00 | |
| 197.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5 | GM | 45,00 | |
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 2,05 | |
| 03629 | FURANTOIN LECIVA | tbl vag 30x100mg | LEX | CZ | |||
| 197.5 | G01AX | polykresol | vag. | 1 | GM | 1,15 | |
| 197.6 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 41,60 | L/GYN,URN |
| 197.7 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 8,75 | |
| 197.8 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.2 | GM | 6,40 | |
| 197.9 | G01AX12 | ciklopirox | vag. | 1 | GM | 6,40 | |
| 197.10 | G01A | sulfathiazol | vag. | 1 | DF | 6,75 | |
| 197.11 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,30 | |
| 198 | G02AB | uterotonika ze skupiny námelových alkaloidů | p.o. | ||||
| 198.1 | G02AB02 | ergotové alkaloidy | p.o. | 0.2 | MG | 1,15 | |
| 00710 | CORNUTAMIN | gtt 10ml (0.25mg/ml) | GNO | CZ | |||
| 198.2 | G02AB03 | ergometrin | p.o. | 0.2 | MG | 1,15 | |
| 199 | G02AB | uterotonika ze skupiny námelových alkaloidů | parent. | ||||
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 10,40 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1ml/0.2mg | SPX | CZ | |||
| 199.2 | G02AB03 | ergometrin | parent. | 0.2 | MG | 9,60 | |
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | H | |||
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 97,50 | H |
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | K/P |
Léčbu ordinuje gynekolog:
- a) preindukce porodu při ukončení těhotenství,
- b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
- c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
- d) v poporodním období při závažné metrorhagii.
| 201.1 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 951,70 | K/P |
|---|---|---|---|---|---|---|---|
| 201.2 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 464,35 | K/P |
| 91607 | PROSTIN E2 | tbl vag 4x3mg | UPJ | B | |||
| 201.3 | G02AD02 | dinoproston (od 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1176,60 | K/P |
| 94406 | PROSTIN E2 | gel vag 1x3gm/1mg | UPJ | B | |||
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P |
Léčbu ordinuje gynekolog:
- a) preindukce porodu při ukončení těhotenství,
- b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
- c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
- d) v poporodním období při závažné metrorhagii.
| 202.1 | G02AD01 | dinoprost | parent. | 25 | MG | 666,80 | K/P |
|---|---|---|---|---|---|---|---|
| 202.2 | G02AD02 | dinoproston | parent. | 0.5 | MG | 412,80 | K/P |
| 67188 | PROSTIN E2 SS 1MG/ML | inj 1x0.75ml | UPJ | B | |||
| 67189 | PROSTIN E2 SS 10MG/ML | inj 1x0.5ml | UPJ | B | |||
| 202.3 | G02AD04 | karboprost | parent. | 0.25 | MG | 691,10 | K/P |
| 202.4 | G02AD05 | sulproston | parent. | 0.5 | MG | 666,80 | K/P |
| 203 | G02CA | tokolytika ze skupiny beta-sympatomimetik | p.o. | P |
Léčbu ordinuje gynekolog:
pouze jako pokračování parenterální aplikace tokolytik.
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 11,05 | P |
|---|---|---|---|---|---|---|---|
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,80 | P |
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,80 | P |
| 21391 | PARTUSISTEN | tbl 50x5mg | BOE | D | |||
| 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P |
Léčbu ordinuje gynekolog:
- a) zahájení tokolytické léčby po 20. týdnu těhotenství,
- b) léčba porodní dystokie,
- c) intrapartální akutní tokolýza.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 46,40 | U/P |
|---|---|---|---|---|---|---|---|
| 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 46,40 | U/P |
| 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 46,40 | U/P |
| 03399 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | D | |||
| 205 | G02CB | inhibitory prolaktinu | p.o. | ||||
| 205.1 | G02CB | tergurid | p.o. | 1 | MG | 4,35 | |
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ | |||
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 2,55 | |
| 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,55 | |
| 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,70 | Z |
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,70 | Z |
| 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX | |||
| 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 30,10 | L/END,ONK, GYN, SEX |
| 80218 | UNDESTOR | cps 60x40mg | ORG | NL | |||
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,50 | L/END,ONK, GYN, SEX |
| 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX | |||
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 11,15 | L/END,ONK, GYN, SEX |
| 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK | |||
| 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | P |
Estradiol, léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:
- a) substituční léčba žen po předčasné menopauze,
- b) léčba postmenopausálního vegetativního a estrogen-deficitního syndromu. Estriol, léčbu ordinuje gynekolog, urolog, sexuolog nebo endokrinolog: léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 208.1 | G03CA | mestranol | p.o. | 0.15 | MG | 3,85 | P |
|---|---|---|---|---|---|---|---|
| 21105 | MESTRANOL | tbl 20x50rg | VJP | D | |||
| 208.2 | G03CA | přírodní konj. estrogeny | p.o. | 1.25 | MG | 9,00 | P |
| 208.3 | G03CA03 | estradiol (do 2 mg v jedné tabletě včetně) | p.o. | 2 | MG | 9,00 | P |
| 208.4 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 5,80 | P |
| 208.5 | G03CA03 | estradiol (s uvolněním do 50 RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 5,80 | P |
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 100 RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 9,00 | P |
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 13,50 | P |
| 208.8 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 6,00 | P |
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 6,00 | P |
| 208.10 | G03CA04 | estriol | p.o. | 2 | MG | 8,25 | P |
| 208.11 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,25 | P |
| 208.12 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 6,00 | P |
| 208.13 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,35 | P |
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | ||||
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,40 | |
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK | |||
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,50 | |
| 209.3 | G03CA04 | estriol | parent. | 2 | MG | 4,40 | |
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX | |||
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 4,30 | L/GYN,URN, END, INT,SEX |
| 91231 | PROVERA | tbl 24x5mg | UPJ | B | |||
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 17,80 | L/GYN,URN, END, INT,SEX |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 4,30 | L/GYN,URN, END, INT,SEX |
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,85 | L/GYN,URN, END, INT,SEX |
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 4,30 | L/GYN,URN, END, INT,SEX |
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 34,00 | Z |
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX | |||
| 211.1 | G03DA03 | hydroxyprogesteron | parent. | 10 | MG | 1,65 | L/GYN,URN, SEX |
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,05 | L/GYN,URN, SEX |
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,15 | L/GYN,URN, SEX |
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK | |||
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | L/GYN,END,SEX | |||
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 23,40 | L/GYN,END, SEX |
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK | |||
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 75,00 | L/GYN,END, SEX |
| 213 | G03F | progestiny a estrogeny | p.o. | P |
Léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:
léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 213.1 | G03FA01 | norethisteron a estrogen | p.o. | 1 | DF | 9,50 | P |
|---|---|---|---|---|---|---|---|
| 213.2 | G03FA01 | norethisteron a estrogen | transd. | 50 | RG | 9,50 | P |
| 213.3 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,20 | P |
| 213.4 | G03FB05 | norethisteron a estrogen | p.o. | 1 | DF | 7,55 | P |
| 213.5 | G03HB01 | cyproteron/ estradiol | p.o. | 0.75 | DF | 8,15 | P |
| 75013 | CLIMEN | drg 1x21 (11 + 10) | SAG | D | |||
| 83374 | CLIMEN | drg 3x21 (11 + 10) | SAG | D | |||
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX | |||
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 23,15 | L/GYN,END, PDD, SEX |
| 10809 | PREGNYL | inj 3x500ut+solv. | ORG | NL | |||
| 214.2 | G03GA01 | choriový gonadotrofin (od 500 U do 1500 U v 1 ampuli včětně) | parent. | 250 | U | 15,00 | L/GYN,END, PDD, SEX |
| 00563 | PRAEDYN | inj 5x1.5ku+5x2ml | LEX | CZ | |||
| 214.3 | G03GA01 | chonový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 11.15 | L/GYN,END, POD, SEX |
| 02966 | PRAEDYN | inj sic 5x3ku+sol | LEX | CZ | |||
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL | |||
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z | |||
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 367,40 | Z |
| 96324 | HUMEGON 75UT | inj 10x75ut+solv. | ORG | NL | |||
| 97397 | HUMEGON 150UT | inj 10x150ut+solv. | ORG | NL | |||
| 70522 | PERGOGREEN 75 | inj sic 1x75ut+1ml | LSE | CH | |||
| 83166 | PERGOGREEN 75 | inj sic 10x75ut+1ml | LSE | CH | |||
| 83167 | PERGOGREEN 75 | inj sic 10x75ut+1ml | SRO | I | |||
| 97845 | PERGONAL 75 | inj sic 1+solv. | LSE | CH | |||
| 97857 | PERGONAL 75 | inj sic 10+solv. | LSE | CH | |||
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 367,40 | Z |
| 215.3 | G03GA05 | folitrofin beta | parent. | 75 | U | 450,00 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX | |||
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,35 | L/GYN,END, SEX |
| 83672 | CLOMHEXAL 50 | tbl 10x50mg | HEX | D | |||
| 02628 | GRAVOSAN | tbl 30x50mg | LEX | CZ | |||
| 217 | G03HA | antiandrogeny | p.o. | L/PSY,END,URN,GYN, SEX | |||
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 250,20 | L/PSY,END, URN, GYN,SEX |
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D | |||
| 77007 | ANDROCUR 10MG | tbl (3x15)=45x10mg | SAG | D | |||
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 87,55 | L/PSY,END, URN, GYN,SEX |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D | |||
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D | |||
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX | |||
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 142,00 | L/PSY,SEX |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D | |||
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM,ALG, SEX | |||
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 87,75 | L/GYN,END, HEM, ALG,SEX |
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY | |||
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY | |||
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 48,45 | L/GYN,END, HEM, ALG,SEX |
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | ||||
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 7,90 | |
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 20,00 | |
| 220.3 | G04AB04 | kyselina oxolinová | p.o. | 1 | GM | 7,90 | |
| 91101 | DESUROL | tbl 50x250mg | LEX | CZ | |||
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | ||||
| 221.1 | G04AC01 | nitrofurantoin | p.o. | 0.2 | GM | 1,90 | |
| 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ | |||
| 221.2 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 1,90 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | ||||
| 222.1 | G04BC | rozpouštědla močových kamenů | p.o. | 10 | GM | 6,15 | |
| 02150 | ALKALIT | gra 1x200gm | IHO | CZ | |||
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX | |||
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 14,00 | L/URN,GYN, SEX |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 14,00 | L/URN,GYN, SEX |
| 04365 | CYSTRIN 5MG | tbl obd 100x5mg | LOY | SF | |||
| 66791 | DITROPAN | tbl 30x5mg | MDD | F | |||
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 14,00 | L/URN,GYN, SEX PDD |
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 12,15 | L/URN,GYN, SEX |
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | |||
| 224.1 | G04BX | doxazosin | p.o. | 4 | MG | 23,10 | L/URN |
| 224.2 | G04BX | terazosin | p.o. | 5 | MG | 23,10 | L/URN |
| 224.3 | G04BX | extrakt Pyg. africanum v komb. | p.o. | 2 | DF | 20,60 | L/URN |
| 224.4 | G04BX | mepartricin | p.o. | 150 | KU | 27,75 | L/URN |
| 224.5 | G04BX02 | alfuzosin | p.o. | 7.5 | MG | 27,75 | L/URN |
| 224.6 | G04BX02 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 27,75 | L/URN |
| 224.7 | G04BX04 | finasterid | p.o. | 5 | MG | 27,75 | L/URN |
| 224.8 | G04BX07 | extrakt Pyg. africanum | p.o. | 2 | DF | 20,60 | L/URN |
| 224.9 | G04BX08 | tamsulosin | p.o. | 0.4 | MG | 27,75 | L/URN |
| 224.10 | G04BX09 | extrakt Serenoa repens | p.o. | 320 | MG | 20,60 | L/URN |
| 75843 | CAPISTAN 160MG | cps 60x160mg | PFB | F | |||
| 225 | H01A | hormony předního laloku hypofýzy | parent. | ||||
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 62,45 | L/END |
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 782,75 | L/J5 |
| 86419 | SAIZEN | inj sic 1x4ut+1ml | SRO | MEX | |||
| 91584 | SAIZEN | inj sic 1x4ut+1ml | SRO | CH | |||
| 61227 | SAIZEN 10 | inj sic 1x10ut+5ml | SRO | CH | |||
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H | |||
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 84,30 | H |
| 226.2 | H01BA04 | terlipresin | parent. | 1 | DF | 61,80 | H |
| 226.3 | H01BA05 | ornipresin | parent. | 5 | U | 28,20 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | ||||
| 227.1 | H01BA02 | desmopresin (nasálně) | lok. | 25 | RG | 21,10 | |
| 02634 | ADIURETIN SD | gtt nas 1x5ml/0.5mg | FRL | CZ | |||
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H | |||
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 41,10 | H |
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 18,20 | H |
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | |||
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,40 | Z |
| 86238 | KRYPTOCUR | inh sol 1x10gm+pump | HOE | D | |||
| 86239 | KRYPTOCUR | inh sol 2x10gm+pump | HOE | D | |||
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X | |||
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 8240,00 | X |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5166,60 | X |
| 93864 | SANDOSTATIN | inj 5x1ml/0.05mg | SAN | CH | |||
| 93865 | SANDOSTATIN | inj 5x1ml/0.1mg | SAN | CH | |||
| 93866 | SANDOSTATIN | inj 5x1ml/0.5mg | SAN | CH | |||
| 93867 | SANDOSTATIN | inj 5x1ml/1mg-lahv. | SAN | CH | |||
| 230.3 | H01CB03 | lantreotid | parent. | 2,14 | MG | 2265,70 | X |
| 231 | H02AA | mineralokortikoidy | p.o. | ||||
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,75 | |
| 23865 | FLUDROCORTISON | tbl 100x0.1mg | SQH | D | |||
| 232 | H02AB | glukokortikoidy | p.o. | ||||
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,50 | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 9,90 | |
| 67218 | FORTECORTIN 4 | tbl 30x4mg | MEC | D | |||
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | |||
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,50 | |
| 00105 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-lahv. | LEX | CZ | |||
| 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ | |||
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,50 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,55 | |
| 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 2,55 | |
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,75 | |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,75 | |
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,95 | |
| 233 | H02AB | glukokortikoidy | parent. | O | |||
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,95 | O |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 4,35 | O |
| 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,50 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | |||
| 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,70 | O |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | |||
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 34,00 | O |
| 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,60 | O |
| 233.7 | H02AB04 | methylprednisolon (od 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 25,55 | O |
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 18,90 | O |
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 13,25 | O |
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 11,60 | O |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 10,55 | O |
| 234 | H03AA | hormony štítné žlázy | p.o. | ||||
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,40 | |
| 234.2 | H03AA01 | levothyroxin sodný (nad 50 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,45 | |
| 85602 | ELTROXIN | tbl 1000x0.1mg | GLA | D | |||
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | |||
| 62191 | EUTHYROX 150 | tbl 100x150rg | MEC | D | |||
| 77587 | L-THYROXIN 100 BERLIN-CHEMIE | tbl 100x100rg | BCE | D | |||
| 96146 | L-THYROXINE 100 HENNING | tbl 100x100rg | HNB | D | |||
| 96150 | L-THYROXINE 150 HENNING | tbl 100x150rg | HNB | D | |||
| 234.3 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 2,00 | |
| 62190 | EUTHYROX 50 | tbl 100x50rg | MEC | D | |||
| 77584 | L-THYROXIN 50 BERLIN-CHEMIE | tbl 100x50rg | BCE | D | |||
| 234.4 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,10 | |
| 234.5 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 2,70 | |
| 234.6 | H03CA | jódová terapie | p.o. | 200 | RG | 1,95 | |
| 235 | H03B | thyreostatika | p.o. | ||||
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,45 | |
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 0,95 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | |||
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,30 | |
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,70 | |
| 236 | H03B | thyreostatika | parent. | H | |||
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,85 | H |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | |||
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 320,20 | L/DIA |
| 90511 | GLUCAGON | inj sic 1x10mg+sol | LIL | USA | |||
| 97533 | GLUCAGON | inj sic 1x1mg+sol | LIL | D | |||
| 97534 | GLUCAGON | inj sic 1x10mg+sol | LIL | D | |||
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 905,70 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | |||
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | |||
| 238.1 | H05BA01 | kalcitonin (lososí, do 50 U v jednom balení včetně) | inhal. | 200 | U | 297,00 | L/INT,GYN, ORT, END |
| 78279 | MIACALCIC NASAL (+POCITAC DAVEK) | spr 1x14x50ut | SAN | CH | |||
| 238.2 | H05BA01 | kalcitonin (lososí, nad 50 U v jednom balení) | inhal. | 200 | U | 263,00 | L/INT,GYN, ORT, END |
| 78280 | MIACALCIC NASAL (+POCITAC DAVEK) | spr 1x14x100ut | SAN | CH | |||
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | |||
| 239.1 | H05BA01 | kalcitonin (lososí, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 120,80 | L/INT,GYN, ORT, END |
| 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B | |||
| 239.2 | H05BA01 | kalcitonin (lososí, nad 50 U v jedné ampuli) | parent. | 100 | U | 178,40 | L/INT,GYN, ORT, END |
| 89222 | UCECAL 100 I.U. | inj 5x1ml/100ut | UCB | B | |||
| 239.3 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 120,80 | L/INT,GYN, ORT, END |
| 239.4 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 178,40 | L/INT,GYN, ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | ||||
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,10 | |
| 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ | |||
| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | |||
| 97509 | DOXYCYCLIN-RATIOPHARM 100 | cps 10x100mg | MCK | D | |||
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | |||
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | |||
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | |||
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | |||
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | |||
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | |||
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,10 | |
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,10 | |
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,10 | |
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,10 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K | |||
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 96,80 | K |
| 94790 | VIBRAMYCIN | inj sic 1x200mg | PFI | B | |||
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 96,80 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | ||||
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,30 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | |||
| 243 | J01BA | amfenikolová antibiotika | parent. | K | |||
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 206,45 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | |||
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 180,35 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | ||||
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 17,00 | |
| 96893 | APO-AMPI 250MG | cps 100x250mg | APT | CND | |||
| 96895 | APO-AMPI 500MG | cps 100x500mg | APT | CND | |||
| 60916 | AMPICILIN 250 LECIVA | cps 20x250mg | LEX | CZ | |||
| 60917 | AMPICILIN 250 LECIVA | cps 30x250mg | LEX | CZ | |||
| 60920 | AMPICILIN 500 LECIVA | cps 20x500mg | LEX | CZ | |||
| 60921 | AMPICILIN 500 LECIVA | cps 30x500mg | LEX | CZ | |||
| 71996 | AMPICILIN K | cps 24x500mg | KRK | SLO | |||
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 20,70 | |
| 84508 | AMPICILIN 250 LECIVA | sir sic 1x5gm/100ml | LEX | CZ | |||
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) | p.o. | 1 | GM | 10,35 | |
| 244.4 | J01CA04 | amoxicilin (tekuté lékové formy) | p.o. | 1 | GM | 13,35 | |
| 244.5 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 17,00 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K | |||
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 28,20 | K |
| 60248 | PENTREXYL | inj sic 50x250mg | BMS | I | |||
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | |||
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 1.046,30 | U/ATB |
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1500,35 | U/ATB |
| 93546 | ISIPEN | inj 1x2gm | KRK | SLO | |||
| 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR | |||
| 94252 | PIPRIL | inj sic 1x4gm | LED | USA | |||
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 2026,35 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | ||||
| 247.1 | J01CE02 | fenoxymethylpenicilin (1 MU a více v jedné tabletě) | p.o. | 2 | GM | 21,50 | |
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | |||
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | |||
| 69468 | PENBENE | tbl obd 30x1mu | MCK | D | |||
| 69467 | PENICILLIN V 1 MEGA VON CT | tbl obd 10x1mu | CTA | D | |||
| 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 1 MU v jedné tabletě) | p.o. | 2 | GM | 20,45 | |
| 56831 | OSPEN 500 | tbl obd 12x500ku | BCA | A | |||
| 84626 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-lekov. | SLO | SK | |||
| 84627 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-lekov. | SLO | SK | |||
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | |||
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | |||
| 247.3 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,50 | |
| 247.4 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 32,20 | |
| 247.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 kIU v 5 ml včetně) | p.o. | 2 | GM | 69.50 | |
| 98281 | INFECTOCILLIN 250 SIRUP | gra sus 1x75ml | INF | D | |||
| 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 kIU v 5 ml) | p.o. | 2 | GM | 26.90 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | |||
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 140,90 | K |
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK | |||
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | |||
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 52,50 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | |||
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.0 | MU | 82,30 | K |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.0 | MU | 33,70 | K |
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 75,10 | K |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 34,70 | K |
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,40 | K |
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | ||||
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 29,40 | |
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 40,90 | |
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 29,40 | |
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ | |||
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I | |||
| 60247 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | I | |||
| 60437 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | USA | |||
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 40,90 | |
| 02999 | OXACILIN | plv sus 80ml 4.84gm | GNO | CZ | |||
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | |||
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 84,60 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | |||
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | ||||
| 251.1 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 41,80 | |
| 251.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 52,00 | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 42,00 | |
| 96416 | AMOKSIKLAV FORTE | plv sus 1x100ml | LEK | SLO | |||
| 251.4 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 104,80 | |
| 251.5 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 137,70 | |
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg v 1 tabletě) | p.o. | 1 | GM | 38,00 | |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | |||
| 252.1 | J01CR01 | ampicilin a inhibitor beta-laktamázy | parent. | 1,5 | GM | 214,60 | U/ATB |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 113,80 | U/ATB |
| 97659 | AUGMENTIN I.V. | inj 10x600mg | LEX | CZ | |||
| 97660 | AUGMENTIN I.V. | inj 5x1.2gm | LEX | CZ | |||
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1862,60 | U/ATB |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 2026,35 | U/ATB |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 73,45 | U |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 406,10 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | ||||
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 39,00 | |
| 67208 | CEPHABENE 500MG | tbl obd 10x500mg | MCK | D | |||
| 67209 | CEPHABENE 500MG | tbl obd 20x500mg | MCK | D | |||
| 67211 | CEPHABENE 1000MG | tbl obd 10x1000mg | MCK | D | |||
| 67212 | CEPHABENE 1000MG | tbl obd 20x1000mg | MCK | D | |||
| 83719 | CEPHALEXIN DH 250MG DIAG HUMAN | cps 30x250mg | GNS | GB | |||
| 83720 | CEPHALEXIN DH 500MG DIAG HUMAN | cps 30x500mg | GNS | GB | |||
| 98015 | CEPHALEXIN DH 250MG DIAG HUMAN | cps 100x250mg | GNS | GB | |||
| 98017 | CEPHALEXIN DH 500MG DIAG HUMAN | cps 100x500mg | GNS | GB | |||
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,80 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 117,00 | |
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 132,00 | |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 98,00 | |
| 253.6 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 132,00 | |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 121,00 | |
| 253.8 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 56,25 | |
| 253.9 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 75,55 | |
| 253.10 | J01DA23 | cefixim | p.o. | 0.4 | GM | 117,00 | ATB |
| 253.11 | J01DA26 | cefetamet | p.o. | 1 | GM | 110,00 | ATB |
| 253.12 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 117,00 | ATB |
| 253.13 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 117,00 | ATB |
| 253.14 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 95,00 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB |
Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog
- a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,
- b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 192,65 | U |
|---|---|---|---|---|---|---|---|
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 192,65 | U |
| 76039 | KEFZOL | inj sic 1x1gm | LIL | E | |||
| 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND | |||
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 959,30 | U/ATB |
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 509,10 | U/ATB |
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 629,80 | U/ATB |
| 254.6 | J01DA10 | cefotaxim | parent. | 6 | GM | 629,80 | U/ATB |
| 254.7 | J01DA11 | ceftazidim | parent. | 6 | GM | 1872,80 | U/ATB |
| 254.8 | J01DA12 | cefsulodin | parent. | 6 | GM | 629,80 | U/ATB |
| 254.9 | J01DA13 | ceftriaxon | parent. | 2 | GM | 900,20 | ambulantně: K/P ústavně: U/ATB |
| 254.10 | J01DA22 | ceftizoxim | parent. | 4 | GM | 629,80 | U/ATB |
| 254.11 | J01DA30 | cefapirin | parent. | 4 | GM | 199,20 | U/ATB |
| 254.12 | J01DA32 | cefoperazon | parent. | 6 | GM | 1836,75 | U/ATB |
| 254.13 | J01DA37 | cefpirom | parent. | 4 | GM | 1743,20 | U/ATB |
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | |||
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1450,40 | U/ATB |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I | |||
| 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | |||
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2492,60 | U/ATB |
| 83487 | MERONEM 500MG I.V. | inj sic 10x500mg | ZNC | GB | |||
| 83488 | MERONEM 500MG I.M. | inj sic 1x500mg+sol | ZNC | GB | |||
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2492,60 | U/ATB |
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | ||||
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 13,20 | |
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 10,20 | |
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,95 | |
| 00313 | SULFISOXAZOL LECIVA | tbl 20x500mg-blistr | LEX | CZ | |||
| 01178 | SULFISOXAZOL LECIVA | tbl 20x500mg-lahv. | LEX | CZ | |||
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | ||||
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 16,40 | |
| 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 7,30 | |
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | |||
| 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND | |||
| 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND | |||
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,60 | |
| 98100 | BERLOCID 240 | sus 1x100ml | BCE | D | |||
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 7,10 | |
| 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,60 | |
| 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 7,10 | |
| 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,60 | |
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 7,10 | |
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | |||
| 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 109,10 | K |
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | |||
| 260 | J01FA | makrolidová antibiotika | p.o. | ||||
| 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,55 | |
| 72544 | ERYC | cps 24x250mg | BOL | H | |||
| 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 54,35 | |
| 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D | |||
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | |||
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | |||
| 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 68,80 | |
| 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 19,65 | |
| 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 49,75 | |
| 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 43,00 | |
| 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 43,00 | |
| 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 54,35 | |
| 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 68,80 | |
| 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 79,60 | |
| 260.11 | J01FA10 | azithromycin (pevné lékové formy do 250 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 94,60 | |
| 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 102,85 | |
| 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 68,80 | |
| 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 250 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 89,90 | |
| 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,90 | |
| 261 | J01FA | makrolidová antibiotika | parent. | K | |||
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 808,00 | K |
| 261.2 | J01FA02 | spiramycin | parent. | 3 | GM | 1278,55 | K |
| 78174 | ROVAMYCINE 1.5MU | inj sic 1x1.5mu | SPC | F | |||
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | |||
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 70,10 | ATB |
| 91193 | DALACIN C | cps 100x150mg | UPJ | B | |||
| 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | |||
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 167,70 | ATB |
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 27,50 | ATB |
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 167,70 | ATB |
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | |||
| 263.1 | J01FF01 | klindamycin | parent. | 1.8 | GM | 661,35 | U/ATB |
| 98212 | DALACIN C PHOSPHATE | inj 3x6ml 900mg | UPJ | B | |||
| 263.2 | J01FF02 | linkomycin | parent. | 1.8 | GM | 52,85 | U/ATB |
| 264 | J01GA | streptomycin a jeho deriváty | parent. | ||||
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 87,00 | |
| 21694 | STREPTOMYCIN GRUNENTHAL 1GM | inj sic 1x1gm+solv. | GRU | D | |||
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | |||
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 44,85 | U |
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,55 | U |
| 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 46,20 | U |
| 96330 | GENTAMICIN BELUPO | inj 10x2ml/40mg | BLU | CHO | |||
| 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 24,25 | U |
| 96331 | GENTAMICIN BELUPO | inj 10x2ml/80mg | BLU | CHO | |||
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2.467,30 | U/ATB |
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1 | DF | 156,40 | U/ATB |
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 125,90 | U/ATB |
| 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 861,30 | U/ATB |
| 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 466,40 | U/ATB |
| 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 531,85 | U/ATB |
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 311,50 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. | ||||
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 30,00 | |
| 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 37,50 | |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | |||
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | |||
| 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 30,00 | |
| 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 24,70 | |
| 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 24,70 | |
| 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 30,00 | |
| 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 30,00 | |
| 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 90,00 | ATB |
| 267 | J01MA | fluorované chinolony | parent. | U/ATB | |||
| 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 209,20 | U/ATB |
| 267.2 | J01MA02 | ciprofloxacin | parent. | 0.5 | GM | 224,20 | U/ATB |
| 96040 | CIPRINOL | inj 5x10ml/100mg | KRK | SLO | |||
| 267.3 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 95,15 | U/ATB |
| 267.4 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 209,20 | U/ATB |
| 268 | J01XA | ostatní antibiotika | parent. | U/ATB | |||
| 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1708,00 | U/ATB |
| 76214 | LYPHOCIN | inf sic 10x1gm | LYP | USA | |||
| 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 3575,00 | U/ATB |
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 111,00 | U/ATB |
| 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 105,45 | U/ATB |
| 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB | |||
| 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 45,50 | U/ATB |
| 01832 | COLIMYCINE | tbl 50x1.5mu | RBE | F | |||
| 86794 | COLIMYCINE | tbl 50x1.5mu | PRO | F | |||
| 270 | J01XD | imidazolová chemoterapeutika | parent. | U | |||
| 270.1 | J01XD01 | metronidazol | parent. | 1.5 GM | 180,95 | U | |
| 270.2 | J01XD03 | ornidazol | parent. | 1 GM | 47,80 | U | |
| 96404 | AVRAZOR | inj 5x3ml/500mg | LEX | CZ | |||
| 271 | J02AA | antimykotická antibiotika | parent. | U | |||
| 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 290,60 | U |
| 71969 | AMPHOTERICIN B | inj sic 1x50mg | SQH | D | |||
| 272 | J02AB | imidazolová antimykotika | p.o. | ||||
| 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 28,00 | |
| 04243 | NIZORAL | tbl 10x200mg | JAN | B | |||
| 88192 | NIZORAL | tbl 30x200mg | JAN | B | |||
| 273 | J02AB | imidazolová antimykotika | parent. | U | |||
| 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 480,40 | U |
| 04159 | DAKTARIN | inj 5x20ml/200mg | JAN | B | |||
| 274 | J02AC | triazolová antimykotika | p.o. | P |
Krátkodobou léčbu ordinuje gynekolog nebo dermatolog:
- a) vaginální mykózy nereagující na lokálně aplikovaná antimykotika,
- b) recidivy vaginálních mykóz.
Vícedenní léčbu ordinuje infekcionista, hematolog, onkolog, specialista pracující na transplantačních jednotkách nebo dermatolog:
- a) systémové mykózy u imunokomprimovaných pacientů,
- b) těžké formy slizničních a nehtových mykóz vyvolaných kandidami nebo dermatofyty,
- c) profylakticky u imunokomprimovaných pacientů nebo u pacientů před provedením transplantace.
| 274.1 | J02AC01 | flukonazol (do 100 mg v 1 tabletě nebo 5 ml sirupu včetně) | p.o. | 0.2 | GM | 446,60 | P |
|---|---|---|---|---|---|---|---|
| 94381 | DIFLUCAN | cps 28x100mg | PFI | F | |||
| 274.2 | J02AC01 | flukonazol (nad 100 mg v 1 tabletě nebo 5 ml sirupu) | p.o. | 0.2 | GM | 446,60 | P |
| 274.3 | J02AC01 | flukonazol (do 150 mg v jednom balení včetně) | p.o. | 0.15 | GM | 380,70 | P |
| 274.4 | J02AC02 | itrakonazol | p.o. | 0.2 | GM | 122,20 | P |
| 274.5 | J02AC02 | itrakonazol (do 400 mg v jednom balení včetně) | p.o. | 0.2 | GM | 157,30 | P |
| 274.6 | J02AX01 | flucytosin | p.o. | 10 | GM | 877,90 | P |
| 275 | J02AC | triazolová antimykotika | parent. | U/P |
Terapeuticky: těžké, život ohrožující systémové mykózy.
Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.
| 275.1 | J02AC01 | flukonazol | parent. | 0.2 | GM | 1154,90 | U/P |
|---|---|---|---|---|---|---|---|
| 96548 | DIFLUCAN I.V. | inf 1x100ml 2mg/ml | PFI | F | |||
| 275.2 | J02AX01 | flucytosin | parent. | 10 | GM | 2.773,00 | U/P |
| 276 | J04AB | antibiotika k léčbě tuberkulózy | p.o. |
Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 13,40 | |
|---|---|---|---|---|---|---|---|
| 96780 | ARFICIN | cps 100x300mg | BLU | CHO | |||
| 93922 | BENEMICIN | cps 100x300mg | POL | PL | |||
| 11038 | TUBOCIN | cps 100x150mg | PMM | BG | |||
| 11039 | TUBOCIN | cps 100x300mg | PMM | BG | |||
| 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 128,60 | P |
| 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | ||||
| 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 250,00 | |
| 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 565,80 | |
| 98383 | CAPASTAT | inj sic 5x1gm | LIL | F | |||
| 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | ||||
| 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 0,90 | |
| 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ | |||
| 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | ||||
| 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 8,90 | |
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,35 | |
| 03023 | SURAL | tbl 100x400mg | CHN | H | |||
| 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | ||||
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,30 | |
| 93821 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | SPC | F | |||
| 281 | J05A | antivirotika | p.o. | P |
Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog a specialista pracující na transplantačních jednotkách:
- a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,
- b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),
- c) léčba herpes zoster při lokalizaci v obličeji,
- d) profylaxe po alogenní transplantaci kostní dřeně.
Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.
Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir a indavir) indikuje infekcionista pracující v AIDS centrech.
| 281.1 | J05AB | brivudin | p.o. | 0.5 | GM | 469,40 | P |
|---|---|---|---|---|---|---|---|
| 281.2 | J05AB01 | acyklovir | p.o. | 4 | GM | 469,40 | P |
| 84127 | HERPESIN 200 | tbl 25x200mg | LCM | CZ | |||
| 84128 | HERPESIN 400 | tbl 25x400mg | LCM | CZ | |||
| 281.3 | J05AB05 | zidovudin | p.o. | 1.5 | GM | 701,00 | P |
| 281.4 | J05AB07 | didanosin | p.o. | 0.4 | GM | 241,85 | P |
| 281.5 | J05AB08 | zalcitabin | p.o. | 2.25 | MG | 247,30 | P |
| 281.6 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 469,40 | P |
| 281.7 | J05AB10 | lamivudin | p.o. | 0.3 | GM | 253,70 | P |
| 281.8 | J05AB11 | valacyklovir | p.o. | 3 | GM | 469,40 | P |
| 281.9 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 32,90 | P |
| 281.10 | J05AE01 | saquinavir | p.o. | 1 | MG | 701,00 | P |
| 281.11 | JG5AEG3 | ritonavir | p.o. | 1 | MG | 701,00 | P |
| 281.12 | JG5AE | indavir | p.o. | 1 | MG | 701,00 | P |
| 282 | JG5AB | antivirotika ze skupiny nukloeosidů | parent. | U/P |
Léčbu acyklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog a specialista pracující na transplantačních centrech: léčba těžkých infekcí vyvolaných Herpesvirus sp. nebo případy kde nelze podávat léčivo perorálně. Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
- a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,
- b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,
- c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
Léčbu foskarnetem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
- a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů v případě nemožnosti podat gancyklovir nebo při jeho neúčinnosti pro rezistenci,
- b) profylaxe a léčba u pacientů s transplantací u gancyklovir CMV rezistentních infekcí nebo v případě nemožnosti podat gancyklovir.
Léčbu zidovudinem indikuje infekcionista pracující v AIDS centrech.
| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1587,60 | U/P |
|---|---|---|---|---|---|---|---|
| 93260 | HERPESIN 250 | inj sic 10x250mg | LCM | CZ | |||
| 282.2 | J05AB05 | zidovudin | parent. | 1 | GM | 2811,50 | U/P |
| 282.3 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 2005,80 | U/P |
| 282.4 | J05AD01 | foskarnet | parent. | 6.5 | GM | 3075,20 | U/P |
| 283 | J06AA | imunitní séra | parent. | K/P |
Sérum proti stafylokokovým infekcím ordinuje lékař ke komplexní léčbě těžkých stafylokokových infekcí.
Sérum proti záškrtu ordinuje infekcionista nebo pediatr ke komplexní léčbě záškrtu.
Sérum proti hadímu jedu ordinuje lékař k léčbě uštknutí zmijí obecnou.
Sérum proti botulismu ordinuje lékař ke komplexní léčbě botulismu.
Sérum proti plynaté sněti ordinuje infekcionista nebo specialista chirurgických oborů k profylaxi a terapii klostiridiových infekcí.
Sérum proti vzteklině ordinuje infekcionista k profylaxi nebo terapii vztekliny.
| 283.1 | J06AA | sérum proti stafylokokovým infekcím | parent. | | | plně | K/P | | 01194 | STASEA SEVAC | inj. 1x5000ut | SEV | CZ | | | | | 283.2 | J06AA01 | sérum proti záškrtu | parent. | | | plně | K/P | | | | | | | | | | | 283.3 | J06AA03 | sérum proti hadímu jedu | parent. | | | plně | K/P | | 83330 | IPSER EUROPE PASTEUR | inj. 1x5ml | PMX | F | | | | | 01206 | VENISE SEVAC | inj. 1x10ml/10ku | SEV | CZ | | | | | 283.4 | J06AA04 | sérum proti botulinu | parent. | | | plně | K/P | | 01190 | BOSEA SEVAC | inj. 1x35ml | SEV | CZ | | | | | 283.5 | J06AA05 | sérum proti plynaté sněti | parent. | | | plně | K/P | | 01194 | GASEA SEVAC | inj. 1x20ml/25ku | SEV | CZ | | | | | 283.6 | J06AA06 | sérum proti vzteklině | parent. | | | plně | K/P | | 94015 | SERUM ANTIRAB. 1000 U.I.PASTEUR | inj 1x5ml 200ut/ml | PMX | F | | | | | 284 | J06BA | imunoglobuliny, normální lidské | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 284.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci | parent. | 1 | DF | 53,50 | O | | | | | | | | | | | 284.2 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (z tuzemské plazmy zakázkovou frakcionací) | parent. | 1 | GM | 1137,00 | B | | 99819 | NIGA SEVAC | inj sic 1x500mg+sol | SEV | CZ | | | | | 99820 | NIGA SEVAC | inj sic 1x1gm+solv. | SEV | CZ | | | | | 56054 | NIGA SEVAC | inj sic 1x5gm+solv. | SEV | CZ | | | | | 62463 | VENIMMUN | inj sic 1x5gm+solv. | BEH | D | | | | | 284.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1 | GM | 1137,00 | B | | 62553 | INTRAGLOBIN F PRO INFUS. | inf 1x50ml | BTP | D | | | | | 62554 | INTRAGLOBIN F PRO INFUS. | inf 1x100ml | BTP | D | | | | | 62555 | INTRAGLOBIN F PRO INFUS. | inf 1x200ml | BTP | D | | | | | 03833 | IVEGA (IMUNOGLOBUL.LIDSKY I.V.) | inj sic 500mg bilk. | IMA | SK | | | | | 284.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1 | GM | 2000,00 | U | | 285 | J06BB | specifické imunoglobuliny | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu imunoglobuliny proti neštovicím a pásovému oparu ordinuje infekcionista, onkolog, hematolog a pediatr:
- a) neočkované těhotné ženy,
- b) novorozenec po kontaktu s varicellou,
- c) imunokomprimovaný pacient po kontaktu s varicellou,
- d) varicelózní primární pneumonitis.
Léčbu imunoglobulinem proti cytomegalovirové infekci ordinuje infekcionista, onkolog, hematolog nebo pediatr:
- a) novorozenec s prokázanou cytomegalovirovou infekcí,
- b) generalizovaná cytomegalovirová infekce u imunokomprimovaných pacientů,
- c) profylaxe cytomegalovirových infekcí u transplantovaných pacientů při pozitivitě dárce nebo příjemce. Imunoglobulin proti cytomegalovirové infekci je hrazen dle symbolu U.
Imunoglobulin proti tetanu je hrazen dle symbolu B.
| 285.1 | J06BB | protiencefalický globulin | parent. | 1 | ML | 332,30 | K |
|---|---|---|---|---|---|---|---|
| 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 RG v jedné ampuli včetně) | parent. | 250 | RG | 1440,25 | K |
| 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 RG v jedné ampuli) | parent. | 250 | RG | 1110,00 | K |
| 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | plně | B | ||
| 80530 | HUMAN ANTITETANUS IMMMUNEGLOB. | inj sic 1x250ut+2ml | GFO | E | |||
| 80531 | HUMAN ANTITETANUS IMMMUNEGLOB. | inj sic 1x500ut+2ml | GFO | E | |||
| 83607 | TETABULIN | inj 250ut/ml | IMM | A | |||
| 88069 | TEGA IMUNA | inj 1x2ml/250ut | IMA | SK | |||
| 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 34566,40 | K/P |
| 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | plně | K | ||
| 94265 | AUNATIV | inj. 1x5ml | KBP | S | |||
| 01194 | HEPATECT (R) | inj. 1x2ml | BTP | D | |||
| 01194 | HEPATECT (R) | inj. 1x10ml | BTP | D | |||
| 285.7 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 5070,55 | U/P |
| 286 | J07AM | očkovací látky proti tetanu | parent. | K | |||
| 286.1 | J07AM01 | tetanový toxoid | parent. | plně | K | ||
| 83622 | ALTEANA SEVAC | inj 10x0.5ml | SEV | CZ | |||
| 69795 | ALTEANA S IMUNA | inj 10x0.5ml | IMA | SK | |||
| 69796 | ALTEANA S IMUNA | inj 10x1ml | IMA | SK | |||
| 69797 | ALTEANA S IMUNA | inj 10x5ml | IMA | SK | |||
| 69798 | ALTEANA S IMUNA | inj 50x0.5ml | IMA | SK | |||
| 69799 | ALTEANA S IMUNA | inj 50x1ml | IMA | SK | |||
| 83443 | TETAVAX | inj 1x0.05ml-strik. | PMX | F | |||
| 83444 | TETAVAX | inj 20x0.5ml-strik. | PMX | F | |||
| 83445 | TETAVAX | inj 1x10ml | PMX | F | |||
| 83447 | TETAVAX | inj 10x20ml | PMX | F | |||
| 83525 | TETAVAX | inj 20x0.5ml-ampule | PMX | F | |||
| 83526 | TETAVAX | inj 10x10ml | PMX | F | |||
| 287 | J07AN | očkovací látky proti tuberkulóze | parent. | H | |||
| 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 183,00 | H |
| 288 | J07AX | jiné bakteriální očkovací látky | parent. | K | |||
| 288.1 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | plně | K | ||
| 94269 | POLYSTAFANA SEVAC | inj 10x0.5ml | SEV | CZ | |||
| 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,75 | K |
| 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcína) | parent. | 1 | DF | 210,75 | O |
| 289 | J07BG | očkovací látky proti vzteklině | parent. | K | |||
| 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | plně | K | ||
| 66854 | MERIEUX INACTIVAT.RABIES VACC. | lyo 1davka+1ml solv | PMX | F | |||
| 75379 | RABIPUR(PCEC RABIES VACCINE) | inj sic 1x2.5ut+1ml | BEH | D | |||
| 90996 | RABIPUR(PCEC RABIES VACCINE) | inj sic 5x2.5ut+1ml | BEH | D | |||
| 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F | |||
| 290 | L01AA | alkylační cytostatika | p.o. | ||||
| 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,85 | |
| 94174 | CYCLOPHOSPHAMID | tbl 50x50mg | FAO | SF | |||
| 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,60 | |
| 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,80 | |
| 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,40 | |
| 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,95 | |
| 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,70 | |
| 291 | L01AA | alkylační cytostatika | parent. | B/ONK,HEM | |||
| 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,85 | B |
| 94546 | CYCLOPHOSPHAMIDE 200MG | inj 10x200mg | FAO | SF | |||
| 87127 | ENDOXAN | inj sic 1x500mg | ASD | D | |||
| 87128 | ENDOXAN | inj sic 1x1gm | ASD | D | |||
| 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,90 | B/ONK,HEM |
| 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 35,00 | B/ONK,HEM |
| 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,65 | B/ONK,HEM |
| 291.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1 | MG | 1,45 | B/ONK,HEM |
| 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,80 | B/ONK,HEM |
| 292 | L01AB | alkylsulfaty | p.o. | L/ONK,HEM | |||
| 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 15,20 | L/ONK,HEM |
| 93587 | MYLERAN | tbl 25x0.5mg | BWE | GB | |||
| 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 | MG | 5,00 | L/ONK,HEM |
| 21157 | MYLERAN | tbl 100x2mg | BWE | GB | |||
| 293 | L01AD | nitrosomočoviny | p.o. | L/ONK,HEM | |||
| 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,85 | L/ONK,HEM |
| 293.2 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,55 | L/ONK,HEM |
| 293.3 | L01AD02 | lomustin (od 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 | MG | 6,15 | L/ONK,HEM |
| 03735 | LOMUSTINE | cps 6 | BMS | USA | |||
| 294 | L01AD | nitrosomočoviny | parent. | B/ONK,HEM | |||
| 294.1 | L01AD01 | karmustin | parent. | 1 | MG | 10,15 | B/ONK,HEM |
| 80470 | BICNU(CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | D | |||
| 83482 | BICNU(CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | USA | |||
| 294.2 | L01AD04 | streptozocin | parent. | 10 | MG | 15,15 | B/ONK,HEM |
| 295 | L01BA | antimetabolity ze skupiny analog kyseliny listové | p.o. | ||||
| 295.1 | L01BA01 | metotrexát | p.o. | 1 | MG | 1,20 | |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | LCM | CZ | |||
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 296 | L01BA | antimetabolity ze skupiny analog kyseliny listové | parent. | B | |||
| 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 8,85 | B |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ | |||
| 296.2 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,75 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | |||
| 296.3 | L01BA01 | metotrexát (od 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,15 | B |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ | |||
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | |||
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | |||
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ | |||
| 83484 | METHOTREXAT LEDERLE | inf 1x20ml/500mg | LED | D | |||
| 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. | L/ONK,HEM | |||
| 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 6,35 | L/ONK,HEM |
| 94241 | PURI-NETHOL | tbl 25x50mg | BWE | GB | |||
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9,55 | L/ONK,HEM |
| 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. | B/ONK,HEM | |||
| 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 1199,00 | B/ONK,HEM |
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 139,20 | B/ONK,HEM |
| 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG | D | |||
| 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. | L/ONK,HEM | |||
| 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,70 | L/ONK,HEM |
| 299.2 | L01BC02 | fluorouracil | p.o. | 10 | MG | 1,45 | L/ONK,HEM |
| 10407 | FTORAFUR | cps 100x400mg | MDX | SU | |||
| 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. | B/ONK,HEM | |||
| 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,30 | B/ONK,HEM |
| 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,10 | B/ONK,HEM |
| 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,90 | B/ONK,HEM |
| 84119 | 5-FU LEDERLE | inj 1x20ml/1gm | LED | D | |||
| 300.4 | L01BC05 | gemcitabin | parent. | 1 | MG | 6,30 | B/ONK,HEM |
| 301 | L01CA | vinka alkaloidy a jejich deriváty | parent. | B/ONK,HEM | |||
| 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 27,15 | B/ONK,HEM |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 186,80 | B/ONK,HEM |
| 74990 | CITOMID 1MG | inj sic 1x1mg+10ml | LMR | MEX | |||
| 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 110,75 | B/ONK,HEM |
| 302 | L01CB | podofylotoxinové deriváty | p.o. | L/ONK,HEM | |||
| 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 4,00 | L/ONK,HEM |
| 86416 | VEPESID | cps 20x50mg | BMS | D | |||
| 86417 | VEPESID | cps 10x100mg | BMS | D | |||
| 303 | L01CB | podofylotoxinové deriváty | parent. | B/ONK,HEM | |||
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 4,25 | B/ONK,HEM |
| 78088 | ETOPOSIDE PIERRE FABRE | inj 5x5ml/100mg | PFB | F | |||
| 86418 | VEPESID | inj 10x5ml/100mg | BMS | D | |||
| 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,45 | B/ONK,HEM |
| 304 | L01CD | taxany | parent. | X | |||
| 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 191,30 | X |
| 44134 | TAXOL | inj 1x17ml/100mg | BMS | I | |||
| 76204 | TAXOL | inj 1x5ml/30mg | BMS | I | |||
| 92494 | TAXOL | inj 10x5ml/30mg | BMS | I | |||
| 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 335,30 | X |
| 305 | L01DA | aktinomyciny | parent. | B/ONK,HEM | |||
| 305.1 | L01DA01 | daktinomycin | parent. | 1 | MG | 680,10 | B/ONK,HEM |
| 21055 | LYOVAC COSMEGEN | inj sic 1x0.5mg | MSD | USA | |||
| 306 | L01DB | antracykliny a jejich deriváty | p.o. | X | |||
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 303,40 | X |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | |||
| 78813 | ZAVEDOS 10MG | cps 1x10mg | FAE | I | |||
| 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I | |||
| 307 | L01DB | antracykliny a jejich deriváty | parent. | B/ONK,HEM | |||
| 307.1 | L01DB01 | doxorubicin | parent. | 1 | MG | 39,70 | B/ONK,HEM |
| 12663 | DOXORUBICIN EBEWE 10MG | inj 1x5ml/10mg | EBW | A | |||
| 12664 | DOXORUBICIN EBEWE 50MG | inj 1x25ml/50mg | EBW | A | |||
| 94567 | RASTOCIN | inj 10x10mg | PLI | CHO | |||
| 307.2 | L01DB02 | daunorubicin | parent. | 1 | MG | 21,45 | B/ONK,HEM |
| 307.3 | L01DB03 | epirubicin | parent. | 1 | MG | 47,90 | B/ONK,HEM |
| 307.4 | L01DB04 | aklarubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 307.5 | L01DB05 | zorubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 307.6 | L01DB06 | idarubicin | parent. | 1 | MG | 770,85 | B/ONK,HEM |
| 307.7 | L01DB07 | mitoxantron | parent. | 1 | MG | 40,00 | B/ONK,HEM |
| 308 | L01DC | ostatní cytotoxická antibiotika | parent. | B/ONK,HEM | |||
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 59,25 | B/ONK,HEM |
| 03404 | BLEOCIN | inj 1x15mg | NKU | J | |||
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 86,60 | B/ONK,HEM |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 69,30 | B/ONK,HEM |
| 309 | L01XA | platinová cytostatika | parent. | B/ONK,HEM | |||
| 309.1 | L01XA01 | cisplatina | parent. | 1 | MG | 8,00 | B/ONK,HEM |
| 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ | |||
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | |||
| 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ | |||
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | MG | 6,35 | B/ONK,HEM |
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 4,00 | B/ONK,HEM |
| 310 | L01XB | methylhydrazinová cytostatika | p.o. | L/ONK,HEM | |||
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2,50 | L/ONK,HEM |
| 01814 | NATULAN | cps 50x50mg | HLR | CH | |||
| 311 | L01XX | ostatní cytostatika | p.o. | L/ONK,HEM,URN | |||
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,35 | L/ONK,HEM, URN |
| 95122 | LITALIR | cps 100x500mg | BMS | D | |||
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 4,10 | L/ONK,HEM, URN |
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 107,25 | L/ONK,HEM, URN |
| 312 | L01XX | ostatní cytostatika | parent. | B/ONK,HEM |
Léčbu L-asparaginázou ordinuje onkolog nebo hematolog. Revizní lékař pojišťovny může na základě žádosti lékaře povolit plnou úhradu ekonomicky náročnějších přípravků obsahujících L-asparaginázu v případě, že se jedná o podání dětem do 18 let věku, nebo že se jedná o opakované podání starším osobám, případně u pacientů s alergickou anamnézou.
| 312.1 | L01XX01 | amsakrin | parent. | 1 | MG | 29,00 | B/ONK,HEM |
|---|---|---|---|---|---|---|---|
| 312.2 | L01XX02 | asparagináza | parent. | 1 | MG | 2848,40 | B/P |
| 312.3 | L01XX11 | estramustin | parent. | 1 | MG | 1,30 | B/ONK,HEM, URN |
| 312.4 | L01XX13 | dakarbazin | parent. | 10 | MG | 8,10 | B/ONK,HEM |
| 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | |||
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | |||
| 312.5 | L01XX17 | topotekan | parent. | 1 | MG | 3136,70 | X |
| 313 | L02AA | estrogeny | p.o. | L/ONK,HEM,URN,GYN, SEX | |||
| 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,40 | L/ONK,HEM, URN GYN,SEX |
| 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,15 | L/ONK,HEM, URN GYN,SEX |
| 87548 | TURISTERON | drg 21x1mg | VJP | D | |||
| 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,40 | L/ONK,HEM, URN GYN,SEX |
| 314 | L02AA | estrogeny | parent. | B/ONK,HEM,URN,SEX | |||
| 314.1 | L02AA | polyestradioli phosphas | parent. | 1 | MG | 3,55 | B/ONK,HEM, URN,SEX |
| 88381 | ESTRADURIN | inj sic 10x80mg+2ml | KBP | S | |||
| 314.2 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,70 | B/ONK,HEM, URN,SEX |
| 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,90 | B/ONK,HEM, URN,SEX |
| 315 | L02AB | progestiny | p.o. | L/ONK,HEM,URN,GYN, SEX | |||
| 315.1 | L02AB01 | megestrol | p.o. | 10 | MG | 3,15 | L/ONK,HEM, URN GYN,SEX |
| 315.2 | L02AB02 | medroxyproges-teron | p.o. | 10 | MG | 2,00 | L/ONK,HEM, URN GYN,SEX |
| 88429 | FARLUTAL | tbl 30x500mg | FAR | I | |||
| 91618 | PROVERA | tbl 20x500mg | UPJ | GB | |||
| 316 | L02AB | progestiny | parent. | L/ONK,GYN,SEX | |||
| 316.1 | L02AB02 | medroxyproges-teron | parent. | 10 | MG | 3,35 | L/ONK,GYN, SEX |
| 90993 | DEPO-PROVERA 500 | inj 1x3.3ml/500mg | UPJ | B | |||
| 85678 | FARLUTAL DEPOT | inj 1x2.5ml/500mg | PHA | I | |||
| 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,15 | L/ONK,GYN, SEX |
| 317 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | inhal. | Z | |||
| 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 229,85 | Z |
| 90966 | SUPREFACT NASAL | sol nas 4x10gm/10mg | HOE | D | |||
| 318 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | parent. | K/P |
Léčbu ordinuje onkolog, urolog nebo gynekolog:
- a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen, jen po dobu adjuvantní chemo- nebo radioterapie.
- b) léčba karcinomu prostaty,
- c) léčba myomatózy spojené s poruchou fertility nebo její těžké formy vyžadující předoperační redukci nálezu,
- d) léčba těžkých, jinak konzervativně nereagujících forem endometriózy,
- e) pubertas precox,
- f) indukce ovulace při in vitro fertilizaci pouze na základě předchozího schválení revizním lékařem.
| 318.1 | L02AE01 | buserelin | parent. | 1 | MG | 273,65 | K/P | | 90961 | SUPREFACT | inj 2x5.5ml/5.5mg | HOE | D | | | | | 318.2 | L02AE01 | buserelin (depotní lékové formy) | parent. | 1 | MG | 2077,15 | K/P | | | | | | | | | | | 318.3 | L02AE02 | leuprorelin | parent. | 1 | MG | 273,65 | K/P | | | | | | | | | | | 318.4 | L02AE02 | leuprorelin (depotní lékové formy) | parent. | 1 | MG | 1852,35 | K/P | | | | | | | | | | | 318.5 | L02AE03 | goserelin (depotní lékové formy) | parent. | 1 | MG | 1944,45 | K/P | | | | | | | | | | | 318.6 | L02AE04 | triptorelin | parent. | 1 | MG | 273,65 | K/P | | | | | | | | | | | 318.7 | L02AE04 | triptorelin (depotní lékové formy) | parent. | 1 | MG | 1901,50 | K/P | | 319 | L02BA | antiestrogeny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 319.1 | L02BA01 | tamoxifen (do 20mg v 1 tabletě včetně) | p.o. | 10 | MG | 3,45 | | | 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | | | | | 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBW | A | | | | | 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBW | A | | | | | 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | | | 71959 | ZITAZONIUM 10MG | tbl 10x10mg | EGI | H | | | | | 71958 | ZITAZONIUM 10MG | tbl 30x10mg | EGI | H | | | | | 44144 | ZITAZONIUM 20MG | tbl 30x20mg | EGI | H | | | | | 31243 | ZITAZONIUM 20MG | tbl 60x20mg | EGI | H | | | | | 319.2 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 10 | MG | 2,50 | | | 44058 | TAMOXIFEN EBEWE 30 | tbl 30x30mg | EBW | A | | | | | 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | | | | | 320 | L02BB | antiandrogeny | p.o. | L/ONK,URN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 320.1 | L02BB01 | flutamid | p.o. | 10 | MG | 1,35 | L/ONK,URN, SEX | | 55953 | FLUTACAN 250MG | tbl 100x250mg | LOY | SF | | | | | 320.2 | L02BB02 | nilutamid | p.o. | 1 | MG | 0,70 | L/ONK,URN, SEX | | | | | | | | | | | 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 101,25 | L/ONK,URN, SEX | | 321 | L02BG | inhibitory tvorby steroidních hormonů | p.o. | L/ONK,END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 321.1 | L02BG01 | aminogluthetim-id | p.o. | 10 | MG | 0,70 | L/ONK,END | | 07510 | ORIMETEN | tbl 100x250mg | CGC | CH | | | | | 322 | L02BG | inhibitory tvorby steroidních hormonů | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 322.1 | L02BG02 | formestan | parent. | 250 | MG | 4103,40 | X | | 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+2ml | CGC | CH | | | | | 323 | L03AA | cytokiny | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 323.1 | L03AA01 | interleukin 2 | parent. | 1 | MG | 8006,85 | X | | | | | | | | | | | 323.2 | L03AA02 | filgrastim | parent. | 1 | MG | 14664,95 | X | | | | | | | | | | | 323.3 | L03AA03 | molgramostim | parent. | 1 | MG | 15801,45 | X | | | | | | | | | | | 323.4 | L03AA10 | lenograstim | parent. | 1 | MG | 18193,20 | X | | | | | | | | | | | 323.5 | L03AA04 | interferon alfa | parent. | 1 | MU | 263,45 | X | | 76997 | ALPHAFERON 3MU | lyo 1x3mu+solv. | CFD | KOR | | | | | 83942 | HEBERON ALFA R | inj sic 25x3mu | HBC | C | | | | | 89225 | ROFERON A | inj 1x3ml/18mu | HLR | CH | | | | | 323.6 | L03AA08 | interferon gamma | parent. | 1 | MU | 1566,45 | X | | | | | | | | | | | 323.7 | L03AA11 | interferon beta (1a i 1b) | parent. | 1 | MU | 330,15 | X | | 324 | L03AX | ostatní imunostimulační léčiva | lok., p.o. | L/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 324.1 | L03AX | směs bakteriálních lyzátů | lok. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 324.2 | L03AX | směs bakteriálních lyzátů | p.o. | 1 | BA | 75% | | | | | | | | | | | | 324.3 | L03AX | vaccin. staphyl. phagolys. | lok. | 1 | ML | 37,35 | L/ALG | | 94631 | STAVA-NASAL | gtt 10x5ml | BIU | CZ | | | | | 325 | L03AX | ostatní imunostimulační léčiva | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 325.1 | L03A | dialyzát lidských leukocytů | parent. | 1 | DF | 1011,05 | O/ALG,IMU | | 56930 | IMMODIN SEVAC | inj sic 1x2ml+solv. | SEV | CZ | | | | | 97146 | IMMODIN SEVAC | inj sic 5x2ml+solv. | SEV | CZ | | | | | 325.2 | L03A | thymostimulin | parent. | 1 | MG | 42,60 | Z | | | | | | | | | | | 325.3 | L03AX | bac. propionibacterii acnes | parent. | 1 | MG | 74,50 | O/ONK | | | | | | | | | | | 325.4 | L03AX | laktobacillus acidophilus | parent. | 3 | DF | 639,80 | O/GYN | | | | | | | | | | | 325.5 | L03AX | vaccin. staphyl. phagolys. | parent. | 1 | DF | 74,65 | O | | | | | | | | | | | 325.6 | L03AX03 | BCG vakcína | parent. | 1 | MG | 44,35 | O/ONK,URN | | | | | | | | | | | 325.7 | L03AX | dialyzát vepřových leukocytů | p.o. | | | 50% | O/ALG,IMU | | 326 | L04AA | selektivní imunosupresivní léčiva | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu cyklosporinem ordinuje lékař pracující v transplantačních centrech, onkolog, hematolog, dermatolog, urolog a revmatolog:
- a) prevence reakce štěpu proti hostiteli po transplatnacích,
- b) léčba myelodysplaastického sysndromu nereagující na standardní léčbu,
- c) léčba aplastické anemie nereagující na standardní léčbu,
- d) léčba autoimunní hemolytické anemie a autoimunní trombocytopenické purpury nereagující na standardní léčbu,
- e) léčba nefrotického syndromu nereagující na standardní léčbu,
- f) těžké formy revmatoidní artritidy dospělých a dětí se středně těžkým a těžkým průběhem kloubního postižení nebo se současným postižením jiných orgánů (zvláště plic),
- g) těžké generalizované formy psoriázy (psoriasis vulgaris, arthropatica, pustulosa) nereagující na standardní léčbu,
- h) systémový lupus erythematodes nereagující na standardní léčbu,
- i) těžké formy polymyositidy/dermatomyositidy nereagující na standardní léčbu.
Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).
Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů, u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinaci s cyklosporinem a kortikosteroidy.
| 326.1 | L04AA01 | cyklosporin | p.o. | 1 | MG | 1,40 | P | | 94052 | CONSUPREN | sol 1x50ml 100mg/ml | GNO | CZ | | | | | 92572 | CONSUPREN 25MG | cps 50x25mg | GNO | CZ | | | | | 92573 | CONSUPREN 50MG | cps 50x50mg | GNO | CZ | | | | | 92574 | CONSUPREN 100MG | cps 50x100mg | GNO | CZ | | | | | 326.2 | L04AA06 | mophetil mycophenolát | p.o. | 10 | MG | 2,70 | P | | 327 | L04AA | selektivní imunosupresivní léčiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 327.1 | L04AA | antilymfocytár ní IG | parent. | 10 | MG | 106,25 | U/J10 | | | | | | | | | | | 327.2 | L04AA | antithymocy tární IG | parent. | 1 | MG | 124,25 | U/J10 | | | | | | | | | | | 327.3 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,70 | U/J10 | | 95041 | SANDIMMUN KONZENTRAT | inf 10x1ml 50mg/1ml | SAN | CH | | | | | 88514 | SANDIMMUN KONZENTRAT | inf 10x5ml 50mg/1ml | SAN | CH | | | | | 327.4 | L04AA02 | muromonab-CD3 | parent. | 1 | MG | 1250,00 | U/J10 | | 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,60 | L/J10,REV, HEM NEU,OPH,DER | | 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | | | | | 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,15 | L/J10,REV, HEM NEU,OPH,DER | | 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | | | | | 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 10,05 | U/J10 | | 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | | | | | 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 330.1 | M01AA | butylpyrazoli diny | p.o. | 3 | DF | 3,40 | | | 00179 | KETAZON | drg 20x250mg | LEX | CZ | | | | | 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,40 | | | 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 331.1 | M01AA | butylpyrazoli diny | parent. | 1 | DF | 7,05 | | | 00490 | KETAZON | inj 5x5ml/1gm | LEX | CZ | | | | | 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,80 | | | | | | | | | | | | 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,60 | | | 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | | | 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | | | 67403 | INDOBENE 50MG | cps 20x50mg | MCK | D | | | | | 67404 | INDOBENE 50MG | cps 50x50mg | MCK | D | | | | | 02630 | INDREN | cps 30x25mg | LEX | CZ | | | | | 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 5,20 | | | | | | | | | | | | 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 5,20 | | | | | | | | | | | | 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 5,20 | | | | | | | | | | | | 332.6 | M01AB05 | diklofenak (lékové formy s rychlým nástupem účinku) | p.o. | 0.1 | GM | 5,75 | | | | | | | | | | | | 332.7 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 5,20 | | | | | | | | | | | | 332.8 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 5,20 | | | | | | | | | | | | 332.9 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 5,20 | | | | | | | | | | | | 332.10 | M01AB55 | diklofenak/miso-prostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 30,00 | Z | | 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,15 | | | 96329 | INDOMETACIN | sup 10x100mg | BLU | CHO | | | | | 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 11,50 | | | | | | | | | | | | 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 11,50 | | | | | | | | | | | | 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 11,50 | | | 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 11,15 | | | 91579 | METINDOL | inj 10x2ml/60mg | POL | PL | | | | | 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 13,20 | | | 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,55 | | | 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | | | | | 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | | | 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | | | | | 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | | | 67174 | PIROX 10 | tbl 20x10mg | CTA | D | | | | | 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | | | 67175 | PIROX 20 | tbl 20x20mg | CTA | D | | | | | 68582 | PIROX 20 | tbl 50x20mg | CTA | D | | | | | 335.2 | M01AC02 | tenoxikam | p.o. | 20 | MG | 2,55 | | | | | | | | | | | | 335.3 | M01AC06 | meloxikam | p.o. | 15 | MG | 14,65 | L/ORT,REV | | | | | | | | | | | 335.4 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 5,75 | | | 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 11,50 | | | 67172 | PIROX 20 | sup 10x20mg | CTA | D | | | | | 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 11,50 | | | | | | | | | | | | 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 11,50 | | | 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 337.1 | M01AC01 | piroxikam | parent. | 20 | MG | 12,10 | | | 89853 | PIROX 20 VON CT | inj 5x1ml/20mg | CTA | D | | | | | 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 12,10 | | | 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,45 | | | 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | | | 83721 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 30x400mg | GNS | GB | | | | | 98321 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 250x400mg | GNS | GB | | | | | 98324 | IBUPROFEN DH 600MG DIAG HUMAN | tbl obd 250x600mg | GNS | GB | | | | | 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 20,00 | | | | | | | | | | | | 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 5,20 | | | | | | | | | | | | 338.4 | M01AE02 | naproxen (tekuté lékové formy) | p.o. | 0.5 | GM | 13,45 | | | | | | | | | | | | 338.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 5,20 | | | | | | | | | | | | 338.6 | M01AE07 | suprofen | p.o. | 0.4 | GM | 5,20 | | | | | | | | | | | | 338.7 | M01AE08 | pirprofen | p.o. | 0.8 | GM | 5,20 | | | | | | | | | | | | 338.8 | M01AE09 | flurbiprofen | p.o. | 0.2 | GM | 5,20 | | | | | | | | | | | | 338.9 | M01AE10 | indoprofen | p.o. | 0.6 | GM | 5,20 | | | | | | | | | | | | 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 8,80 | | | | | | | | | | | | 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 5,20 | | | 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 11,50 | | | 67504 | IBUPROF VON CT | sup 10x500mg | CTA | D | | | | | 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 11,50 | | | | | | | | | | | | 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 11,50 | | | | | | | | | | | | 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 11,50 | | | 340 | M01A | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 340.1 | M01AE01 | ibuprofen | parent. | 1.2 | GM | 20,20 | | | | | | | | | | | | 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 20,20 | | | 62598 | NAPROSYN | inj 5x5ml/500mg | KRK | SLO | | | | | 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 20,20 | | | | | | | | | | | | 340.4 | M01AG | etofenamat | parent. | 1 | GM | 20,20 | | | 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 29,25 | L/REV | | 83731 | RELIFEX | tbl obd 20x500mg | LEX | CZ | | | | | 341.2 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 5,20 | | | | | | | | | | | | 341.3 | M01AX05 | glukosamin sulfat | p.o. | 1.5 | GM | 11,70 | L/REV | | | | | | | | | | | 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 5,20 | | | | | | | | | | | | 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,65 | L/REV | | | | | | | | | | | 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 20,00 | L/REV,PDD | | | | | | | | | | | 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,65 | L/REV | | 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,40 | L/REV | | 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | | | 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | | | 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu kyselinou hyaluronovou ordinuje ortoped nebo revmatolog:
součást léčby primární osteoarthrózy kolenních kloubů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 32,65 | | | 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | | | 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 23,50 | | | 92732 | TROLOVOL | tbl obd 50x300mg | ASD | D | | | | | 09738 | TROLOVOL | tbl obd 100x300mg | ASD | D | | | | | 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 200,00 | P | | | | | | | | | | | 343.4 | M09AX02 | chondroitin sulfat | p.o. | 1.6 | GM | 20,00 | L/REV | | 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.2 | M02AA | ketofenylbutaz-on | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.3 | M02AA05 | benzydamin | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.4 | M02AA06 | etofenamát | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.5 | M02AA07 | piroxikam | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.6 | M02AA10 | ketoprofen | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.7 | M02AA13 | ibuprofen | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.8 | M02AA15 | diklofenak | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.9 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,20 | | | | | | | | | | | | 344.10 | M02AA17 | kyselina niflumová | lok. | 1 | GM | 1,00 | | | 344.11 | M02AA21 | tolectin | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.12 | M02AA23 | indomethacin | lok. | 1 | GM | 1,00 | | | 67408 | INDOBENE | gel 1x50gm | MCK | D | | | | | 67409 | INDOBENE | gel 1x100gm | MCK | D | | | | | 88595 | INDOMETACINOVY GEL 1% GLO | gel 1x50gm | GAO | CZ | | | | | 66959 | VONUM CUTAN | ung 1x75gm | LIC | D | | | | | 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 1,00 | | | 03574 | RHEUMOSIN | ung 1x30gm | LEX | CZ | | | | | 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 1,00 | | | 83872 | UNGUENTUM CAMPHORATUM 10% MVM | ung 1x1kg | MVM | CZ | | | | | 83873 | UNGUENTUM CAMPHORATUM 20% MVM | ung 1x1kg | MVM | CZ | | | | | 91114 | VIPROSAL B | ung 1x50gm | TAL | EST | | | | | 91764 | YELLON | gel 1x50gm | SLO | SK | | | | | 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,40 | | | 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 65,00 | H | | | | | | | | | | | 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 57,10 | H | | 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 348.1 | M03AB | decamethonium | parent. | 10 | MG | 24,30 | H | | | | | | | | | | | 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 55,00 | H | | | | | | | | | | | 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 31,20 | H | | 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 116,20 | H | | | | | | | | | | | 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 44,10 | H | | | | | | | | | | | 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 116,20 | H | | | | | | | | | | | 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 118,50 | H | | | | | | | | | | | 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 105,85 | H | | | | | | | | | | | 349.6 | M03AC10 | mivacuronium | parent. | 10 | MG | 132,55 | H | | 350 | M03AX | ostatní svalová relaxancia | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 8950,00 | X | | | | | | | | | | | 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2318,55 | X | | 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | | | | | 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 351.1 | M03BX | tetrazepam | p.o. | 0.1 | GM | 18,00 | L/NEU,ORT, REV | | | | | | | | | | | 351.2 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 10,20 | | | 40274 | BACLOFEN | tbl 50x10mg | POL | PL | | | | | 351.3 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,45 | | | 40275 | BACLOFEN | tbl 50x25mg | POL | PL | | | | | 351.4 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 27,60 | L/NEU,ORT, REV | | | | | | | | | | | 351.5 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 20,40 | L/NEU,ORT, REV | | | | | | | | | | | 351.6 | M03BX04 | tolperison | p.o. | 200 | MG | 2,55 | | | | | | | | | | | | 351.7 | M03BX04 | tolperison | parent. | 200 | MG | 8,40 | | | 352 | M03CA | přímo působící svalová relaxancia | parent. | T | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7484,60 | T | | 91583 | DANTROLEN | inj sic 3x12x20mg+so | RHA | D | | | | | 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,50 | | | 96332 | ALOPURINOL BELUPO | tbl 100x100mg | BLU | CHO | | | | | 97981 | APO-ALLOPURINOL 100MG | tbl 100x100mg | APT | CND | | | | | 67216 | PURINOL 100MG | tbl 100x100mg | MCK | A | | | | | 67217 | PURINOL 300MG | tbl 30x300mg | MCK | A | | | | | 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,20 | | | | | | | | | | | | 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,90 | | | 11854 | DESURIC | tbl 60x100mg | SWI | F | | | | | 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | | | 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,85 | | | 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | KCH | D | | | | | 356 | M05BA | bisfosfonáty | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog nebo endokrinolog:
- a) osteoporotické patologické zlomeniny,
- b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),
- c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,
- d) hyperkalcémie provázejícící zhoubné nádory s kostními metastázami nebo i bez metastáz, mnohočetný myelom.
| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 232,35 | P | | 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | | | 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 54,70 | P | | 357 | M05BA | bisfosfonáty | parent. | O/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog nebo endokrinolog:
- a) osteoporotické patologické zlomeniny,
- b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),
- c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,
- d) hyperkalcémie provázejícící zhoubné nádory s kostními metastázami nebo i bez metastáz, mnohočetný myelom.
| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2402,60 | O/P | | 94548 | BONEFOS | inj 5x5ml 60mg/ml | STF | SF | | | | | 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 2402,60 | O/P | | 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,80 | H | | 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 287,80 | H | | | | | | | | | | | 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 2343,15 | H | | 360 | N01AF | injkeční anestetika ze skupiny barbiturátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 145,90 | H | | | | | | | | | | | 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 52,00 | H | | | | | | | | | | | 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 30,20 | H | | 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 361.1 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 112,25 | O | | 01449 | FENTANYL | inj 50x10ml/0.5mg | JAN | B | | | | | 361.2 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 169,00 | O | | 76526 | FENTANYL | inj 5x2ml/0.1mg | JAN | B | | | | | 76527 | FENTANYL | inj 50x2ml/0.1mg | JAN | B | | | | | 362 | N01AH | opioidní anestetika (ostatní) | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 52,75 | H | | | | | | | | | | | 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1435,80 | H | | | | | | | | | | | 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 767,70 | H | | | | | | | | | | | 362.4 | N01AH03 | sufentanyl (od 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1255,65 | H | | | | | | | | | | | 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 39,10 | H | | | | | | | | | | | 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 270,35 | H | | 363 | N01AX | ostatní celková anestetika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 363.1 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 100 | ML | 231,80 | O | | 87779 | NARKAMON | inj 10x10ml 1% | LEX | CZ | | | | | 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 10 | ML | 113,00 | O | | 87780 | NARKAMON | inj 5x2ml 5% | LEX | CZ | | | | | 87814 | CALYPSOL | inj 5x10ml/500mg | GED | H | | | | | 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,85 | O | | | | | | | | | | | 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 167,40 | O | | | | | | | | | | | 363.5 | N01AX10 | propofol | parent. | 10 | ML | 126,70 | O | | 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 13,50 | O | | | | | | | | | | | 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,30 | O | | 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | | | | | 00565 | PROCAIN LECIVA 1% | inj 10x10ml 1% | LEX | CZ | | | | | 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,55 | O | | 69669 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x80ml 0.2% | ARD | CZ | | | | | 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | | | | | 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | | | | | 69672 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | | | 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | | | 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | | | 69676 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x250ml 1% | ARD | CZ | | | | | 69677 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x500ml 1% | ARD | CZ | | | | | 86437 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 40x80ml 0.2% | ARD | CZ | | | | | 86444 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x250ml 0.2% | ARD | CZ | | | | | 86445 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 12x500ml 0.2% | ARD | CZ | | | | | 86447 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | | | 86448 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | | | 86450 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 20x250ml 1% | ARD | CZ | | | | | 86451 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 12x500ml 1% | ARD | CZ | | | | | 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | | | | | 89213 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x200ml 0.2% | ARD | CZ | | | | | 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml 0.5% | ARD | CZ | | | | | 89215 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x200ml 0.5% | ARD | CZ | | | | | 89216 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x200ml 1% | ARD | CZ | | | | | 89217 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 20x200ml 1% | ARD | CZ | | | | | 01691 | PROCAINII HYDROCHL.0.2% MEDVIR | inj 1x200ml | VYS | CZ | | | | | 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,10 | O | | 02684 | MESOCAIN | gel 1x20gm | SLO | SK | | | | | 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 8,75 | O | | | | | | | | | | | 365.3 | N01BB02 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1 | GM | 2,15 | O | | 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,70 | O | | 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | | | | | 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | | | | | 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | | | | | 86452 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 40x80ml 0.5% | ARD | CZ | | | | | 86453 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | | | | | 86454 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | | | | | 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,40 | O | | 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ | | | | | 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,75 | O | | 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ | | | | | 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | | | | | 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | | | | | 86455 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 40x80ml 1% | ARD | CZ | | | | | 86456 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 20x250ml 1% | ARD | CZ | | | | | 86457 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 12x500ml 1% | ARD | CZ | | | | | 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,25 | O | | 00503 | MESOCAIN | inj 10x5ml 2% | LEX | CZ | | | | | 366.5 | N01BB | trimekain/ adrenalin | parent. | 1 | ML | 2,40 | O | | | | | | | | | | | 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,60 | O | | | | | | | | | | | 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 49,90 | O | | | | | | | | | | | 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,25 | O | | | | | | | | | | | 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,60 | O | | | | | | | | | | | 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,25 | O | | | | | | | | | | | 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,45 | O | | | | | | | | | | | 366.12 | N01BB51 | bupivakain/ adrenalin | parent. | 1 | ML | 3,90 | O | | | | | | | | | | | 366.13 | N01BB52 | lidokain/ adrenalin | parent. | 1 | ML | 2,40 | O | | | | | | | | | | | 366.14 | N01BB58 | artikain/ adrenalin | parent. | 1 | ML | 4,25 | O | | 367 | N01BX | ostatní lokální anestetika | lok. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 95,50 | O | | 02088 | CHLORAETHYL | spr 1x100ml | LZK | CZ | | | | | 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 100,00 | | | | | | | | | | | | 368.2 | N02AA01 | morfin (od 10 mg do 100 mg v jedné tabletě) | p.o. | 0.1 | GM | 67,00 | | | 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | | | | | 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 63,00 | | | 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | | | | | 80409 | VENDAL RETARD | tbl fc 30x200mg | LAR | D | | | | | 368.4 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 67,90 | | | | | | | | | | | | 368.5 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 57,85 | | | 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 14,50 | O | | 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | | | | | 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 8,75 | O | | 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | | | | | 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 37,70 | | | 01116 | DOLSIN | gtt 1x10ml/500mg | SLO | SK | | | | | 371 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 371.1 | N02AB02 | pethidin (do 50 mg v jedné ampuli včetně) | parent. | 0.4 | GM | 52,10 | O | | 02715 | DOLSIN | inj 10x1ml 5% | HBS | SK | | | | | 371.2 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.4 | GM | 32,85 | O | | 02716 | DOLSIN | inj 10x2ml 5% | HBS | SK | | | | | 371.3 | N02AC03 | piritramid | parent. | 45 | MG | 26,40 | O | | 372 | N02AC | analgetika ze skupupiny difenylpropylaminových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 372.1 | N02AC05 | benzitramid | p.o. | 10 | MG | 13,00 | | | 03362 | BURGODIN | tbl 25x5mg | JAN | B | | | | | 373 | N02AD | analgetika ze skupiny benzomorfanových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 23,65 | | | 08968 | FORTRAL | tbl 100x50mg | KRK | SLO | | | | | 374 | N02AD | analgetika ze skupiny benzomorfanových derivátů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 92,40 | O | | 08966 | FORTRAL | inj 10x1ml/30mg | KRK | SLO | | | | | 375 | N02AX | analgetika ze skupiny ostatních opioidů | p.o., subling. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 375.1 | N02AE01 | buprenorfin | sublng. | 1.2 | MG | 112,95 | | | | | | | | | | | | 375.2 | N02AX01 | tilidin | p.o. | 0.2 | GM | 12,15 | | | | | | | | | | | | 375.3 | N02AX02 | tramadol | p.o. | 0.3 | GM | 35,00 | | | 83094 | TRAMAL | cps 20x50mg | LEX | CZ | | | | | 83095 | TRAMAL | gtt 1x10ml/1gm | LEX | CZ | | | | | 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect., parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 376.1 | N02AE01 | buprenorfin | parent. | 1.2 | MG | 279,15 | O | | | | | | | | | | | 376.2 | N02AF01 | butorfanol | parent. | 12 | MG | 70,80 | O | | | | | | | | | | | 376.3 | N02AF02 | nalbufin | parent. | 80 | MG | 70,80 | O | | | | | | | | | | | 376.4 | N02AX01 | tilidin | parent. | 0.2 | GM | 16,75 | O | | | | | | | | | | | 376.5 | N02AX02 | tramadol | p.rect. | 0.3 | GM | 61,30 | | | 06201 | TRAMAL | sup 5x100mg | GRU | D | | | | | 83096 | TRAMAL | sup 5x100mg | LEX | CZ | | | | | 376.6 | N02AX02 | tramadol (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 124,80 | O | | 83097 | TRAMAL 50 | inj 5x1ml/50mg | LEX | CZ | | | | | 376.7 | N02AX02 | tramadol (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 63,55 | O | | 83098 | TRAMAL 100 | inj 5x2ml/100mg | LEX | CZ | | | | | 377 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 377.1 | N02BA01 | kyselina acetylsalicylová | p.o. | 3 | GM | 5,85 | | | 00011 | ACYLPYRIN | tbl 10x500mg | SLO | SK | | | | | 377.2 | N02BA02 | aloxiprin | p.o. | 3 | GM | 5,85 | | | | | | | | | | | | 377.3 | N02BA03 | cholin salicylát | p.o. | 3 | GM | 8,85 | | | | | | | | | | | | 377.4 | N02BA11 | diflunisal | p.o. | 0.75 | GM | 5,85 | | | | | | | | | | | | 377.5 | N02BA13 | lysin acetylsalicylát (do 100 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,85 | | | | | | | | | | | | 377.6 | N02BA13 | lysin acetylsalicylát (nad 100 mg v jedné tabletě) | p.o. | 3 | GM | 5,85 | | | 378 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 378.1 | N02BA | lysin salicylát | parent. | 3 | GM | 42,45 | | | | | | | | | | | | 378.2 | N02BA04 | salicylát sodný | parent. | 3 | GM | 36,45 | | | 00527 | NATRIUM SALICYLICUM BIOTIKA | inj 10x10ml 10% | HBS | SK | | | | | 378.3 | N02BA13 | lysin acetylsalicylát | parent. | 3 | GM | 42,75 | | | 379 | N02BE | analgetika ze skupiny anilidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,45 | | | 97656 | PARALEN PRO INFANTIBUS | tbl 20x125mg | LEX | CZ | | | | | 379.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3 | GM | 5,05 | | | 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND | | | | | 71997 | PARACETAMOL K | tbl 10x500mg | KRK | SLO | | | | | 03837 | PARALEN | tbl 10x500mg | LEX | CZ | | | | | 379.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3 | GM | 8,85 | | | 380 | N02BE | analgetika ze skupiny anilidů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 380.1 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3 | GM | 93,05 | | | 91249 | PARALEN PRO INFANTIBUS | sup 5x100mg | LEX | CZ | | | | | 67226 | EFFERALGAN JEUNE ENFANT 150MG | sup 10x150mg | UPS | F | | | | | 67230 | EFFERALGAN NOURRISSON 80MG | sup 10x80mg | UPS | F | | | | | 380.2 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3 | GM | 27,60 | | | 67233 | DAFALGAN ADULTE 600MG | sup 10x600mg | UPS | F | | | | | 53169 | EFFERALGAN ADULTE 600MG | sup 10x600mg | UPS | F | | | | | 94982 | MEXALEN | sup 6x1000mg | MCK | D | | | | | 04343 | PARALEN | sup 5x500mg | LEX | CZ | | | | | 381 | N02B | ostatní analgetika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 381.1 | N02BB | metamizol (nad 1 g v 1 ampuli) | parent. | 3 | GM | 17,75 | O | | 62813 | NOVALGIN | inj 5x5ml/2500mg | HOE | D | | | | | 381.2 | N02BB | metamizol (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 42,80 | O | | 62437 | NOVALGIN | inj 10x2ml/1000mg | HOE | D | | | | | 381.3 | N02BB | aminophenazon v kombinacích | parent. | 1 | DF | 6,75 | O | | | | | | | | | | | 381.4 | N02BE05 | propacetamol | parent. | 1 | GM | 42,80 | O | | 382 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 382.1 | N02CA01 | dihydroergotam-in | p.o. | 4 | MG | 1,25 | | | | | | | | | | | | 382.2 | N02CA07 | lisurid | p.o. | .075 | MG | 0,75 | | | | | | | | | | | | 382.3 | N02CA52 | ergotamin, kombinace | p.o. | 4 | DF | 9,60 | | | 00130 | ERGOFEIN | drg 10 | LEX | CZ | | | | | 383 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 383.1 | N02CA01 | dihydroergotam-in | parent. | 4 | MG | 116,50 | | | 90795 | DIHYDERGOT | inj 5x1ml 1mg/ml | SAN | CH | | | | | 384 | N02C | jiná antimigrenika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 384.1 | N02CC01 | sumatriptan | p.o. | 0.1 | GM | 150,00 | | | | | | | | | | | | 384.2 | N02CX | oxetoron | p.o. | 0.12 | GM | 6,00 | | | | | | | | | | | | 384.3 | N02CX | pipethiaden | p.o. | 3 | DF | 3,00 | | | 94583 | MIGRENAL | tbl 50x1mg | LEX | CZ | | | | | 384.4 | N02CX01 | pizotifen | p.o. | 1.5 | MG | 6,00 | | | 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.1 | GM | 2,10 | | | | | | | | | | | | 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,30 | | | 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D | | | | | 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,35 | | | 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D | | | | | 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 5,00 | | | | | | | | | | | | 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 46,55 | | | 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 386.1 | N03AA02 | fenobarbital | parent. | 0.1 | GM | 125,50 | O | | 66845 | GARDENAL | inj sic 1x40mg+solv | SPC | F | | | | | 84449 | LUMINAL | inj 5x1ml/219mg | DET | D | | | | | 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,35 | | | 62234 | EPILAN D GEROT | tbl 100x100mg | GER | A | | | | | 00297 | SODANTON | tbl 20x100mg | SLO | SK | | | | | 387.2 | N03AB04 | mefenytoin | p.o. | 0.4 | GM | 2,35 | | | | | | | | | | | | 387.3 | N03AB52 | fenytoin, kombinace | p.o. | 3 | DF | 1,95 | | | 388 | N03AB | antiepileptika ze skupiny hydantoinů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 128,30 | O | | 03300 | EPANUTIN | inj 5x5ml/250mg | PDA | GB | | | | | 66564 | PHENHYDAN | inj 5x5ml/250mg | DET | D | | | | | 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 16,75 | | | 93710 | SUXILEP | cps 120x250mg | VJP | D | | | | | 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 24,25 | | | 68585 | PETNIDAN | sir 1x150ml/7.5gm | DET | D | | | | | 02035 | SUXILEP | gtt 50gm 50% | GMD | D | | | | | 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 25,35 | | | 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 37,90 | | | 03029 | RIVOTRIL | gtt 10ml 25mg | HLR | CH | | | | | 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 30,40 | | | | | | | | | | | | 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 16,10 | | | 03878 | ANTELEPSIN | tbl 50x1mg | VAD | D | | | | | 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 244,00 | O | | 03636 | RIVOTRIL | inj 25x1mg/1ml+sol | HLR | CH | | | | | 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,65 | | | 62309 | APO-CARBAMAZEPINE 200MG | tbl 100x200mg | APT | CND | | | | | 03417 | BISTON | tbl 50x200mg | SLO | SK | | | | | 02355 | FINLEPSIN | tbl 50x200mg | VAD | D | | | | | 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 18,50 | | | 92039 | TEGRETOL CR | tbl obd 50x200mg | CGC | CH | | | | | 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 43,50 | | | 12197 | TEGRETOL 2% | sir 1x100ml 2% | CGC | CH | | | | | 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,35 | | | 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (kyselina valproová) | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 393.1 | N03AG01 | valproová kyselina (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 21,40 | | | 08768 | CONVULEX | cps 100x150mg | GER | A | | | | | 61183 | ORFIRIL 150 | drg 50x150mg | DET | D | | | | | 61186 | ORFIRIL 150 | drg 100x150mg | DET | D | | | | | 393.2 | N03AG01 | valproová kyselina (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 16,00 | | | 08769 | CONVULEX | cps 100x300mg | GER | A | | | | | 75296 | CONVULEX | cps 100x500mg | GER | A | | | | | 92587 | DEPAKINE CHRONO 500MG(PULENE) | tbl ret 30x500mg | SWI | F | | | | | 61187 | ORFIRIL 300 | drg 100x300mg | DET | D | | | | | 61185 | ORFIRIL 600 | drg 50x600mg | DET | D | | | | | 393.3 | N03AG01 | valproová kyselina (retardované pevné lékové formy) | p.o. | 1.5 | GM | 31,50 | | | 62705 | ORFIRIL 300 RETARD | drg ret 100x300mg | DET | D | | | | | 393.4 | N03AG01 | valproová kyselina (tekuté lékové formy) | p.o. | 1.5 | GM | 25,55 | | | 08770 | CONVULEX | gtt 100ml 300mg/ml | GER | A | | | | | 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | L/NEU,PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 394.1 | N03AG02 | valpromid | p.o. | 1.5 | GM | 29,05 | L/PSY,NEU | | 80151 | DEPAMIDE | tbl obd 30x300mg | SWI | F | | | | | 93255 | DIPROZIN 300MG | drg 100x300mg | PLI | CHO | | | | | 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 148,85 | L/PSY,NEU | | 395 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 395.1 | N03AG01 | valproová kyselina | parent. | 1.5 | GM | 1718,75 | K | | 84386 | DEPAKINE | inj sic 4x0.4gm+4ml | SWI | F | | | | | 396 | N03AX | ostatní antiepileptika | p.o. | L/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 17,40 | L/PSY,NEU | | | | | | | | | | | 396.2 | N03AX09 | lamotrigin (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 572,00 | L/PSY,NEU | | | | | | | | | | | 396.3 | N03AX09 | lamotrigin (nad 5 mg v jedné tabletě) | p.o. | 0.3 | GM | 194,55 | L/PSY,NEU | | 68802 | LAMICTAL | tbl 30x100mg | BWE | GB | | | | | 84513 | LAMICTAL 100MG DISPERSIBLE/CHEW | ctb 30x100mg | BWE | GB | | | | | 396.4 | N03AX10 | felbamat | p.o. | 2.4 | GM | 365,95 | L/PSY,NEU | | | | | | | | | | | 396.5 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 145,20 | L/PSY,NEU | | 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 5,10 | | | | | | | | | | | | 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 14,40 | | | 20054 | AKINETON | tbl 50x2mg | KNO | D | | | | | 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,50 | | | | | | | | | | | | 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 8,75 | | | 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 58,75 | O | | 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | | | | | 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,75 | O | | 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 0,45 | | | 96751 | APO-BENZTROPINE 2MG | tbl 100x2mg | APT | CND | | | | | 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 25,20 | | | | | | | | | | | | 400.2 | N04BA02 | levodopa/ karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 35,40 | | | | | | | | | | | | 400.3 | N04BA02 | levodopa/ karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 20,90 | | | 03591 | NAKOM | tbl 100x275mg | LEK | SLO | | | | | 400.4 | N04BA02 | levodopa/ benserazid | p.o. | 0.6 | GM | 25,20 | | | 12095 | MADOPAR 250 ROCHE | tbl 30x250mg | LEX | CZ | | | | | 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy) | p.o. | 0.6 | GM | 25,30 | | | 94843 | SINEMET CR | tbl obd 100x250mg | MSD | NL | | | | | 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 401.1 | N04BB01 | amantadin | p.o. | 0.2 | GM | 4,35 | L/NEU,PSY, GER | | 02871 | VIREGYT-K | cps 50x100mg | EGI | H | | | | | 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 402.1 | N04BD01 | selegilin | p.o. | 5.0 | MG | 6,50 | L/NEU,PSY, GER | | 92500 | SEPATREM 5 | tbl 50x5mg | LEX | CZ | | | | | 92501 | SEPATREM 10 | tbl 50x10mg | LEX | CZ | | | | | 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 9,30 | | | 02114 | PLEGOMAZIN | drg 50x25mg | EGI | H | | | | | 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,00 | | | 62313 | PLEGOMAZIN | drg 30x100mg | EGI | H | | | | | 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 64,20 | | | | | | | | | | | | 403.4 | N05AA02 | levomepromazi-n | p.o. | 0.3 | GM | 14,50 | | | | | | | | | | | | 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,80 | | | 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 22,35 | O | | 00560 | PLEGOMAZIN | inj 10x5ml/25mg | EGI | H | | | | | 00561 | PLEGOMAZIN | inj 10x2ml/50mg | EGI | H | | | | | 404.2 | N05AA02 | levomepromazi-n | parent. | 0.1 | GM | 33,35 | O | | 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,80 | | | 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | | | | | 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 8,45 | | | | | | | | | | | | 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 7,15 | | | | | | | | | | | | 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,85 | | | 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 4,10 | O | | 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | | | | | 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | L/NEU,PSY,GER | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 53,40 | L/NEU,PSY, GER | | | | | | | | | | | 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 6,85 | L/NEU,PSY, GER | | | | | | | | | | | 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 9,80 | | | 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | | | | | 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | | | | | 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,20 | | | 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | | | | | 67110 | HALOPER 2MG VON CT | tbl 50x2mg | CTA | D | | | | | 67111 | HALOPER 5MG VON CT | tbl 50x5mg | CTA | D | | | | | 67112 | HALOPER 10MG VON CT | tbl 20x10mg | CTA | D | | | | | 67113 | HALOPER 10MG VON CT | tbl 100x10mg | CTA | D | | | | | 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 8,70 | | | | | | | | | | | | 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,90 | | | | | | | | | | | | 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 4,00 | | | | | | | | | | | | 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 28,33 | | | 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 7,60 | O | | 12061 | HALOPERIDOL DECANOAT | inj 5x1ml/50mg | GED | H | | | | | 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 14,75 | O | | 02538 | HALOPERIDOL | inj 5x1ml/5mg | GED | H | | | | | 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,65 | O | | | | | | | | | | | 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 57,30 | O | | | | | | | | | | | 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 57,30 | O | | 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,70 | | | | | | | | | | | | 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 17,90 | | | | | | | | | | | | 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 27,00 | | | 00082 | MINITHIXEN | drg 50x5mg | LEX | CZ | | | | | 410.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,75 | | | 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | | | | | 410.5 | N05AF03 | chlorprothixen (od 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 10,35 | | | 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | | | | | 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 17,90 | | | 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,35 | O | | 88379 | MECLOPIN | inj 5x1ml/25mg | SPX | CZ | | | | | 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 17,65 | O | | | | | | | | | | | 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,10 | O | | | | | | | | | | | 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 106,00 | O | | | | | | | | | | | 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 13,70 | O | | 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 11,40 | | | 98120 | ORAP | tbl 75x1mg | JAN | B | | | | | 02757 | ORAP FORTE | tbl 20x4mg | JAN | B | | | | | 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,65 | | | 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 13,50 | O | | 09164 | IMAP | inj 1x6ml/12mg | JAN | B | | | | | 98114 | IMAP | inj 3x1ml/2mg | JAN | B | | | | | 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | L/PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 414.1 | N05AH01 | loxapin | p.o. | 0.1 | GM | 53,40 | L/PSY | | | | | | | | | | | 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 80,05 | L/PSY | | 03617 | LEPONEX | tbl 50x25mg | SAN | CH | | | | | 414.3 | N05AH02 | klozapin (od 25 do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 58,30 | L/PSY | | 75299 | ALEMOXAN | tbl 100x50mg-blistr | VAD | D | | | | | 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 62,00 | L/PSY | | 02970 | LEPONEX | tbl 50x100mg | SAN | CH | | | | | 414.5 | N05AH05 | olanzapin | p.o. | 10 | MG | 175,00 | L/PSY | | 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 88,20 | H | | 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | L/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 70,00 | | | DOGMATIL 50MG | cps 30x50mg | EGJ | F | | | | | | 416.2 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 25,15 | L/PSY,NEU | | DOGMATIL 200MG | tbl 12x200mg | EGJ | F | | | | | | PROSULPIN | tbl 30x200mg | PMP | CZ | | | | | | 416.3 | N05AL03 | tiaprid | p.o. | 0.4 | GM | 34,00 | | | 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | O/PSY,NEU | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 79,35 | O/PSY,NEU | | DOGMATIL 100 | inj 6x2ml/100mg | EGJ | F | | | | | | 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 75,40 | O | | 418 | N05AN | lithium | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 418.1 | N05AN01 | lithium | p.o. | 1 | GM | 2,45 | | | 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | | | | | 04385 | CONTEMNOL | tbl 100x500mg | SLO | SK | | | | | 419 | N05AX | ostatní antipsychotika | p.o. | L/PSY | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 419.1 | N05AX08 | risperidon | p.o. | 6 | MG | 151,80 | L/PSY | | 75900 | RISPERDAL 1MG | tbl obd 20x1mg | JAN | B | | | | | 75901 | RISPERDAL 1MG | tbl obd 60x1mg | JAN | B | | | | | 75902 | RISPERDAL 2MG | tbl obd 20x2mg | JAN | B | | | | | 75903 | RISPERDAL 2MG | tbl obd 60x2mg | JAN | B | | | | | 75904 | RISPERDAL 3MG | tbl obd 20x3mg | JAN | B | | | | | 75905 | RISPERDAL 3MG | tbl obd 60x3mg | JAN | B | | | | | 75906 | RISPERDAL 4MG | tbl obd 20x4mg | JAN | B | | | | | 75907 | RISPERDAL 4MG | tbl obd 60x4mg | JAN | B | | | | | 419.2 | N05A | sertindol | p.o. | 1 | DF | 130,00 | L/PSY | | 420 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti.
| 420.1 | N05BA | tofisopam | p.o. | 0.15 | GM | 0,60 | |
|---|---|---|---|---|---|---|---|
| 420.2 | N05BA01 | diazepam | p.o. | 10 | MG | 0,60 | |
| 02476 | DIAZEPAM SLOVAKOFARMA | tbl 20x2mg | SLO | SK | |||
| 02477 | DIAZEPAM SLOVAKOFARMA | tbl 20x5mg | SLO | SK | |||
| 02478 | DIAZEPAM SLOVAKOFARMA | tbl 20x10mg | SLO | SK | |||
| 420.3 | N05BA02 | chlordiazepoxid | p.o. | 30 | MG | 0,60 | |
| 420.4 | N05BA03 | medazepam | p.o. | 20 | MG | 0,60 | |
| 420.5 | N05BA04 | oxazepam | p.o. | 50 | MG | 0,60 | |
| 420.6 | N05BA05 | klorazepát draselný | p.o. | 20 | MG | 0,60 | |
| 420.7 | N05BA06 | lorazepam | p.o. | 2.5 | MG | 0,60 | |
| 420.8 | N05BA08 | bromazepam | p.o. | 10 | MG | 0,60 | |
| 420.9 | N05BA09 | klobazam | p.o. | 20 | MG | 0,60 | |
| 420.10 | N05BA11 | prazepam | p.o. | 30 | MG | 0,60 | |
| 420.11 | N05BA12 | alprazolam (do 1 mg v jedné tabletě) | p.o. | 1 | MG | 0,60 | |
| 420.12 | N05BA12 | alprazolam (1 mg a více v jedné tabletě) | p.o. | 1 | MG | 2,55 | P |
| 421 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.rect. | L/NEU,PSY,PDD | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10 | MG | 115,45 | L/NEU,PSY, PDD |
| 69417 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/5mg | DET | D | |||
| 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 70,60 | L/NEU,PSY, PDD |
| 69418 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/10mg | DET | D | |||
| 422 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 422.1 | N05BA01 | diazepam | parent. | 10 | MG | 7,95 | |
| 96610 | APAURIN | inj 10x2ml/10mg | KRK | SLO | |||
| 30362 | SEDUXEN | inj 5x2ml/10mg | GED | H | |||
| 422.2 | N05BA05 | klorazepát draselný | parent. | 20 | MG | 15,00 | |
| 423 | N05BX | ostatní anxiolytika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 423.1 | N05BB01 | hydroxyzin | p.o. | 75 | MG | 0,60 | |
| 423.2 | N05BC01 | meprobamat | p.o. | 1.2 | GM | 0,60 | |
| 423.3 | N05BX01 | mefenoxalon | p.o. | 1.2 | GM | 15,50 | |
| 03645 | DIMEXOL | tbl 30x200mg | LEX | CZ | |||
| 424 | N05CA | hypnotika ze skupiny barbiturátů | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 424.1 | N05CA01 | pentobarbital | parent. | 0.1 | GM | 23,85 | H |
| 425 | N05CD | hypnotika ze skupiny benzodiazepinů | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 425.1 | N05CD03 | flunitrazepam | parent. | 1 | MG | 6,50 | O |
| 90559 | ROHYPNOL | inj 5x1ml+5x1ml sol | LEX | CZ | |||
| 425.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15 | MG | 126,20 | O |
| 425.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15 | MG | 83,85 | O |
| 426 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 426.1 | N06AA01 | desipramin | p.o. | 0.1 | GM | 18,50 | |
| 426.2 | N06AA02 | imipramin | p.o. | 0.1 | GM | 10,25 | |
| 426.3 | N06AA04 | klomipramin | p.o. | 0.1 | GM | 18,30 | |
| 426.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 12,30 | |
| 426.5 | N06AA07 | lofepramin | p.o. | 105 | MG | 18,50 | |
| 426.6 | N06AA08 | dibenzepin | p.o. | 0.3 | GM | 18,50 | |
| 426.7 | N06AA09 | amitriptylin | p.o. | 75 | MG | 1,85 | |
| 426.8 | N06AA10 | nortriptylin | p.o. | 75 | MG | 10,45 | |
| 426.9 | N06AA16 | dosulepin | p.o. | 150 | MG | 8,85 | |
| 03851 | PROTHIADEN 10 | tbl obd 50x10mg | LEX | CZ | |||
| 04207 | PROTHIADEN 25 | drg 30x25mg | LEX | CZ | |||
| 77047 | PROTHIADEN 75 | tbl obd 30x75mg | LEX | CZ | |||
| 426.10 | N06AA21 | maprotilin | p.o. | 100 | MG | 14,20 | |
| 426.11 | N06AA22 | venlafaxin | p.o. | 75 | MG | 29,00 | L/NEU,PSY, SEX |
| 427 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 427.1 | N06AA01 | desipramin | parent. | 0.1 | GM | 98,65 | O |
| 427.2 | N06AA02 | imipramin | parent. | 0.1 | GM | 47,60 | O |
| 427.3 | N06AA04 | klomipramin | parent. | 0.1 | GM | 98,65 | O |
| 427.4 | N06AA08 | dibenzepin | parent. | 0.3 | GM | 98,65 | O |
| 427.5 | N06AA09 | amitriptylin | parent. | 75 | MG | 28,45 | O |
| 04079 | AMITRIPTYLIN LECIVA | inj 10x2ml/20mg | LEX | CZ | |||
| 427.6 | N06AA21 | maprotilin | parent. | 100 | MG | 111,80 | O |
| 428 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | L/PSY,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 428.1 | N06AB03 | fluoxetin | p.o. | 20 | MG | 19,50 | |
| 92346 | DEPREX | cps 30x20mg | LEX | CZ | |||
| 428.2 | N06AB04 | citalopram | p.o. | 20 | MG | 26,50 | L/PSY,SEX, NEU, INT |
| 428.3 | N06AB05 | paroxetin | p.o. | 20 | MG | 26,50 | L/PSY,SEX, NEU, INT |
| 428.4 | N06AB06 | sertralin | p.o. | 50 | MG | 26,50 | L/PSY,SEX, NEU, INT |
| 428.5 | N06AB08 | fluvoxamin | p.o. | 100 | MG | 26,50 | L/PSY,SEX, NEU, INT |
| 429 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | parent. | O/PSY,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 429.1 | N06AB04 | citalopram | parent. | 20 | MG | 255,60 | O/PSY,SEX |
| 60113 | SEROPRAM | inf 10x1ml/40mg | LUN | DK | |||
| 430 | N06A | ostatní antidepresiva | p.o. | L/PSY,SEX,NEU | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 430.1 | N06AF01 | isocarbaxazid | p.o. | 15 | MG | 4,40 | L/PSY,SEX, NEU |
| 430.2 | N06AF04 | tranylcypromin | p.o. | 10 | MG | 5,15 | L/PSY,SEX, NEU |
| 430.3 | N06AG02 | moklobemid | p.o. | 0.3 | GM | 25,70 | L/PSY,SEX, NEU |
| 85901 | AURORIX 300MG | tbl obd 30x300mg | HLR | CH | |||
| 430.4 | N06AX03 | mianserin (do 10 mg v jedné tabletě včetně) | p.o. | 60 | MG | 19,50 | L/PSY,SEX, NEU |
| 430.5 | N06AX03 | mianserin (nad 10 mg v jedné tabletě) | p.o. | 60 | MG | 15,50 | L/PSY,SEX, NEU |
| 430.6 | N06AX05 | trazodon | p.o. | 0.3 | GM | 14,55 | L/PSY,SEX, NEU |
| 430.7 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,55 | L/PSY,SEX, NEU |
| 430.8 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 26,50 | L/PSY,SEX, NEU, INT |
| 431 | N06BA | centrálně působící stimulancia | p.o. | L/NEU,PSY,PDD,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,55 | L/NEU,PSY, PDD, SEX |
| 83328 | RITALIN | tbl 30x10mg | CGC | CH | |||
| 432 | N06BX | ostatní psychostimulancia a nootropika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 8,00 | |
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 20,00 | |
| 432.3 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 8,00 | |
| 56779 | GERATAM 800MG | tbl obd 60x800mg | UCB | B | |||
| 96718 | OIKAMID | cps 60x400mg | PLI | CHO | |||
| 66646 | PIRACETAM AL 800 | tbl obd 30x800mg | APA | D | |||
| 66647 | PIRACETAM AL 800 | tbl obd 50x800mg | APA | D | |||
| 66648 | PIRACETAM AL 800 | tbl obd 100x800mg | APA | D | |||
| 432.4 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 20,00 | |
| 88156 | NOOTROPIL 20% ORAL | sol 1x125ml 20% | UCB | B | |||
| 04289 | NOOTROPIL 33% ORAL | sol 1x125ml 33% | UCB | B | |||
| 432.5 | N06BX17 | vinpocetin | p.o. | 15 | MG | 6,00 | |
| 432.6 | N06BX19 | extrakty z Ginkgo biloba | p.o. | 120 | MG | 6,00 | |
| 433 | N06BX | ostatní psychostimulancia a nootropika | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 433.1 | N06BX01 | meklofenoxat | parent. | 0.5 | GM | 85,45 | H |
| 433.2 | N06BX02 | pyritinol | parent. | 0.3 | GM | 85,45 | H |
| 433.3 | N06BX03 | piracetam | parent. | 6 | GM | 69,40 | H |
| 433.4 | N06BX17 | vinpocetin | parent. | 15 | MG | 29,15 | H |
| 434 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 434.1 | N07AA01 | neostigmin | p.o. | 60 | MG | 15,55 | |
| 434.2 | N07AA02 | pyridostigmin (do 10 mg v jedné tabletě včetně) | p.o. | 180 | MG | 28,00 | |
| 01335 | KALYMIN | tbl obd 50x10mg | VAD | D | |||
| 434.3 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180 | MG | 17,20 | |
| 434.4 | N07AA03 | distigmin | p.o. | 5 | MG | 6,00 | |
| 434.5 | N07AA30 | ambenonium | p.o. | 60 | MG | 18,45 | |
| 435 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 435.1 | N07AA01 | neostigmin | parent. | 2 | MG | 18,45 | |
| 435.2 | N07AA02 | pyridostigmin | parent. | 10 | MG | 122,50 | |
| 01468 | KALYMIN MITE | inj 10x1ml/1mg | VAD | D | |||
| 435.3 | N07AA03 | distigmin | parent. | 0.25 | MG | 5,75 | |
| 436 | N07CA | léčiva s antivertiginózním účinkem | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 436.1 | N07CA | jiné piperazinové deriváty | p.o. | 3 | DF | 4,90 | |
| 436.2 | N07CA01 | betahistin | p.o. | 24 | MG | 11,65 | |
| 88529 | BETASERC | tbl 100x8mg | SDU | NL | |||
| 436.3 | N07CA02 | cinarizin | p.o. | 90 | MG | 1,90 | |
| 436.4 | N07CA03 | flunarizin | p.o. | 10 | MG | 4,90 | |
| 437 | N07XX | ostatní léčiva nervové soustavy | parent. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 437.1 | N07XX01 | tirilazad | parent. | 150 | MG | 5256,90 | X |
| 83502 | FREEDOX TM | inf 1x100ml/150mg | UPJ | B | |||
| 438 | P01AB | chemoterapeutika ze skupiny nitroimidazolových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 438.1 | P01AB01 | metronidazol | p.o. | 2 | GM | 13,60 | |
| 438.2 | P01AB01 | metronidazol | p.rect. | 2 | GM | 10,60 | |
| 438.3 | P01AB02 | tinidazol | p.o. | 2 | GM | 13,60 | |
| 438.4 | P01AB03 | ornidazol | p.o. | 1.5 | GM | 22,50 | |
| 91132 | AVRAZOR | tbl 6x500mg | LEX | CZ | |||
| 439 | P01BA | antimalarika ze skupiny aminochinolonových derivátů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu hydroxychlorochinem ordinuje infekcionista, revmatolog a dermatolog:
- a) systémový lupus erythematodes,
- b) revmatoidní arthritis,
- c) juvenilní chronická arthritis,
- d) diskoidní forma lupus erythematodes.
Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).
| 439.1 | P01BA01 | chlorochin | p.o. | 0.5 | GM | 2,40 | | | 00098 | DELAGIL | tbl 30x250mg | IDA | H | | | | | 439.2 | P01BA02 | hydroxychlo-rochin | p.o. | 0.4 | GM | 18,10 | P | | | | | | | | | | | 439.3 | P01BA05 | meflochin | p.o. | 1 | GM | 385,40 | P | | 440 | P01BD | antimalarika ze skupiny diaminopyrimidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 440.1 | P01BD01 | pyrimethamin | p.o. | 75 | MG | 7,80 | | | 02443 | DARAPRIM | tbl 30x25mg | BWE | GB | | | | | 440.2 | P01BD51 | pyrimethamin, kombinace | p.o. | 75 | MG | 65,50 | | | 441 | P01CX | ostatní léčiva k léčbě protozoóz | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 441.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1112,50 | X | | 97578 | PENTACARINAT 300 | inj sic 1x300mg | RBE | F | | | | | 442 | P02CA | anthelmintika ze skupiny benzimidazolových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 15,30 | | | | | | | | | | | | 442.2 | P02CA02 | tiabendazol | p.o. | 3 | GM | 128,30 | | | | | | | | | | | | 442.3 | P02CA03 | albendazol | p.o. | 0.4 | GM | 66,00 | | | 88300 | ZENTEL | sus 20ml/400mg | SKF | F | | | | | 91146 | ZENTEL | tbl obd 2x200mg | SKF | F | | | | | 443 | P02CB | anthelmintika ze skupiny piperazinu a jeho derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 443.1 | P02CB01 | piperazin | p.o. | 2 | GM | 3,60 | | | 00165 | HELMIRAZIN | tbl 50x300mg | SLO | SK | | | | | 444 | P02CE | anthelmintika ze skupiny imidazothiazolových derivátů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 22,50 | | | 04030 | DECARIS | tbl 2x50mg | GED | H | | | | | 445 | P02CX | ostatní anthelmintika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 445.1 | P02CX01 | pyrvinium | p.o. | 0.3 | GM | 16,65 | | | 02139 | PYRVINIUM | sus 1x100ml | GNO | CZ | | | | | 446 | P02DA | anticestodika ze skupiny derivátů kyseliny salicylové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 446.1 | P02DA01 | niklosamid | p.o. | 2 | GM | 145,50 | | | 02969 | YOMESAN | tbl 4x500mg | BAY | D | | | | | 447 | P03AB | ektoparazitika ze skupiny halogenovaných léčiv | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 447.1 | P03AB02 | lindan (lékové formy gelu) | lok. | 1 | GM | 2,60 | | | | | | | | | | | | 447.2 | P03AB02 | lindan (lékové formy lotia) | lok. | 1 | ML | 1,10 | | | 62364 | JACUTIN | lot 1x100ml | HEM | D | | | | | 97547 | JACUTIN | lot 1x200ml | HEM | D | | | | | 62365 | JACUTIN | lot 1x1000ml | HEM | D | | | | | 92765 | SKABICID | lot 1x100gm | AVE | CZ | | | | | 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1,20 | | | 448 | P03AC | ektoparazitika ze skupiny pyrethrinů | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 448.1 | P03AC | esdepallethrin | lok. | 1 | ML | 1,20 | | | 76126 | SPREGAL | spr 1x160gm | SCT | F | | | | | 448.2 | P03AC04 | permerthrin | lok. | 1 | ML | 1,20 | | | 449 | R01AC | protialergická léčiva k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 449.1 | R01AC01 | kyselina kromogliková | lok. | 40 | MG | 14,95 | L/ALG,TRN, ORL | | 83761 | CROMOBENE | spr nas 1x15ml | MCK | D | | | | | 83652 | CROMOHEXAL | spr nas 1x15ml | HEX | D | | | | | 86429 | CROMOHEXAL | spr nas 1x30ml | HEX | D | | | | | 449.2 | R01AC02 | levokabastin | lok. | 0.6 | MG | 11,05 | L/ALG,TRN, ORL | | | | | | | | | | | 449.3 | R01AC03 | azelastin | lok. | 0.56 | MG | 11,05 | L/ALG,TRN, ORL | | 450 | R01AD | kortikosteroidy k lokálnímu podání | lok. | L/ALG,TRN,ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 450.1 | R01AD01 | beclomethason | lok. | 0.4 | MG | 4,25 | | | 12830 | BECONASE | spr nas 200x50rg | GLA | GB | | | | | 10165 | BECONASE NASAL | aer 200x50rg | GLA | GB | | | | | 450.2 | R01AD04 | flunisolid | lok. | 0.15 | MG | 8,90 | L/ALG,TRN, ORL | | | | | | | | | | | 450.3 | R01AD05 | budesonid | lok. | 0.3 | MG | 8,90 | L/ALG,TRN, ORL | | | | | | | | | | | 450.4 | R01AD08 | flutikason | lok. | 0.3 | MG | 20,00 | L/ALG,TRN, ORL | | 451 | R03AC | inhalační selektivní beta-2 sympatomimetika | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 451.1 | R03AC | fenoterol/ cromoglykat | inhal. | 0.6 | MG | 28,05 | L/ALG,TRN | | | | | | | | | | | 451.2 | R03AC02 | salbutamol (lékové formy aerosolu) | inhal. | 0.8 | MG | 3,20 | | | 91081 | SALBUTAMOL POLFA | aer 10ml/200x0.1mg | POL | PL | | | | | 451.3 | R03AC02 | salbutamol (lékové formy prášku k inhalaci) | inhal. | 0.8 | MG | 7,40 | | | 83047 | VENTODISKS | inh plv 15x8x400rg | GLA | F | | | | | 451.4 | R03AC02 | salbutamol (lékové formy roztoku) | inhal. | 10 | MG | 11,40 | | | 94814 | VENTOLIN SOL.AD RESPIR. | inh 1x20ml/120mg | GLA | GB | | | | | 451.5 | R03AC03 | terbutalin (lékové formy aerosolu) | inhal. | 2 | MG | 3,60 | | | | | | | | | | | | 451.6 | R03AC03 | terbutalin (lékové formy prášku k inhalaci) | inhal. | 2 | MG | 7,40 | | | | | | | | | | | | 451.7 | R03AC04 | fenoterol (lékové formy aerosolu) | inhal. | 0.6 | MG | 2,80 | | | | | | | | | | | | 451.8 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4 | MG | 25,20 | | | | | | | | | | | | 451.9 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.6 | MG | 7,40 | | | | | | | | | | | | 451.10 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.5 | MG | 2,80 | | | | | | | | | | | | 451.11 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.1 | MG | 21,10 | L/ALG,TRN | | | | | | | | | | | 451.12 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) | inhal. | 0.1 | MG | 21,10 | L/ALG,TRN | | | | | | | | | | | 451.13 | R03AC13 | formoterol (lékové formy prášku k inhalaci) | inhal. | 24 | RG | 21,10 | L/ALG,TRN | | 452 | R03AK | inhalační sympatomimetika a jiná antiastmatika | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 452.1 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy aerosolu) | inhal. | 6 | DF | 4,90 | | | 87899 | BERODUAL | aer dos 15ml/300df | BOE | D | | | | | 452.2 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4 | ML | 21,10 | | | | | | | | | | | | 452.3 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy prášku k inhalaci) | inhal. | 3 | DF | 13,30 | | | 453 | R03BA | inhalační kortikosteroidy | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 453.1 | R03BA01 | beklomethason (lékové formy aerosolu) | inhal. | 0.8 | MG | 6,60 | | | 80532 | ALDECIN | aer dos 200x50rg | SCH | B | | | | | 12827 | BECLAZONE 50RG | aer dos 200x50rg | GNO | CZ | | | | | 12828 | BECLAZONE 100RG | aer dos 200x100rg | GNO | CZ | | | | | 12829 | BECLAZONE 250RG | aer dos 200x250rg | GNO | CZ | | | | | 94331 | BECLOMET 250RG | aer 1x12.5ml/200df | ORN | SF | | | | | 453.2 | R03BA01 | beklomethason (lékové formy prášku k inhalaci do 100 RG v 1 dávce včetně) | inhal. | 0.8 | MG | 21,25 | | | | | | | | | | | | 453.3 | R03BA01 | beklomethason (lékové formy prášku k inhalaci nad 100 RG v 1 dávce) | inhal. | 0.8 | MG | 19,10 | | | | | | | | | | | | 453.4 | R03BA02 | budesonid (lékové formy aerosolu) | inhal. | 0.8 | MG | 12,40 | | | | | | | | | | | | 453.5 | R03BA02 | budesonid (lékové formy prášku k inhalaci, do 200 RG v 1 dávce včetně) | inhal. | 0.8 | MG | 21,25 | | | | | | | | | | | | 453.6 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 RG v 1 dávce) | inhal. | 0.8 | MG | 19,10 | | | | | | | | | | | | 453.7 | R03BA03 | flunisolid (lékové formy aerosolu) | inhal. | 1 | MG | 12,40 | | | | | | | | | | | | 453.8 | R03BA03 | flunisolid (lékové formy prášku k inhalaci) | inhal. | 1 | MG | 21,25 | | | | | | | | | | | | 453.9 | R03BA05 | flutikason (lékové formy aerosolu) | inhal. | 0.6 | MG | 12,40 | | | | | | | | | | | | 453.10 | R03BA05 | flutikason (lékové formy prášku k inhalaci do 100 RG včetně) | inhal. | 0.6 | MG | 21,25 | | | | | | | | | | | | 453.11 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 100 RG) | inhal. | 0.6 | MG | 19,10 | | | 454 | R03BB | inhalační anticholinergika | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 454.1 | R03BB01 | bromid ipratropia (lékové formy aerosolu) | inhal. | 0.12 | MG | 7,20 | | | 80103 | ATROVENT | aer dos 15ml(21gm) | BOE | D | | | | | 454.2 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2,30 | | | 75847 | ATROVENT INHALETTEN | cps inh 100x0.2mg | BOE | D | | | | | 454.3 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4 | ML | 35,10 | L/ALG,TRN, ORL | | 92351 | ATROVENT 0.025% | inh sol 1x20ml | BOE | D | | | | | 455 | R03BC | inhalační protialergická léčiva | inhal. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 455.1 | R03BC01 | kyselina kromoglyková (lékové formy aerosolu) | inhal. | 40 | MG | 56,80 | | | 02540 | INTAL | cps 30x20mg | FIS | GB | | | | | 69462 | CROMO VON CT DOSIERAEROSOL | aer dos 1x10ml | CTA | D | | | | | 92438 | CROMOGEN 1MG | inh aer dos 200x1mg | GNO | CZ | | | | | 92439 | CROMOGEN 5MG | inh aer dos 112x5mg | GNO | CZ | | | | | 66769 | DNCG-STADA | aer dos 1x10ml | STD | D | | | | | 76564 | INTAL INHALER | inh dos 112x5mg | FIS | GB | | | | | 455.2 | R03BC01 | kyselina kromoglyková (lékové formy prášku k inhalaci) | inhal. | 80 | MG | 22,15 | | | 68835 | CROMOLYN | inh cps 50 | ORN | SF | | | | | 90538 | INTAL | cps 30(3x10)x20mg | LEX | CZ | | | | | 455.3 | R03BC01 | kyselina kromoglyková (lékové formy roztoku) | inhal. | 80 | MG | 13,80 | | | | | | | | | | | | 455.4 | R03BC01 | kyselina kromoglyková (lékové formy prášku k insuflaci) | lok. | 40 | MG | 19,55 | | | | | | | | | | | | 455.5 | R03BC03 | nedokromil | inhal. | 8 | MG | 33,20 | L/ALG,TRN | | 455.6 | R03BC01 | kyselina kromoglyková | p.o. | 80 | MG | 6,50 | P |
Diagnózu prokazuje a léčbu indikuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek: při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit.
| 93797 | NALCROM | cps 100x100mg | FIS | GB | | | | | 456 | R03CB | celkově podávaná neselektivní sympatomimetika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 456.1 | R03CA02 | efedrin | p.o. | 50 | MG | 1,45 | | | 00126 | EPHEDRIN SLOVAKOFARMA | tbl 20x25mg | SLO | SK | | | | | 456.2 | R03CB03 | orciprenalin | p.o. | 60 | MG | 6,70 | | | 457 | R03CB | celkově podávaná neselektivní sympatomimetika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 457.1 | R03CA01 | epinefrin | parent. | 0.5 | MG | 3,40 | O | | 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | | | | | 457.2 | R03CA02 | efedrin | parent. | 50 | MG | 5,40 | O | | | | | | | | | | | 457.3 | R03CB03 | orciprenalin | parent. | 0.5 | MG | 5,40 | O | | | | | | | | | | | 457.4 | R03CA01 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 700,00 | P |
Léčivý přípravek obsahující epinefrin v lékových formách autoinjektoru předepisuje alergolog a klinický imunolog u pacientů s anamnézou anafylaktického šoku vyvolaného alergií na hmyz.
| 458 | R03CC | celkově podávaná selektivní sympatomimetika | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 458.1 | R03CC02 | salbutamol (pevné lékové formy) | p.o. | 12 | MG | 4,85 | |
| 91085 | SALBUTAMOL POLFA | tbl 30x4mg | POL | PL | |||
| 458.2 | R03CC02 | salbutamol (tekuté lékové formy) | p.o. | 12 | MG | 13,40 | |
| 458.3 | R03CC03 | terbutalin | p.o. | 15 | MG | 4,80 | |
| 458.4 | R03CC05 | hexoprenalin | p.o. | 1.5 | MG | 4,80 | |
| 458.5 | R03CC08 | prokaterol (pevné lékové formy) | p.o. | 0.1 | MG | 5,05 | |
| 458.6 | R03CC08 | prokaterol (tekuté lékové formy) | p.o. | 0.1 | MG | 18,30 | |
| 458.7 | R03CC13 | klenbuterol (pevné lékové formy) | p.o. | 0.04 | MG | 6,85 | |
| 458.8 | R03CC13 | klenbuterol (tekuté lékové formy) | p.o. | 0.04 | MG | 34,55 | |
| 459 | R03CC | celkově podávaná selektivní sympatomimetika | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 459.1 | R03CC03 | terbutalin | parent. | 0.5 | MG | 17,30 | O |
| 80134 | BRICANYL | inj 10x1ml/0.5mg | EGI | H | |||
| 459.2 | R03CC05 | hexoprenalin | parent. | 5 | RG | 16,45 | O |
| 460 | R03D | ostatní antiastmatika k celkovému podání | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 460.1 | R03DA04 | teofylin | p.o. | 0.4 | GM | 4,70 | |
| 460.2 | R03DA05 | aminofylin | p.o. | 0.6 | GM | 6,00 | |
| 00316 | SYNTOPHYLLIN | drg 50x100mg | SLO | SK | |||
| 460.3 | R03DA05 | aminofylin (retardované lékové formy do 150 mg včetně) | p.o. | 0.6 | GM | 11,15 | |
| 97502 | EUPHYLLIN CR 150 | cps 50x150mg | CCS | CZ | |||
| 460.4 | R03DA05 | aminofylin (retardované lékové formy od 150 do 250 mg včetně) | p.o. | 0.6 | GM | 8,35 | |
| 97503 | EUPHYLLIN CR 250 | cps 50x250mg | CCS | CZ | |||
| 460.5 | R03DA05 | aminofylin (retardované lékové formy nad 250 mg) | p.o. | 0.6 | GM | 6,00 | |
| 91741 | AMINOPHYLLINUM RETARD | tbl ret 20x350mg | LEK | SLO | |||
| 460.6 | R03DC01 | zafirlukast | p.o. | 40 | MG | 49,70 | Z |
| 461 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | p.rect. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 461.1 | R03DA05 | aminofylin | p.rect. | 0.6 | GM | 6,50 | |
| 03353 | SYNTOPHYLLIN | sup 10 (neo) | LEC | CZ | |||
| 462 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 462.1 | R03DA05 | aminofylin | parent. | 0.6 | GM | 28,20 | O |
| 00610 | SYNTOPHYLLIN | inj 5x10ml/240mg | HBS | SK | |||
| 463 | R05CB | mukolytika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 463.1 | R05CB | prednoxdiazin | p.o. | 300 | MG | 2,00 | |
| 463.2 | R05CB01 | acetylcystein | p.o. | 0.5 | GM | 7,40 | |
| 83632 | ACC 200 | cps 50x200mg | HEX | D | |||
| 83633 | ACC 200 | cps 100x200mg | HEX | D | |||
| 83467 | ACC LONG | tbl eff 10x600mg | HEX | D | |||
| 83634 | ACC LONG | tbl eff 20x600mg | HEX | D | |||
| 83635 | ACC LONG | tbl eff 50x600mg | HEX | D | |||
| 83636 | ACC LONG | tbl eff 100x600mg | HEX | D | |||
| 72949 | ACETYLCYSTEIN AL 200 | tbl eff 50x200mg | APA | D | |||
| 72950 | ACETYLCYSTEIN AL 600 | tbl eff 10x600mg | APA | D | |||
| 72951 | ACETYLCYSTEIN AL 600 | tbl eff 20x600mg | APA | D | |||
| 72952 | ACETYLCYSTEIN AL 600 | tbl eff 50x600mg | APA | D | |||
| 463.3 | R05CB02 | bromhexin (pevné lékové formy) | p.o. | 24 | MG | 2,00 | |
| 463.4 | R05CB02 | bromhexin (tekuté lékové formy) | p.o. | 24 | MG | 3,30 | |
| 463.5 | R05CB03 | karbocystein (pevné lékové formy) | p.o. | 1.5 | GM | 15,25 | |
| 463.6 | R05CB03 | karbocystein (tekuté lékové formy) | p.o. | 1.5 | GM | 21,90 | |
| 463.7 | R05CB06 | ambroxol (pevné lékové formy) | p.o. | 0.15 | GM | 8,00 | |
| 463.8 | R05CB06 | ambroxol (tekuté lékové formy) | p.o. | 0.15 | GM | 12,35 | |
| 464 | R05CB | mukolytika | inhal. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu alfadornázou ordinuje specializované pracoviště zajištující péči o pacienty s cystickou fibrózou, při zajištění dobré spolupráce pacienta:
- a) při nedostatečné účinnosti inhalačních mukolytik nebo amiloridu,
- b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.
| 464.1 | R05CB01 | acetylcystein | inhal. | 1.6 | GM | 50,60 | |
|---|---|---|---|---|---|---|---|
| 464.2 | R05CB02 | bromhexin | inhal. | 24 | MG | 3,55 | |
| 464.3 | R05CB05 | mesna | inhal. | 600 | MG | 43,80 | |
| 03614 | MISTABRON | sol 6x3ml/600mg | UCB | B | |||
| 464.4 | R05CB13 | alfadornáza | inhal. | 2.5 | MG | 1225,05 | P |
| 465 | R05CB | mukolytika | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 465.1 | R05CB01 | acetylcystein | parent. | 0.5 | GM | 6,35 | |
| 02206 | BRONCHOLYSIN | inj 5x5ml/1gm | LEX | CZ | |||
| 465.2 | R05CB02 | bromhexin | parent. | 24 | MG | 41,30 | |
| 465.3 | R05CB06 | ambroxol | parent. | 0.15 | GM | 231,20 | |
| 465.4 | R05CA03 | guaifenesin | parent. | 0.9 | GM | 16,95 | |
| 465.5 | R05CB06 | ambroxol (koncentrát k infuzi) | parent. | 1 | DF | 351,70 | H |
| 466 | R05DA | antitusika ze skupiny derivátů opioidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 466.1 | R05DA01 | ethylmorfin | p.o. | 50 | MG | 9,80 | |
| 466.2 | R05DA04 | kodein | p.o. | 0.1 | GM | 10,60 | |
| 00088 | CODEIN SLOVAKOFARMA | tbl 10x15mg | SLO | SK | |||
| 00090 | CODEIN SLOVAKOFARMA | tbl 10x30mg | SLO | SK | |||
| 56992 | CODEIN SLOVAKOFARMA 15MG | tbl 10x15mg-blistr | SLO | SK | |||
| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | SLO | SK | |||
| 466.3 | R05DA08 | folkodin | p.o. | 50 | MG | 3,75 | |
| 466.4 | R05DA09 | dextromethorp-han | p.o. | 90 | MG | 3,75 | |
| 466.5 | R05DA20 | kombinace antitusik | p.o. | 3 | DF | 3,75 | |
| 467 | R05DB | antitusika chemicky blízká lokálním anestetikům | p.o., p.rect., parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 467.1 | R05DB | dropropizin | p.o. | 25 | MG | 1,80 | |
| 467.2 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25 | MG | 5,95 | |
| 66846 | SINECOD 50MG DEPOT | tbl obd 10x50mg | ZYM | CH | |||
| 467.3 | R05DB13 | butamirát (tekuté lékové formy) | p.o. | 25 | MG | 9,00 | |
| 94859 | TUSSIN | gtt 1x10ml | GNO | CZ | |||
| 467.4 | R05DB03 | klobutinol | parent. | 120 | MG | 114,60 | H |
| 467.5 | R05DB05 | pentoxyverin (do 8 mg v jednom čípku včetně) | p.rect. | 100 | MG | 149,80 | L/PDD |
| 467.6 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100 | MG | 68,20 | L/PDD |
| 468 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 468.1 | R06AA | embramin | p.o. | 50 | MG | 1,35 | |
| 468.2 | R06AA02 | difenhydramin | p.o. | 0.2 | GM | 9,50 | |
| 468.3 | R06AA04 | klemastin | p.o. | 2 | MG | 7,90 | |
| 02005 | TAVEGYL | tbl 20x1mg | SAN | CH | |||
| 468.4 | R06AA07 | difenylpyralin | p.o. | 10 | MG | 7,90 | |
| 468.5 | R06AA52 | difenhydramin, kombinace | p.o. | 0.2 | GM | 9,50 | |
| 469 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 469.1 | R06AA04 | klemastin | parent. | 2 | MG | 33,55 | O |
| 02559 | TAVEGYL | inj 5x2ml/2mg | SAN | CH | |||
| 470 | R06AB | antihistaminika ze skupiny derivátů alkylaminů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 470.1 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4 | MG | 8,70 | |
| 60135 | FENISTIL RETARD | tbl ret 20x2.5mg | ZYM | CH | |||
| 470.2 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4 | MG | 9,50 | |
| 470.3 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2 | DF | 8,70 | |
| 471 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 471.1 | R06AD02 | prometazin (pevné lékové formy) | p.o. | 25 | MG | 4,95 | |
| 00276 | PROTHAZIN | drg 20x25mg | RPG | D | |||
| 471.2 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25 | MG | 9,50 | |
| 471.3 | R06AD03 | thiethylperazin | p.o. | 13 | MG | 4,65 | |
| 471.4 | R06AD03 | thiethylperazin | p.rect. | 13 | MG | 23,70 | |
| 472 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 472.1 | R06AD02 | prometazin | parent. | 25 | MG | 7,15 | O |
| 87916 | PHENERGAN | inj 5x2ml/50mg | SPC | F | |||
| 472.2 | R06AD03 | thiethylperazin | parent. | 13 | MG | 28,40 | O |
| 473 | R06AX | jiná antihistaminika k systémovému použití | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 473.1 | R06AE06 | oxatomid | p.o. | 60 | MG | 7,20 | |
| 473.2 | R06AE07 | cetirizin (pevné lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.3 | R06AE07 | cetirizin (tekuté lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.4 | R06AE07 | kombinace antihistaminik | p.o. | 2 | DF | 1,10 | |
| 473.5 | R06AX | bisulepin | p.o. | 4 | MG | 3,40 | |
| 02479 | DITHIADEN | tbl 20x2mg | LEX | CZ | |||
| 473.6 | R06AX01 | bamipin | p.o. | 0.1 | GM | 6,20 | |
| 473.7 | R06AX02 | cyproheptadin (pevné lékové formy) | p.o. | 12 | MG | 6,20 | |
| 473.8 | R06AX02 | cyproheptadin (tekuté lékové formy) | p.o. | 12 | MG | 9,50 | |
| 473.9 | R06AX09 | azatadin | p.o. | 2 | MG | 6,20 | |
| 473.10 | R06AX11 | astemizol (pevné lékové formy) | p.o. | 10 | MG | 8,00 | |
| 473.11 | R06AX11 | astemizol (tekuté lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.12 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 8,00 | |
| 473.13 | R06AX13 | loratadin (pevné lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.14 | R06AX13 | loratadin (tekuté lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.15 | R06AX17 | ketotifen (pevné lékové formy) | p.o. | 2 | MG | 8,00 | |
| 473.16 | R06AX17 | ketotifen (tekuté lékové formy) | p.o. | 2 | MG | 9,50 | |
| 473.17 | R06AX18 | akrivastin | p.o. | 24 | MG | 8,00 | |
| 473.18 | R06AX25 | mizolastin | p.o. | 10 | MG | 9,50 | |
| 474 | R06AX | jiná antihistaminika k systémovému použití | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 474.1 | R06AX | bisulepin | parent. | 4 | MG | 25,70 | O |
| 04071 | DITHIADEN | inj 10x2ml/1mg | LEX | CZ | |||
| 474.2 | R06AX | medosulepin/ vápník | parent. | 2 | DF | 31,50 | O |
| 475 | R07AA | plicní surfaktanty | parent. | T | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 475.1 | R07AA01 | kolfosceril palmitát | parent. | 108 | MG | 13638,10 | T |
| 475.2 | R07AA02 | přirozené fosfolipidy (telecího původu) | parent. | 1 | DF | 13638,10 | T |
| 475.3 | R07AA02 | přirozené fosfolipidy (vepřového původu) | parent. | 160 | MG | 20548,15 | T |
| 87226 | CUROSURF | sus 2x1.5ml/120mg | CHS | I | |||
| 476 | S01AA | antibiotika k lokálnímu podání | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 476.1 | S01AA | azidamfenikol | lok. | 1 | ML | 2,85 | |
| 90770 | OPHTHALMO-AZAPHENICOL | gtt oph 1x10ml | GNO | CZ | |||
| 476.2 | S01AA | neomycin/ bacitracin/ hydrokortison | lok. | 1 | GM | 5,50 | |
| 476.3 | S01AA | neomycin/ polymyxin/ fenylefrin | lok. | 1 | ML | 21,10 | |
| 476.4 | S01AA | polymyxin/ neomycin/ gramicidin | lok. | 1 | ML | 21,10 | |
| 476.5 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1 | ML | 2,85 | |
| 476.6 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1 | GM | 4,55 | |
| 476.7 | S01AA11 | gentamicin | lok. | 1 | ML | 2,85 | |
| 476.8 | S01AA12 | tobramycin (lékové formy očních kapek) | lok. | 1 | ML | 2,85 | |
| 476.9 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1 | GM | 2,85 | |
| 476.10 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1 | ML | 2,85 | |
| 476.11 | S01AA30 | neomycin/ bacitracin | lok. | 1 | GM | 5,00 | |
| 477 | S01AB | chemoteraputika k lokálnímu podání | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 477.1 | S01AB | sulfathiazol | lok. | 1 | GM | 3,50 | |
| 477.2 | S01AB04 | sulfacetamid | lok. | 1 | ML | 6,35 | |
| 93577 | SULPHACETAMID | gtt oph 12x0.5ml | POL | PL | |||
| 478 | S01AD | antivirotika k lokálnímu podání | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 478.1 | S01AD02 | trifluorothimidin | lok. | 1 | GM | 93,00 | L/OPH |
| 478.2 | S01AD03 | acyklovir | lok. | 1 | GM | 93,00 | L/OPH |
| 478.3 | S01AD04 | trifluorothimidin (lékové formy očních kapek) | lok. | 1 | ML | 62,15 | L/OPH |
| 65513 | TRIHERPINE | gtt oph 1x5ml | CBV | CH | |||
| 479 | S01AX | ostatní antiinfektiva | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 479.1 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 1,80 | |
| 00802 | OPHTHALMO-SEPTONEX | gtt oph 1x10ml | GNO | CZ | |||
| 479.2 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 3,95 | |
| 00876 | OPHTHALMO-SEPTONEX | ung oph 1x5gm | LEX | CZ | |||
| 479.3 | S01AX13 | ciprofloxacin | lok. | 1 | ML | 39,15 | L/OPH |
| 480 | S01BA | kortikosteroidy k lokálnímu podání | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 480.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3,05 | |
| 93718 | DEXAMETHASONE POLFA | sus oph 10ml 0.1% | POL | PL | |||
| 480.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1 | GM | 3,70 | |
| 480.3 | S01BA02 | hydrokortison | lok. | 1 | GM | 4,95 | |
| 480.4 | S01BA03 | kortison | lok. | 1 | ML | 21,10 | |
| 480.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1 | ML | 21,10 | |
| 480.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1 | GM | 21,10 | |
| 480.7 | S01BA07 | fluorometholon | lok. | 1 | ML | 21,10 | |
| 481 | S01BC | nesteroidní protizánětlivá léčiva k lokálnímu podání | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 481.1 | S01BC | alkylazuleny | lok. | 1 | GM | 3,55 | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm | LEX | CZ | |||
| 481.2 | S01BC02 | oxyfenbutazon | lok. | 1 | GM | 15,00 | |
| 481.3 | S01BC03 | diklofenak | lok. | 1 | ML | 48,90 | L/OPH |
| 481.4 | S01BC04 | flurbiprofen | lok. | 1 | ML | 48,90 | L/OPH |
| 482 | S01CA | kortikosteroidy a antiinfektiva k lokálnímu podání | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 482.1 | S01CA | chloramfenikol/ dexamethason | lok. | 1 | ML | 21,10 | L/OPH |
| 482.2 | S01CA | gentamicin/ betamethason (lékové formy očních kapek) | lok. | 1 | ML | 12,50 | L/OPH,ORL |
| 91712 | GARASONE | gtt oph 1x5ml | SCH | B | |||
| 482.3 | S01CA | gentamicin/ betamethason (lékové formy očních mastí) | lok. | 1 | GM | 15,90 | L/OPH,ORL |
| 91711 | GARASONE | ung oph 1x5gm | SCH | B | |||
| 482.4 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních kapek) | lok. | 1 | ML | 21,10 | L/OPH |
| 482.5 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních mastí) | lok. | 1 | GM | 21,10 | L/OPH |
| 482.6 | S01CA01 | oxytetracyklin/ dexamethason | lok. | 1 | GM | 21,10 | L/OPH |
| 482.7 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 21,10 | L/OPH |
| 482.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 21,10 | L/OPH |
| 482.9 | S01CA07 | fluorometolon a antiinfektiva | lok. | 1 | ML | 21,10 | L/OPH |
| 482.10 | S01CA07 | fluorometolon a antiinfektiva | lok. | 1 | GM | 21,10 | L/OPH |
| 483 | S01EA | lokální sympatomimetika k léčbě glaukómu | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 483.1 | S01EA01 | epinefrin | lok. | 0.2 | ML | 6,00 | L/OPH |
| 09108 | GLAUCON 2% | gtt oph 1x10ml 2% | ALC | USA | |||
| 483.2 | S01EA02 | dipivefrin | lok. | 0.2 | ML | 6,50 | L/OPH |
| 483.3 | S01EA04 | klonidin | lok. | 1 | ML | 13,10 | L/OPH |
| 484 | S01EB | lokální parasympatomimetika k léčbě glaukómu | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 484.1 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1 | GM | 40,00 | |
| 91606 | PILOGEL HS | gel oph 1x5gm | ALC | USA | |||
| 484.2 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1 | ML | 17,05 | |
| 03865 | PILOCARPIN ANKERPHARM 2% | gtt ole oph 1x10ml | ANW | D | |||
| 484.3 | S01EB01 | pilokarpin (lékové formy očních kapek) | lok. | 1 | ML | 11,80 | |
| 04146 | PILOCARPIN ANKERPHARM 2% | gtt oph 1x10ml | ANW | D | |||
| 484.4 | S01EB02 | karbachol (koncentrace do 1% včetně) | lok. | 1 | ML | 9,10 | L/OPH |
| 484.5 | S01EB02 | karbachol (koncentrace od 1 do 1,5% včetně) | lok. | 1 | ML | 6,20 | L/OPH |
| 484.6 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1 | ML | 6,75 | L/OPH |
| 484.7 | S01EB06 | neostigmin | lok. | 1 | ML | 14,20 | L/OPH |
| 485 | S01EC | inhibitory karboanhydrázy k celkovému podání | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 485.1 | S01EC01 | acetazolamid | p.o. | 0.75 | GM | 5,50 | |
| 00113 | DILURAN | tbl 20x250mg | LEX | ||||
| 485.2 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | GM | 30,00 | |
| 485.3 | S01EC02 | diklofenamid | p.o. | 0.1 | GM | 8,40 | |
| 485.4 | S01EC03 | dorzolamid | lok. | 1 | ML | 68,00 | L/OPH |
| 486 | S01ED | lokální beta-blokátory k léčbě glaukómu | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 486.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1 | ML | 16,50 | |
| 93294 | OCUPRES-E | gtt oph 5ml 0.25% | CAD | ||||
| 96021 | OFTENSIN 0.25% | gtt oph 1x5ml | POL | ||||
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | POL | ||||
| 486.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1 | ML | 19,00 | |
| 93293 | OCUPRES-E | gtt oph 5ml 0.50% | CAD | ||||
| 96020 | OFTENSIN 0.5% | gtt oph 1x10ml | POL | ||||
| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | ||||
| 486.3 | S01ED02 | betaxolol | lok. | 1 | ML | 34,00 | L/OPH |
| 486.4 | S01ED03 | levobunolol | lok. | 1 | ML | 34,00 | L/OPH |
| 486.5 | S01ED04 | metipranolol | lok. | 1 | ML | 13,50 | |
| 487 | S01F | mydriatika a cykloplegika | lok. | O/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 487.1 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,90 | O/OPH |
| 487.2 | S01FA06 | tropikamid | lok. | 1 | ML | 10,45 | O/OPH |
| 21155 | MYDRUM | gtt oph 10ml 0.5% | ANW | D | |||
| 487.3 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 41,25 | O/OPH |
| 488 | S01G | dekongestanty a antialergika | lok. | L/OPH,ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 488.1 | S01GA52 | tetryzolin/ antihistaminikum | lok. | 1 | ML | 5,35 | L/OPH,ALG |
| 488.2 | S01GX | antazolin/ tetryzolin | lok. | 1 | ML | 5,35 | L/OPH,ALG |
| 488.3 | S01GX01 | kyselina kromoglyková (lékové formy očních kapek) | lok. | 1 | ML | 6,60 | L/OPH,ALG |
| 68575 | CROMOHEXAL | gtt oph 1x10ml 2% | HEX | D | |||
| 488.4 | S01GX01 | kyselina kromoglyková (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,55 | L/OPH,ALG, ORL |
| 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | |||
| 488.5 | S01GX02 | levokabastin | lok. | 1 | ML | 20,00 | L/OPH,ALG |
| 488.6 | S01GX05 | lodoxamid | lok. | 1 | ML | 20,00 | L/OPH,ALG |
| 489 | S01HA | lokální místní anestetika | lok. | L/OPH | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 1,15 | L/OPH |
| 489.2 | S01HA02 | oxybuprokain | lok. | 1 | ML | 13,80 | L/OPH |
| 66524 | NOVESIN 0.4% | gtt oph 1x10ml | CBV | CH | |||
| 490 | S01 | jiná oftalmologika | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 490.1 | S01XA | tolazolin (koncentrace 10%) | lok. | 1 | GM | 15,25 | L/OPH |
| 490.2 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 2,75 | |
| 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | |||
| 490.3 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1557,45 | Z |
| 491 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | L/ORL | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 491.1 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | ML | 31,90 | L/ORL |
| 491.2 | S03AA03 | polymyxin B | lok. | 1 | ML | 2,50 | L/ORL |
| 02830 | POLYMYXIN B | gtt oto 10ml 100ku | GNO | CZ | |||
| 491.3 | S02BA | kortikosteroidy a antiifektivita v kombinaci | lok. | 1 | GM | 23,45 | L/ORL |
| 492 | V01AA | extrakty alergenů | p.o. | L/ALG | |||
| 492.1 | V01AA | extrakty alergenů (bakteriální, z plísní, nejvyšší koncentrace) | p.o. | 1 | BA | 442,60 | L/ALG |
| 97141 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol 10000pnu 1x9ml | SEV | CZ | |||
| 97144 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98390 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98393 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98396 | H-AL BACT.SEVAC P.O.SMES HCD | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98402 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98405 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98408 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98411 | H-AL BACT.SEVAC P.O.SMES DCD | sol 10000pnu 1x9ml | SEV | CZ | |||
| 492.2 | V01AA | extrakty alergenů (bakteriální, z plísní, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 919,00 | L/ALG |
| 97139 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 97142 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 97145 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98391 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98394 | H-AL BACT.SEVAC P.O.SMES HCD | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98397 | H-AL BACT.SEVAC P.O.SM.PROTIAKN | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98400 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98403 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98406 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98409 | H-AL BACT.SEVAC P.O.SMES DCD | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98454 | H-AL MYCO SEVAC P.O.SMES KANDID | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98460 | H-AL MYCO SEVAC P.O.SM.PL.DOMOV | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98457 | H-AL MYCO SEVAC P.O.SM.PL.VENK. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 492.3 | V01AA | extrakty alergenů (z hmyzu, z roztočů, nejvyšší koncentrace) | p.o. | 1 | BA | 843,00 | L/ALG |
| 98444 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol 5000pnu 1x9ml | SEV | CZ | |||
| 98450 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol 5000pnu 1x9ml | SEV | CZ | |||
| 98453 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol 10000pnu 1x9ml | SEV | CZ | |||
| 492.4 | V01AA | extrakty alergenů (z hmyzu, z roztočů, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 1757,70 | L/ALG |
| 98442 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol od 0.5pnu 6x9ml | SEV | CZ | |||
| 98443 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol od 0.05pnu 6x9 | SEV | CZ | |||
| 98446 | H-AL INS.SEVAC P.O.VOSI EXTR. | sol od 0.05pnu 6x9 | SEV | CZ | |||
| 98448 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol od 0.5pnu 6x9ml | SEV | CZ | |||
| 98449 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol od 0.05pnu 6x9 | SEV | CZ | |||
| 98451 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98452 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol od 1pnu 6x9ml | SEV | CZ | |||
| 492.5 | V01AA | extrakty alergenů (z plísní, individuální alergeny) | p.o. | 1 | BA | 876,00 | L/ALG |
| 492.6 | V01AA | extrakty alergenů (z prachu obohacené, individuální alergeny) | p.o. | 1 | BA | 827,10 | L/ALG |
| 492.7 | V01AA | extrakty alergenů (z prachu, včetně obohacených, nejvyšší koncentrace) | p.o. | 1 | BA | 281,00 | L/ALG |
| 98414 | H-AL DMX SEVAC P.O.BYT.PR.OBOH. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98432 | H-AL DUSTS SEVAC P.O.BYT.PR. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 492.8 | V01AA | extrakty alergenů (z prachu, včetně obohacených, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 997,60 | L/ALG |
| 98412 | H-AL DMX SEVAC P.O.BYT.PR.OBOH. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98413 | H-AL DMX SEVAC P.O.BYT.PR.OBOH. | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98415 | H-AL DMX SEVAC P.O.BYT.PR.+ROZ | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98416 | H-AL DMX SEVAC P.O.BYT.PR.+ROZ | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98430 | H-AL DUSTS SEVAC P.O.BYT.PR. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98431 | H-AL DUSTS SEVAC P.O.BYT.PR. | sol od 1pnu 6x9ml | SEV | CZ | |||
| 492.9 | V01AA | extrakty alergenů (z pylů, nejvyšší koncentrace) | p.o. | 1 | BA | 491,80 | L/ALG |
| 98081 | H-AL POL.SEVAC P.O.POLL.MIXT. | sol od 10pnu 3x9ml | SEV | CZ | |||
| 98465 | H-AL POL.SEVAC P.O.JAR.SM.CASNA | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98468 | H-AL POL.SEVAC P.O.JAR.SM.POZD. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98471 | H-AL POL.SEVAC P.O.PODZ.SM.PYL. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98474 | H-AL POL.SEVAC P.O.POLL.MIXT. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98477 | H-AL POL.SEVAC P.O.SMES TRAV I. | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98480 | H-AL POL.SEVAC P.O.SM.TR.I+BE.P | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98483 | H-AL POL.SEVAC P.O.SM.T.I+SAM.N | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98486 | H-AL POL.SEVAC P.O.SM.T.I+ART.M | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98489 | H-AL POL.SEVAC P.O.ARTEMIS.MIX | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98492 | H-AL POL.SEVAC P.O.SM.T.I+BR+AG | sol 10000pnu 1x9ml | SEV | CZ | |||
| 98495 | H-AL POL.SEVAC P.O.SMES TRAV II | sol 10000pnu 1x9ml | SEV | CZ | |||
| 492.10 | V01AA | extrakty alergenů (z pylů, plná terapeutická dávka pro pacienta a individuální alergeny) | p.o. | 1 | BA | 897,50 | L/ALG |
| 98463 | H-AL POL.SEVAC P.O.JAR.SM.CASNA | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98464 | H-AL POL.SEVAC P.O.JAR.SM.CASNA | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98466 | H-AL POL.SEVAC P.O.JAR.SM.POZD. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98467 | H-AL POL.SEVAC P.O.JAR.SM.POZD. | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98469 | H-AL POL.SEVAC P.O.PODZ.SM.PYL. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98470 | H-AL POL.SEVAC P.O.PODZ.SM.PYL. | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98472 | H-AL POL.SEVAC P.O.POLL.MIXT. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98473 | H-AL POL.SEVAC P.O.POLL.MIXT. | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98475 | H-AL POL.SEVAC P.O.SMES TRAV I. | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98476 | H-AL POL.SEVAC P.O.SMES TRAV I. | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98478 | H-AL POL.SEVAC P.O.SM.TR.I+BE.P | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98479 | H-AL POL.SEVAC P.O.SM.TR.I+BE.P | sol od 1pnu 6x9ml | SEV | CZ | |||
| 98481 | H-AL POL.SEVAC P.O.SM.T.I+SAM.N | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98484 | H-AL POL.SEVAC P.O.SM.T.I+ART.M | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98487 | H-AL POL.SEVAC P.O.ARTEMIS.MIX | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98490 | H-AL POL.SEVAC P.O.SM.T.I+BR+AG | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 98493 | H-AL POL.SEVAC P.O.SMES TRAV II | sol od 0.1pnu 6x9ml | SEV | CZ | |||
| 492.11 | V01AA | extrakty alergenů (standardizované,úvodní dávka) | p.o. | 1 | DF | 75 % | L/ALG |
| 492.12 | V01AA | extrakty alergenů (standardizované,udržovací dávka dávka) | p.o. | 1 | DF | 75 % | L/ALG |
| 493 | V01AA | extrakty alergenů | intrader. | O/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 137,70 | O/ALG |
| 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98514 | D-AL MITES SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98516 | D-AL MITES SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | |||
| 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | |||
| 98523 | D-AL INSECTS SEVAC | inj 5ml od 0.5pnu | USO | CZ | |||
| 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | |||
| 494 | V01AA | extrakty alergenů | PRICK test | O/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 494.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | PRICK test | 1 | BA | 534,50 | O/ALG |
| 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | |||
| 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | |||
| 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | |||
| 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 372,20 | O/ALG |
| 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | |||
| 494.3 | V01AA | extrakty alergenů (diagnostické, souprava) | PRICK test | 1 | BA | 539,50 | O/ALG |
| 494.4 | V01AA | extrakty alergenů (diagnostické, souprava), jinde nezařazené | PRICK test | 1 | BA | 50 % | O/ALG |
| 495 | V01AA | extrakty alergenů | parent. | L/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 495.1 | V01AA | extrakty alergenů (bakteriální indiviuální dle rozpisu lékaře) | parent. | 1 | BA | 982,60 | L/ALG |
| 495.2 | V01AA | extrakty alergenů (bakteriální, z plísní, nejvyšší koncentrace) | parent. | 1 | BA | 580,90 | L/ALG |
| 495.3 | V01AA | extrakty alergenů (bakteriální, z plísní, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 1194,30 | L/ALG |
| 99667 | H-AL BACT.SEVAC INJ.STAPH.AUR. | inj 5x10ml | USO | CZ | |||
| 99670 | H-AL BACT.SEVAC INJ.SMES HCD | inj 5x10ml | USO | CZ | |||
| 99671 | H-AL BACT.SEVAC INJ.SMES HCD | inj 6x10ml | USO | CZ | |||
| 99673 | H-AL BACT.SEVAC INJ.SM.PROTIAKN | inj 5x10ml | USO | CZ | |||
| 99674 | H-AL BACT.SEVAC INJ.SM.PROTIAKN | inj 6x10ml | USO | CZ | |||
| 99676 | H-AL BACT.SEVAC INJ.SMES DCD | inj 5x10ml | USO | CZ | |||
| 99727 | H-AL MYCO SEVAC INJ.SM.KANDIDA | inj 5x10ml | USO | CZ | |||
| 99730 | H-AL MYCO SEVAC INJ.SM.PL.VENK. | inj 5x10ml | USO | CZ | |||
| 99733 | H-AL MYCO SEVAC INJ.SM.PL.DOMOV | inj 5x10ml | USO | CZ | |||
| 495.4 | V01AA | extrakty alergenů (obecné individuální alergeny dle rozpisu lékaře) | parent. | 1 | BA | 927,70 | L/ALG |
| 495.5 | V01AA | extrakty alergenů (z hmyzu, z roztočů, nejvyšší koncentrace) | parent. | 1 | BA | 764,30 | L/ALG |
| 99711 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 1x5000pnu | USO | CZ | |||
| 99714 | H-AL INS.SEVAC INJ.VOSI EXTR. | inj 1x5000pnu | USO | CZ | |||
| 99726 | H-AL MIT.SEVAC INJ.SM.ROZTOCU | inj 1x10000pnu | USO | CZ | |||
| 495.6 | V01AA | extrakty alergenů (z hmyzu, z roztočů, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 1711,30 | L/ALG |
| 99709 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 6x10ml | USO | CZ | |||
| 99710 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 7x10ml | USO | CZ | |||
| 99712 | H-AL INS.SEVAC INJ.VOSI EXTR. | inj 6x10ml | USO | CZ | |||
| 99713 | H-AL INS.SEVAC INJ.VOSI EXTR. | inj 7x10ml | USO | CZ | |||
| 99715 | H-AL INS.SEVAC KOMARI | inj 6x10ml | USO | CZ | |||
| 99716 | H-AL INS.SEVAC KOMARI | inj 7x10ml | USO | CZ | |||
| 99721 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 6x10ml 1:1 | USO | CZ | |||
| 99722 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 7x10ml 1:1 | USO | CZ | |||
| 99724 | H-AL MIT.SEVAC INJ.SM.ROZTOCU | inj 5x10ml | USO | CZ | |||
| 99725 | H-AL MIT.SEVAC INJ.SM.ROZTOCU | inj 6x10ml | USO | CZ | |||
| 99723 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 1x5000pnu 1:1 | USO | CZ | |||
| 495.7 | V01AA | extrakty alergenů (z hmyzu, z roztočů depotní, nejvyšší koncentrace) | parent. | 1 | BA | 1327,70 | L/ALG |
| 99806 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 10000pnu/5ml | SEV | CZ | |||
| 495.8 | V01AA | extrakty alergenů (z hmyzu, z roztočů depotní, ostatní koncentrace) | parent. | 1 | BA | 491,80 | L/ALG |
| 83556 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 100pnu/1ml | SEV | CZ | |||
| 83557 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 1000pnu/3ml | SEV | CZ | |||
| 99804 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 100pnu/3ml | SEV | CZ | |||
| 99805 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 1000pnu/5ml | SEV | CZ | |||
| 495.9 | V01AA | extrakty alergenů (z plísní dle rozpisu lékaře, individuální alergeny) | parent. | 1 | BA | 708,10 | L/ALG |
| 495.10 | V01AA | extrakty alergenů (z prachu, včetně obohacených, nejvyšší koncetrace) | parent. | 1 | BA | 379,40 | L/ALG |
| 99684 | H-AL DMX SEVAC INJ.BPO+ROZT. | inj 10000pnu 1:1 | USO | CZ | |||
| 99696 | H-AL DUSTS SEVAC INJ.BYT.PRACH | inj 1x10000pnu | USO | CZ | |||
| 495.11 | V01AA | extrakty alergenů (z prachu, včetně obohacených, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 997,60 | L/ALG |
| 99679 | H-AL DMX SEVAC INJ.BYT.PR.OBOH. | inj 6x10ml | USO | CZ | |||
| 99680 | H-AL DMX SEVAC INJ.BYT.PR.OBOH. | inj 7x10ml | USO | CZ | |||
| 99681 | H-AL DMX SEVAC INJ.BYT.PR.OBOH. | inj 1x10000pnu | USO | CZ | |||
| 99682 | H-AL DMX SEVAC INJ.BPO+ROZT. | inj 6x10ml 1:1 | USO | CZ | |||
| 99683 | H-AL DMX SEVAC INJ.BPO+ROZT. | inj 7x10ml 1:1 | USO | CZ | |||
| 99694 | H-AL DUSTS SEVAC INJ.BYT.PRACH | inj 6x10ml | USO | CZ | |||
| 99695 | H-AL DUSTS SEVAC INJ.BYT.PRACH | inj 7x10ml | USO | CZ | |||
| 495.12 | V01AA | extrakty alergenů (z prachu, včetně obohacených depotní, nejvyšší koncentrace) | parent. | 1 | BA | 295,10 | L/ALG |
| 99803 | H-AL DMX SEVAC DEP.BYT.PR.OBOH. | inj 10000pnu/5ml | SEV | CZ | |||
| 495.13 | V01AA | extrakty alergenů (z prachu, včetně obohacených depotní, ostatní koncentrace) | parent. | 1 | BA | 42,20 | L/ALG |
| 83552 | H-AL DMX SEVAC DEP.BYT.PR.OBOH. | inj 100pnu/1ml | SEV | CZ | |||
| 83553 | H-AL DMX SEVAC DEP.BYT.PR.OBOH. | inj 1000pnu/3ml | SEV | CZ | |||
| 495.14 | V01AA | extrakty alergenů (z pylů, nejvyšší koncentrace) | parent. | 1 | BA | 445,10 | L/ALG |
| 99755 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 1x10000pnu | USO | CZ | |||
| 99780 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 1x10000pnu | USO | CZ | |||
| 99784 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 1x10000pnu | USO | CZ | |||
| 99788 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 1x10000pnu | USO | CZ | |||
| 99792 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 1x10000pnu | USO | CZ | |||
| 99796 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 1x10000pnu | USO | CZ | |||
| 99800 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 1x10000pnu | USO | CZ | |||
| 495.15 | V01AA | extrakty alergenů (z pylů, udržovací dávka) | parent. | 1 | BA | 43,60 | L/ALG |
| 99756 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 10-100pnu/10ml | USO | CZ | |||
| 495.16 | V01AA | extrakty alergenů (z pylů, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 850,00 | L/ALG |
| 99740 | H-AL POL.SEVAC INJ.JAR.SM.CASNA | inj 5x10ml | USO | CZ | |||
| 99741 | H-AL POL.SEVAC INJ.JAR.SM.CASNA | inj 6x10ml | USO | CZ | |||
| 99742 | H-AL POL.SEVAC INJ.JAR.SM.CASNA | inj 4x10ml | USO | CZ | |||
| 99744 | H-AL POL.SEVAC INJ.JAR.SM.POZDN | inj 5x10ml | USO | CZ | |||
| 99745 | H-AL POL.SEVAC INJ.JAR.SM.POZDN | inj 6x10ml | USO | CZ | |||
| 99746 | H-AL POL.SEVAC INJ.JAR.SM.POZDN | inj 4x10ml | USO | CZ | |||
| 99748 | H-AL POL.SEVAC INJ.PODZ.SM.PYL. | inj 5x10ml | USO | CZ | |||
| 99749 | H-AL POL.SEVAC INJ.PODZ.SM.PYL. | inj 6x10ml | USO | CZ | |||
| 99750 | H-AL POL.SEVAC INJ.PODZ.SM.PYL. | inj 4x10ml | USO | CZ | |||
| 99752 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 3x5ml+2x10ml | USO | CZ | |||
| 99753 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 3x5ml+3x10ml | USO | CZ | |||
| 99754 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 1x5+3x10ml | USO | CZ | |||
| 99773 | H-AL POL.SEVAC INJ.SM.TRAV I | inj 5x10ml | USO | CZ | |||
| 99774 | H-AL POL.SEVAC INJ.SM.TRAV I | inj 6x10ml | USO | CZ | |||
| 99775 | H-AL POL.SEVAC INJ.SM.TRAV I | inj 4x10ml | USO | CZ | |||
| 99777 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 5x10ml | USO | CZ | |||
| 99778 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 6x10ml | USO | CZ | |||
| 99779 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 4x10ml | USO | CZ | |||
| 99781 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 5x10ml | USO | CZ | |||
| 99782 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 6x10ml | USO | CZ | |||
| 99783 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 4x10ml | USO | CZ | |||
| 99785 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 5x10ml | USO | CZ | |||
| 99786 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 6x10ml | USO | CZ | |||
| 99787 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 4x10ml | USO | CZ | |||
| 99789 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 5x10ml | USO | CZ | |||
| 99790 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 6x10ml | USO | CZ | |||
| 99791 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 4x10ml | USO | CZ | |||
| 99793 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 5x10ml | USO | CZ | |||
| 99794 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 6x10ml | USO | CZ | |||
| 99795 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 4x10ml | USO | CZ | |||
| 99797 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 5x10ml | USO | CZ | |||
| 99798 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 6x10ml | USO | CZ | |||
| 99799 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 4x10ml | USO | CZ | |||
| 495.17 | V01AA | extrakty alergenů (z pylů individuální alergeny dle rozpisu lékaře) | parent. | 1 | BA | 513,00 | L/ALG |
| 495.18 | V01AA | extrakty alergenů (z pylů depotní, nejvyšší koncentrace) | parent. | 1 | BA | 434,90 | L/ALG |
| 99812 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 25000pnu/5ml | SEV | CZ | |||
| 99818 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 25000pnu/5ml | SEV | CZ | |||
| 99824 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 25000pnu/5ml | SEV | CZ | |||
| 99830 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 25000pnu/5ml | SEV | CZ | |||
| 495.19 | V01AA | extrakty alergenů (z pylů depotní, ostatní koncentrace) | parent. | 1 | BA | 88,10 | L/ALG |
| 83554 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 250pnu/1ml | SEV | CZ | |||
| 83555 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 2500pnu/3ml | SEV | CZ | |||
| 83558 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 250pnu/1ml | SEV | CZ | |||
| 83559 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 2500pnu/3ml | SEV | CZ | |||
| 83560 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 250pnu/1ml | SEV | CZ | |||
| 83561 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 2500pnu/3ml | SEV | CZ | |||
| 83562 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 250pnu/1ml | SEV | CZ | |||
| 83563 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 2500pnu/3ml | SEV | CZ | |||
| 495.20 | V01AA | extrakty alergenů (standardizované, úvodní dávka) | parent. | 1 | DF | 75 % | L/ALG |
| 495.21 | V01AA | extrakty alergenů (standardizované, údržovací dávka) | parent. | 1 | DF | 75 % | L/ALG |
| 496 | V03A | všechny jiné terapeutické přípravky | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 496.1 | V03A | antistafylokokový fág. lyzát | lok. | 20 | ML | 253,00 | |
| 86170 | STAFAL SEVAC | sus 1x10ml | SEV | CZ | |||
| 497 | V03AB | antidota | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 497.1 | V03AB | deferaxamin | parent. | 1 | GM | 410,20 | K |
| 497.2 | V03AB | trimedoxim + atropin | parent. | plně | K | ||
| 497.3 | V03AB | obedoxim | parent. | plně | K | ||
| 497.4 | V03AB03 | edetáty | parent. | plně | K | ||
| 497.5 | V03AB06 | thiosulfát | parent. | plně | K | ||
| 497.6 | V03AB08 | dusitan sodný | parent. | plně | K | ||
| 497.7 | V03AB14 | protamin | parent. | 1 | ML | 5,55 | K |
| 85787 | PROTAMIN SULFAT 1% GALENIKA | inj 5x5ml/50mg 1% | GLN | YU | |||
| 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 12,10 | K |
| 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 19,90 | K |
| 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,55 | K |
| 497.11 | V03AB24 | digitalisový antitoxin | parent. | 80 | MG | 33477,20 | K |
| 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 795,70 | K |
| 498 | V03AF | antidota užívaná při léčbě cytostatiky | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 498.1 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 139,15 | |
| 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | |||
| 498.2 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 123,80 | |
| 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | |||
| 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | B/ONK,HEM | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 30,55 | B/ONK,HEM |
| 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 50,85 | B/ONK,HEM |
| 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4491,80 | B/ONK,HEM |
| 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 239,60 | B/ONK,HEM |
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj sic 10x10mg | LCM | CZ | |||
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | |||
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj sic 1x25mg | LCM | CZ | |||
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj sic 10x25mg | LCM | CZ | |||
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj 5x5ml/50mg | LCM | CZ | |||
| 500 | V03AK | tkáňová lepidla | lok. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3568,70 | X |
| 87632 | BERIPLAST P-FIBRINOVE LEPIDLO | glu 1x0.5ml | BEH | D | |||
| 87633 | BERIPLAST P-FIBRINOVE LEPIDLO | glu 1x1ml | BEH | D | |||
| 87634 | BERIPLAST P-FIBRINOVE LEPIDLO | glu 1x3ml | BEH | D | |||
| 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | |||
| 90503 | TISSUCOL KIT | kit 1x1ml | IMM | A | |||
| 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | |||
| 90505 | TISSUCOL KIT | kit 1x5ml | IMM | A | |||
| 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 166,00 | X |
| 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | |||
| 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | |||
| 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | K/END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 433,55 | K/END |
| 01359 | METOPIRONE | cps 50x250mg | CGC | CH | |||
| 502 | V04CF | tuberkulinový test | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 502.1 | V04CF01 | tuberkulin | parent. | 0.6 | RG | 202,05 | H |
| 503 | V04CL | testy pro alergické choroby | intrader. | O/ALG | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 503.1 | V04CL | testy pro alergické choroby (diagnostické alergeny) | intrader. | 1 | BA | 207,90 | O/ALG |
| 84296 | D-AL SEVAC PRICK TEST | sol 1x3ml/3000pnu | SEV | CZ | |||
| 84298 | D-AL INSECTS SEVAC PRICK TEST | soi 500pnu vc.+kom. | SEV | CZ | |||
| 84299 | D-AL INSECTS SEVAC PRICK TEST | sol 500pnu vosa | SEV | CZ | |||
| 84302 | D-AL DUSTS SEVAC PRICK TEST | sol 1000pnu | SEV | CZ | |||
| 84303 | D-AL DUSTS SEVAC PRICK TEST | sol red. 1:1 | SEV | CZ | |||
| 84304 | D-AL SEVAC PRICK TEST | sol 1x3ml/30000pnu | SEV | CZ | |||
| 84307 | D-AL MYCO SEVAC PRICK TEST | sol 1000pnu | SEV | CZ | |||
| 84310 | D-AL FOODS SEVAC PRICK TEST | sol red. 1:1 | SEV | CZ | |||
| 503.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1 | BA | 534,50 | L/ALG |
| 69219 | ALK WASSERIG SQ (DIAG.) 100KU/ML | lyo 5x4.5ml+solv. | EAS | A | |||
| 84309 | D-AL FOODS SEVAC PRICK TEST | sol 1000pnu | SEV | CZ | |||
| 504 | V04CX | jiná diagnostika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 1,25 | |
| 91134 | CONTRATIN | gra 60x2gm | IHO | CZ | |||
| 504.2 | V04D | diagnostická radiofarmaceutika (přípravky uvolňující CO2) | p.o. | 1 | DF | 10,00 | |
| 505 | V04CX | jiná diagnostika | intrader. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 130,00 | O |
| 94513 | IMUNOSKINTEST SEVAC I.D. | inj 8x1ml | SEV | CZ | |||
| 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 245,50 | O |
| 90636 | PATENTBLAU V | inj 1x2ml/50mg | BGL | D | |||
| 506 | V04CX | jiná diagnostika | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 506.1 | V04CG03 | histamin | parent. | 10 | MG | 10,30 | O |
| 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5,10 | O |
| 00416 | COFFEINUM NATRIUM BENZ.LECIVA | inj 10x1ml 10% | LEX | CZ | |||
| 506.3 | V04CH01 | inulin | parent. | 5 | GM | 500,55 | O |
| 506.4 | V04CJ02 | protirelin | parent. | 0.2 | MG | 239,30 | O |
| 506.5 | V04CK01 | sekretin | parent. | 29 | RG | 941,00 | O |
| 506.6 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.1 | MG | 230,80 | O |
| 506.7 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.1 | MG | 504,00 | O |
| 506.8 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1 | ML | 35,35 | O |
| 506.9 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1 | ML | 131,35 | O |
| 506.10 | V04CE01 | galaktóza | parent. | 1 | DF | 906,25 | O |
| 507 | V06CA | výživa bez fenylalaninu | p.o. | L/J4 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 507.1 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1 | GM | 8,55 | L/J4 |
| 91926 | LOFENALAC | plv 1x454gm | MJO | USA | |||
| 94078 | SINFEMIX | plv 1x250gm | IMA | SK | |||
| 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 4,15 | L/J4 |
| 88063 | SINFENAL | plv 1x250gm | IMA | SK | |||
| 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,75 | L/J4 |
| 03969 | P-AM | plv 5x400gm | SHS | D | |||
| 90989 | P-AM | plv 1x400gm | SHS | D | |||
| 75662 | P-AM 1 | plv 1x400gm | SHS | D | |||
| 75663 | P-AM 1 | plv 5x400gm | SHS | D | |||
| 75664 | P-AM 2 | plv 1x400gm | SHS | D | |||
| 75665 | P-AM 2 | plv 5x400gm | SHS | D | |||
| 75666 | P-AM 3 | plv 1x400gm | SHS | D | |||
| 75667 | P-AM 3 | plv 5x400gm | SHS | D | |||
| 75668 | P-AM 4 | plv 1x400gm | SHS | D | |||
| 75669 | P-AM 4 | plv 5x400gm | SHS | D | |||
| 83123 | PKU 1 | plv po 2x500gm | MLP | D | |||
| 83124 | PKU 2 | plv po 2x500gm | MLP | D | |||
| 83125 | PKU 3 | plv po 2x500gm | MLP | D | |||
| 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 24,50 | L/J4 |
| 68847 | ANALOG PKU | plv 6x400gm | SGR | GB | |||
| 94414 | ANALOG PKU | plv 1x400gm | SGR | GB | |||
| 53290 | P-AM MATERNAL | plv 6x500mg | SHS | D | |||
| 508 | V06DA | kombinace sacharidy/proteiny/minerály/vitamíny | p.o. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 508.1 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80 | GM | 89,40 | H |
| 508.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 77,05 | H |
| 509 | V06DB | kombinace tuk/sacharidy/proteiny/minerály/vitamíny | p.o. | H | |||
| 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100 | GM | 71,25 | H |
| 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 81,20 | H |
| 510 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | L/J7 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 101,45 | L/J7 |
| 88115 | KETOSTERIL | tbl obd 100 | FRE | D | |||
| 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | L/J11 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 511.1 | V06DE | náhrady mléka obsahující bílkovinu kravského mléka | p.o. | 100 | GM | 26,05 | L/J11 |
| 98301 | ENFALAC PRAEMATURE FORMULA | plv 1x400gm | MJO | NL | |||
| 511.2 | V06DE | náhrady mléka obsahující bílkovinu kravského mléka, s nízkým obsahem laktózy | p.o. | 100 | GM | 30,25 | L/J11 |
| 61450 | NUTRILON LOW-LACTOSE | plv 1x400gm | NUT | NL | |||
| 511.3 | V06DE | náhrady mléka obsahující proteinové hydrolyzáty | p.o. | 100 | GM | 20,00 | L/J11 |
| 511.4 | V06DE | náhrady mléka obsahující proteinové hydrolyzáty, s nízkým obsahem laktózy | p.o. | 100 | GM | 55,00 | L/J11 |
| 512 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | L/J11 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 512.1 | V06D | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100 | GM | 31,75 | L/J11 |
| 75946 | ISOMIL | plv 1x400gm | ABB | USA | |||
| 95183 | PROSOBEE | plv 1x400gm | MJO | NL | |||
| 513 | V06DX | jiné kombinace přípravků pro výživu | p.o. | L/J11 | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 513.1 | V06DX | MCT olej | p.o. | 100 | ML | 115,05 | L/J11 |
| 83535 | MCT OIL | sol 1x946ml | MJO | USA | |||
| 95198 | MCT OIL | sol 1x946ml | BMS | USA | |||
| 514 | V07AB | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 514.1 | V07AB | voda na injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,60 | |
| 00383 | AQUA PRO INJECTIONE BIOTIKA | inj 10x2ml | BTA | SK | |||
| 514.2 | V07AB | voda na injekci (nad 2 do 10 ml v jedné ampuli včetně) parent. | 10 | ML | 3,35 | ||
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml | BTA | SK | |||
| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml | BTA | SK | |||
| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100x10ml | BTA | SK | |||
| 83699 | WATER FOR INJECTION B.P.CORE | inj 50x5ml | CPL | IND | |||
| 83700 | WATER FOR INJECTION B.P.CORE | inj 50x10ml | CPL | IND | |||
| 514.3 | V07AB | voda na injekci nad 10 ml v jedné ampuli nebo lahvi parent. | 100 | ML | 12,45 | ||
| 00657 | AQUA PRO INJECTIONE IMUNA | inf 1x400ml | IMA | SK | |||
| 66642 | AQUA PRO INJECTIONE CIV | sol 1x500ml | CIV | CZ | |||
| 67802 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml | IMA | SK | |||
| 69788 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x300ml | ARD | CZ | |||
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | |||
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x500ml | MVM | CZ | |||
| 89245 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x400ml | ARD | CZ | |||
| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | |||
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml (vak) | MKS | CZ | |||
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml (vak) | MKS | CZ | |||
| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | |||
| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml | IHO | CZ | |||
| 515 | V08A | rozpustné nefrotropní RTG kontrastní látky | p.o. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 515.1 | V08AA05 | kyselina ioxitalamová | p.o. | 10 | ML | 57,45 | K |
| 93497 | TELEBRIX GASTRO | sol 1x100ml | BGL | D | |||
| 515.2 | V08AB04 | iopamidol | p.o. | 10 | ML | 57,45 | K |
| 516 | V08AA | rozpustné nefrotropní hyperosmolární RTG kontrastní látky | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 516.1 | V08A | meglumin amidotrizoát | parent. | 10 | ML | 75,20 | K |
| 516.2 | V08AA03 | iodamid (koncentrace 300 mg I/ml) | parent. | 10 | ML | 42,00 | K |
| 516.3 | V08AA03 | iodamid (koncentrace 380 mg I/ml) | parent. | 10 | ML | 46,00 | K |
| 516.4 | V08AA03 | iodamid (koncentrace 410 mg I/ml) | parent. | 10 | ML | 89,40 | K |
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg I/ml) | parent. | 10 | ML | 43,20 | K |
| 92348 | TELEBRIX N 300 | inj 6x20ml | LEX | CZ | |||
| 516.6 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg I/ml a více) | parent. | 10 | ML | 49,90 | K |
| 92349 | TELEBRIX N 350 | inj 6x20ml | LEX | CZ | |||
| 92350 | TELEBRIX N 380 | inj 6x20ml | LEX | CZ | |||
| 96587 | TELEBRIX N 380 | inj 10x20ml | LEX | CZ | |||
| 517 | V08AB | rozpustné nefrotropní nízkoosmolání RTG kontrastní látky | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Vyšetření iotrolanem ordinuje rentgenolog:
- a) pro intrathekální podání,
- b) v ostatních případech po předchozím schválení revizním lékařem.
| 517.1 | V08AB02 | iohexol (koncentrace 180 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 248,85 | K | | 87801 | OMNIPAQUE 180 | inj 10x10ml | NYI | N | | | | | 87802 | OMNIPAQUE 180 | inj 10x15ml | NYI | N | | | | | 517.2 | V08AB02 | iohexol (koncentrace 240 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 214,70 | K | | 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N | | | | | 87602 | OMNIPAQUE 240 | inj 6x20ml | NYI | N | | | | | 517.3 | V08AB02 | iohexol (koncentrace 240 mg I/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 297,30 | K | | 94219 | OMNIPAQUE 240 | inj 10x10ml | NYI | N | | | | | 517.4 | V08AB02 | iohexol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) parent. | 10 | ML | 165,15 | K | | | 04338 | OMNIPAQUE 240 | inj 10x50ml | NYI | N | | | | | 04339 | OMNIPAQUE 240 | inj 6x200ml | NYI | N | | | | | 517.5 | V08AB02 | iohexol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K | | 04328 | OMNIPAQUE 300 | inj 6x20ml | NYI | N | | | | | 04329 | OMNIPAQUE 300 | inj 25x20ml | NYI | N | | | | | 517.6 | V08AB02 | iohexol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 345,60 | K | | 94220 | OMNIPAQUE 300 | inj 10x10ml | NYI | N | | | | | 517.7 | V08AB02 | iohexol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) parent. | 10 | ML | 192,00 | K | | | 04330 | OMNIPAQUE 300 | inj 10x50ml (sklo) | NYI | N | | | | | 62466 | OMNIPAQUE 300 | inj 10x50ml (pp) | NYI | N | | | | | 87600 | OMNIPAQUE 300 | inj 10x100ml | NYI | N | | | | | 517.8 | V08AB02 | iohexol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 278,85 | K | | 04332 | OMNIPAQUE 350 | inj 6x20ml | NYI | N | | | | | 04333 | OMNIPAQUE 350 | inj 25x20ml | NYI | N | | | | | 517.9 | V08AB02 | iohexol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K | | 87603 | OMNIPAQUE 350 | inj 10x50ml (sklo) | NYI | N | | | | | 62467 | OMNIPAQUE 350 | inj 10x50ml (pp) | NYI | N | | | | | 04335 | OMNIPAQUE 350 | inj 10x100ml | NYI | N | | | | | 75261 | OMNIPAQUE 350 | inj 6x200ml | NYI | N | | | | | 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 255,10 | K | | | | | | | | | | | 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 201,25 | K | | | | | | | | | | | 517.12 | V08AB04 | iopamidol (koncentrace 200 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 261,15 | K | | | | | | | | | | | 517.13 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 322,80 | K | | | | | | | | | | | 517.14 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 200,20 | K | | | | | | | | | | | 517.15 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 182,70 | K | | | | | | | | | | | 517.16 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 394,10 | K | | | | | | | | | | | 517.17 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, od 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 242,20 | K | | | | | | | | | | | 517.18 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 195,00 K | K | | | | | | | | | | | 517.19 | V08AB05 | iopromid (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 K | K | | | | | | | | | | | 517.20 | V08AB05 | iopromid (koncentrace 300 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K | | | | | | | | | | | 517.21 | V08AB05 | iopromid (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 K | K | | | | | | | | | | | 517.22 | V08AB05 | iopromid (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 223,30 K | K | | | | | | | | | | | 517.23 | V08AB06 | iotrolan (koncentrace 240 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 462,70 | K/P | | | | | | | | | | | 517.24 | V08AB06 | iotrolan (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 575,30 | K/P | | | | | | | | | | | 517.25 | V08AB07 | ioversol (koncentrace 160 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 128,65 K | K | | | | | | | | | | | 517.26 | V08AB07 | ioversol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 K | K | | | | | | | | | | | 517.27 | V08AB07 | ioversol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 345,60 | K | | | | | | | | | | | 517.28 | V08AB07 | ioversol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K | | | | | | | | | | | 517.29 | V08AB07 | ioversol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 K | K | | | | | | | | | | | 517.30 | V08AB07 | ioversol (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 201,25 K | K | | | | | | | | | | | 517.31 | V08AB07 | ioversol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 278,85 | K | | | | | | | | | | | 517.32 | V08AB07 | ioversol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 K | K | | | | | | | | | | | 517.33 | V08AB10 | iomeprol (koncentrace 150 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 124,80 K | K | | | | | | | | | | | 517.34 | V08AB10 | iomeprol (koncentrace 200 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 147,65 K | K | | | | | | | | | | | 517.35 | V08AB10 | iomeprol (koncentrace 250 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,55 K | K | | | | | | | | | | | 517.36 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 249,60 | K | | | | | | | | | | | 517.37 | V08AB10 | iomeprol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K | | | | | | | | | | | 517.38 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 278,85 | K | | | | | | | | | | | 517.39 | V08AB10 | iomeprol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K | | | | | | | | | | | 517.40 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 307,80 | K | | | | | | | | | | | 517.41 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 236,75 | K | | 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg I/ml) | parent. | 10 | ML | 75,95 | K | | | | | | | | | | | 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg I/ml) | parent. | 10 | ML | 38,25 | K | | | | | | | | | | | 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 40,25 | K | | 03394 | ENDOBIL PRO INF. I. V. | inf 100ml | BCC | I | | | | | 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 307,60 | K | | | | | | | | | | | 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 448,85 | K | | 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D | | | | | 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 520.1 | V08BA | síran barnatý | p.o. | 100 | GM | 33,35 | K | | 06303 | MICROPAQUE | sus 1x2000ml | GUE | D | | | | | 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I | | | | | 520.2 | V08BA | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 165,55 | K | | | | | | | | | | | 520.3 | V08BA | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 44,40 | K | | 91066 | MICROPAQUE COLON | plv 1x800gm | GUE | D | | | | | 520.4 | V08BA | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 84,10 | K | | 62535 | PRONTOBARIO ESOFAGO | sus 6x250ml (tuba) | BCC | I | | | | | 520.5 | V08BA | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,10 | K | | 06304 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUE | D | | | | | 521 | V08CA | paramagnetické kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | | | | | | | | | | | 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | | | | | | | | | | | 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | | 55822 | OMNISCAN 0.5MMOL/ML | inj 10x5ml | NYI | N | | | | | 78815 | OMNISCAN 0.5MMOL/ML | inj 10x10ml | NYI | N | | | | | 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | | 78816 | OMNISCAN 0.5MMOL/ML | inj 10x15ml | NYI | N | | | | | 78817 | OMNISCAN 0.5MMOL/ML | inj 10x20ml | NYI | N | | | |